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Zusammenfassung 1
1 Zusammenfassung
In den letzten Jahrzehnten wurde ein immenser Fortschritt im Bereich von Gehirn-
Computer-Schnittstellen (brain-computer interfaces; BCIs) erzielt, welche ein neues
Werkzeug zur Wiederherstellung der Mobilität von Patienten darstellen, die unter einer
Lähmung oder einer Amputation leiden. Zu diesem Zweck können die besten Signale zur
Kontrolle von BCIs durch intrakortikal implantierte Elektroden empfangen werden, welche
die größte Fehlerfreiheit, Bewegungsgenauigkeit und Geschwindigkeit aufweisen. Obwohl
bereits Neuroprothesen entwickelt werden konnten, die in den ersten Humanstudien ihre
Funktionalität sogar Jahre nach einer Verletzung des zentralen Nervensystems
demonstrierten, stellt die Biokompatibilität von chronischen Implantaten weiterhin ein
Problem dar. Es ist von enormem Wert und Interesse, die Gewebsreaktion auf diese
chronischen Gehirnimplantate, wie Elektrodenarrays, besser zu verstehen und zu
kontrollieren, um sicher stellen zu können, dass die chronische Elektrodenimplantation in
klinischer Anwendung sicher und vorteilhaft genug ist, das Risiko des operativen Eingriffs in
Kauf zu nehmen.
Die Gewebsreaktion auf ein chronisch verweilendes Gehirnimplantat wird auch als
„Fremdkörperreaktion“ bezeichnet und beinhaltet eine Glianarbenbildung, die von
fortschreitender Neurodegeneration begleitet wird. Beides trägt zu eine inkonsistenten
Leistungsfähigkeit der ableitenden Elektroden bei und führt zu einem Signalverlust der
abgeleiteten elektrischen Potentiale. Die Fremdkörperreaktion kann in eine akute Phase, die
durch das mechanische Trauma der Implantation hervorgerufen wird, und in eine chronische
Phase, aufgrund der anhaltenden inflammatorischen Prozesse an der Schnittstelle, unterteilt
werden. Die akute Immunreaktion ist ein über ein bis drei Wochen andauernder Prozess, der
durch den Zelltod von Neuronen und Gliazellen, sowie durch die Verletzung von Blutgefäßen
gekennzeichnet ist. Dies wiederum führt zur Gewebsinfiltration durch Makrophagen und zu
einer Aktivierung der Mikrogliazellen und Astrozyten. Die chronische Reaktion ist durch
sogenannte „frustrierte Phagozytose“ der Makrophagen und Mikrogliazellen sowie durch
anhaltende Entzündungsprozesse an der Oberfläche des Implantats gekennzeichnet. Diese
wird von reaktiven Astrozyten begleitet, die eine dichte Verkapselungsschicht um das
Implantat formen, um das gesunde Hirngewebe von den anhaltenden
Entzündungsprozessen zu isolieren.
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Der motorische Kortex, der als wesentliches Implantationsziel für BCIs angesehen
wird, ist Teil des Frontallappens und an der Planung, Kontrolle und Ausführung von
willkürlichen Bewegungen beteiligt. Da die Fähigkeit zu gezielter Greifbewegung (skilled
reaching) nach Futter bei Ratte und Mensch ähnlich ist - wahrscheinlich aufgrund eines
gemeinsamen Ursprungs in frühen Tetrapoden - hat sich die Prüfung der gezielten
Greifbewegung zu einem Modellsystem entwickelt, um die Funktionalität des motorischen
Kortex zu untersuchen. Innerhalb des primären motorischen Kortex bei Ratten (M1) kann die
Repräsentation der Zugreifbewegung (grasp) dem rostralen Vorderbein-Areal (rostral
forelimb area; RFA), und die Annäherungsbewegung (reach) dem kaudalen Vorderbein-Areal
(caudal forelimb area; CFA) zugeordnet werden.
Aufgrund der Sensibilität der gezielten Greifbewegung gegenüber kortikaler
motorischer Störungen, wurde in dieser Arbeit davon ausgegangen, dass das Ausmaß der
Glianarbenbildung und des neuronalen Zelltods durch die chronische Fremdkörper-
implantation in das CFA auch auf Verhaltensebene messbar ist. Im Anschluss an eine
reversible Inaktivierungsstudie durch den GABAA-Agonisten Muscimol, um die akuten
Defizite in der gezielten Greifbewegung und die genaue Funktion des CFA bei Ratten
bestimmen zu können, wurde die Kanülenimplantation von lokaler Substanzapplikation
begleitet, um der Fremdkörperreaktion entgegenzuwirken. Unterschiede in der
Fremdkörperreaktion wurden anhand der Verhaltensperformanz der Ratten in einer
Aufgabe zur gezielten Greifbewegung (skilled reaching task), sowie einer Aufgabe zum
gewandten Laufen auf einer Sprossenleiter (skilled walking task) und im Offenfeld (open
field) bestimmt. Darüber hinaus wurde die Verteilung der Neurone und Gliazellen in der
Umgebung des Implantats untersucht. Die Studien dienten als Grundlagenuntersuchung und
ahmen die Implantation eines Elektrodenarrays anhand der Implantation einer Stahlkanüle
in M1 nach. Das Ziel der Arbeit war es, die Fremdkörperreaktion zu reduzieren, indem bei
den frühen Ereignissen nach der Kanülenimplantation angesetzt wurde, um somit die
induzierten Kaskaden von fortschreitendem Zelltod und Gliazellaktivierung zu hemmen.
1.1 Studie 1 (in Brain Research Bulletin, 2015)
In “Suppression of excitotoxicity and foreign body response by memantine in chronic cannula
implantation into the rat brain” wurde beabsichtigt, die exzitotoxische Kaskade des
Glutamat-induzierten Zelltods zu reduzieren, die in der akuten Phase nach
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Fremdkörperimplantation aufgrund der Gewebsverletzung induziert wird. Die Ansammlung
von Glutamat im Extrazellularraum führt zu einer Überstimulierung von Glutamatrezeptoren,
wobei der N-Methyl-D-Aspartat (NMDA)-Rezeptor eine zentrale Rolle beim exzitotoxischen
Zelltod übernimmt. Extrasynaptisch lokalisierte NMDA-Rezeptoren, die eine NR2B-
Untereinheit enthalten (NR2BRs), haben einen entgegengesetzten Effekt zu den synaptisch
lokalisierten NMDA-Rezeptoren, die eine NR2A-Untereinheit enthalten (NR2ARs). Eine
übermäßige Aktivierung des ersten Typs führt zu einer Hemmung von speziellen
Überlebenssignalwegen und exzitotoxischem Zelltod von apoptotischer oder nekrotischer
Natur. Diesen Zelltod-fördernden Effekten kann durch den nicht-kompetitiven Antagonisten
Memantin, der eine geringe Affinität zum Rezeptor hat, bevorzugt offene Kanäle blockiert,
und darüber hinaus eine Präferenz für die extrasynaptisch lokalisierten NR2BRs aufweist,
entgegengewirkt werden.
Beide Memantin-Dosierungen (20 µg/µl; 50 µg/µl), die lokal während der
Kanülenimplantation in das CFA verabreicht wurden, erhöhten im Vergleich zu den
Kontrolltieren die Anzahl überlebender Neurone in der Nähe des Implantats zwei sowie
sechs Wochen nach Implantation beachtlich. Dieser beträchtliche Neuronenanstieg ging mit
einer leichten Abnahme an reaktiven Astrozyten in Implantatnähe einher, die nach sechs
Wochen deutlicher war, ohne jedoch eine Änderung der Mikroglia-/Makrophagenanzahl zu
bewirken. Die Verhaltensperformanz war generell am stärksten bei der gezielten
Greifbewegung beeinträchtigt, mittelmäßig beim gewandten Laufen, und ohne
offensichtliche Beeinträchtigung im Offenfeld. Die Memantingabe führte zu einer schnellen
Wiederherstellung der Verhaltensperformanz, die lediglich in den ersten zwei Wochen leicht
absank.
Schlussfolgernd legen diese Daten nahe, dass es ein wirkungsvoller Ansatz ist, bei den
ganz frühen Ereignissen nach der Implantation einzugreifen und die Kaskaden sekundären
Zelltods durch die glutamaterge Exzitotoxizität zu inhibieren, um die neuronalen Netzwerke
in Implantatnähe zu erhalten.
1.2 Studie 2  (eingereicht bei Behavioural Brain Research, 2015)
“Suppression of the foreign body response and neuroprotection by apyrase and minocycline
in chronic cannula implantation” zielte darauf ab, das Ausmaß der anhaltenden
Gliazellaktivierung und den sich selbst erhaltenden Zyklus von Mikroglia-induziertem Zelltod
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durch das ATP/ADP-hydrolysierende Enzym Apyrase sowie durch das Breitbandantibiotikum
Minocyclin zu reduzieren. Da ATP und sein Metabolit ADP beide in der akuten Phase nach
einer Hirnverletzung freigesetzt werden und ausschlaggebend an der Vermittlung der
Mikroglia-Migration zur Einstichstelle sowie an der astrozytären Kommunikation beteiligt
sind, wurde angenommen, dass Apyrase die Gliazellaktivierung sowie den Mikroglia-
induzierten sekundären Zelltod unterdrückt. Minocyclin kombiniert aufgrund seines breiten
Spektrums an anti-inflammatorischen und anti-apoptotischen Eigenschaften die Ansätze
beider Strategien. Daher wurde angenommen, dass es die Kaskade fortschreitenden Zelltods
hemmt, die durch das initiale Trauma sowie durch die übermäßige Mikrogliazellaktivierung
ausgelöst wird, die ebenfalls zu dem sich selbst erhaltenden Zelltod-Zyklus beiträgt.
Trotz der eher vorübergehenden Verminderung von Mikrogliazellen in Implantatnähe
nach Apyrasegabe (0,3 U/µl), hatte die Neuronenpopulation schnell wieder den
Ausgangswert erreicht, was jedoch nicht automatisch zu einer äquivalenten
Wiederherstellung der Verhaltensperformanz führte. Das Breitbandantibiotikum Minocyclin
(20 µg/µl) mit seinen anti-inflammatorischen und anti-apoptotischen Eigenschaften führte
zu einem Anstieg der Neuronenpopulation in Implantatnähe nach zwei sowie sechs Wochen,
der äquivalent zur gesteigerten Verhaltensperformanz war und von einer Verminderung der
Mikroglia-Anzahl sowie einer vorübergehenden Minderung der Astrozytendichte begleitet
wurde.
Abschließend lässt sich sagen, dass eine Verminderung der Mikroglia-Aktivierung und
des sich selbst erhaltenden Mikroglia-induzierten Zelltod-Zyklus die geringste Wirkung in
Bezug auf die Erhaltung der Integrität neuronaler Netzwerke zeigt, wie aus den
Verhaltensdaten zu erkennen ist, wohingegen die durch Minocyclin kombinierten Ansätze
eine umfassende Verbesserung hervorrufen.
1.3 Fazit
Zusammengefasst legen die vorliegenden Studien nahe, dass es ein wirkungsvoller Ansatz ist,
bei den ganz frühen Ereignissen nach der Implantation einzugreifen und die Kaskaden
sekundären Zelltods durch die glutamaterge Exzitotoxizität zu inhibieren, um die neuronalen
Netzwerke in Implantatnähe zu erhalten. Obwohl die Inhibition der Mikroglia-Antwort und
die damit verbundene Reduktion von pro-inflammatorischen und neurotoxischen Molekülen
zu einem Anstieg der neuronalen Überlebensrate in Implantatsnähe führt, schafft es dieser
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Ansatz, der auf diese zeitlich später eintretende Kaskade abzielt, nicht, die neuronalen
Netzwerke im selben Ausmaß zu erhalten. Die Langzeitergebnisse der Studien betrachtend,
wird die Glianarbenbildung eher weniger durch die lokale Verabreichung von Substanzen
während der Implantation beeinflusst, sondern scheint stattdessen primär ein Resultat der
chronischen Präsenz des Fremdkörpers zu sein.
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2 Abstract
Over the past decades, immense progress has been made in the field of brain-computer
interfaces (BCIs), which provide a new mean to restore mobility in patients suffering from
paralysis or amputations. For this purpose, best signals for BCI control can be recorded by
intracortically implanted electrodes, providing best precision, accuracy and speed. Although
neuroprosthetics have been developed and demonstrated functionality in some first human
trials even years after an injury to the central nervous system (CNS), several hurdles have yet
to be overcome, since the biocompatibility of these chronic brain implants still remains a
major problem. It is of enormous value and interest to better understand and control the
tissue response to chronically implanted devices into the brain, such as an electrode array,
to ensure that chronic electrode implantation in clinical application is safe and beneficial
enough to take the risk of the surgical intervention.
The tissue response to a chronically indwelling implant in the brain is also referred to
as “foreign body response” and involves the formation of a glial scar that is accompanied by
progressive neurodegeneration. Both contributes to inconsistent performance of recording
electrodes and results in a loss of recorded electrical potentials. The foreign body response
can be subdivided into an acute phase that is caused by the mechanical trauma of insertion,
and a chronic phase due to enduring inflammatory processes at the interface. The acute
immune response is a one-to-three week enduring process that is characterised by neuronal
and glial cell injury and the damage of blood vessels, which infiltrates macrophages and
activates microglial cells and astrocytes. The chronic response is characterised by so called
“frustrated phagocytosis” of the macrophages and microglial cells, and persistent
inflammation at the implant surface, accompanied by reactive astrocytes forming a dense
encapsulating layer to separate the healthy tissue from the enduring inflammation.
The motor cortex, which is considered the main target for BCIs, is part of the frontal
lobe and is involved in planning, control and execution of voluntary movements. Since skilled
reaching for food is similar in rats and humans, most probably due to a common origin in
early tetrapods, the skilled reaching task has evolved into a model system to analyse the
functionality of the motor cortex. Within the primary motor cortex of rats (M1), grasping
representation can be assigned to the rostral forelimb area (RFA), while reaching
representation is primarily found in the caudal forelimb area (CFA).
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Due to the sensitivity of the skilled reaching task to motor cortical disturbances, the
impact of glial scar formation and neuronal cell death following the chronic implantation of a
foreign body into the CFA was suggested in this work to be also measurable on the
behavioural level. In this regard, a reversible inactivation study by means of the GABAA
agonist muscimol was initially conducted in order to examine the acute deficits in the skilled
reaching task and the precise function of the CFA in Lister Hooded rats. Subsequently,
cannula implantation was accompanied by local substance administration, in order to
antagonise the foreign body response. Differences in the foreign body response were
evaluated by means of rats’ behavioural performance in a skilled reaching task as well as in a
skilled walking task (rung ladder) and in the open field. Moreover, the distribution of
neurons and glial cells in the vicinity of the implant was immunohistologically assessed. The
studies served as a proof-of-principle investigation mimicking the implantation of a device
such as an electrode array into M1 by means of a steel cannula. The aim of the thesis was to
reduce the foreign body response by interfering with the very early events after cannula
implantation and to thereby inhibit the induced cascades of enduring cell death and glial cell
activation.
2.1 Study 1 (in Brain Research Bulletin, 2015)
In “Suppression of excitotoxicity and foreign body response by memantine in chronic cannula
implantation into the rat brain”, the excitotoxic cascade of glutamate-induced cell death that
is induced in the acute phase after foreign body implantation due to the tissue injury was
intended to be reduced. The accumulation of glutamate in the extracellular space
overstimulates glutamate receptors with N-methyl-D-aspartate (NMDA) receptors playing a
pivotal role in excitotoxic cell death. Extrasynaptically located NR2B subunit containing
NMDA receptors (NR2BRs) have opposing actions to synaptically located NR2A subunit
containing NMDA receptors (NR2ARs), with excessive activation of the first type resulting in
the inhibition of pro-survival pathways and excitotoxic cell death of apoptotic or necrotic
nature. These cell death promoting effects can be counteracted by the uncompetitive, low-
affinity, open-channel blocker memantine, with a preference for extrasynaptically located
NR2BRs over synaptically located NR2ARs.
Both doses of memantine (20 µg/µl; 50 µg/µl) that were locally applied during
cannula implantation into the CFA, considerably increased the number of surviving neurons
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in the vicinity of the implant compared to controls two as well as six weeks after the
implantation. This remarkable increase in neurons was accompanied by a slight decrease in
reactive astrocytes in implant vicinity that was more pronounced at six weeks and no change
in the number of microglial cells/infiltrated macrophages. Behavioural performance was
generally most impaired in the skilled reaching task, with moderate impairments in the
skilled walking task in the first week and no obvious impairments in the open field.
Memantine administration resulted in a quick recovery of the behavioural performance that
was only slightly decreased in the first two weeks.
In conclusion, these data suggest that interfering with the very initial events after
device implantation targeting the cascades of secondary cell death due to glutamate
excitotoxicity seems to be an efficient approach to maintain neuronal networks in the
vicinity of an implant.
2.2 Study 2  (submitted in Behavioural Brain Research, 2015)
In “Suppression of the foreign body response and neuroprotection by apyrase and
minocycline in chronic cannula implantation”, the extent of persistent glial cell activation and
the self-perpetuating cycle of microglial-induced secondary cell death was aimed to be
reduced by means of the ATP/ADP-hydrolysing enzyme apyrase and the broad spectrum
antibiotic minocycline. Since ATP and its metabolite ADP are both released in the acute
phase after brain injury, and are key in mediating the microglial response towards the site of
injury and also in astrocyte communication, apyrase was assumed to reduce the amount of
glial cell activation as well as the microglial-induced secondary cell death. Minocycline
combined the approaches of both strategies due to its broad range of anti-inflammatory and
anti-apoptotic properties and was assumed to inhibit the cascades of enduring cell death
induced by the initial trauma as well as the excessive microglial cell activation that further
contributes to the self-perpetuating cycle of cell death.
Despite a rather temporary decrease of microglial cells in the vicinity of the implant
after apyrase treatment (0.3 U/µl), neuronal populations had quickly recovered close to
baseline levels, which however did not automatically result in an equivalent recovery of
behavioural performance. The broad-spectrum antibiotic minocycline (20 µg/µl), with anti-
inflammatory and anti-apoptotic properties, caused an increase of the neuronal population
in the vicinity of the implant at two as well as six weeks that was equivalent to the increased
Abstract 9
behavioural performance, accompanied by a decreased number of microglial cells and a
temporary decrease in astrocyte density.
In conclusion, aiming to reduce microglial activation and thereby the self-
perpetuating cycle of microglial-induced cell death, was least effective in terms of
maintaining the integrity of neuronal networks as derived from the behavioural
performance. Nevertheless, the combined approaches of minocycline demonstrated overall
improvements.
2.3 Conclusion
Taken together, the present results suggest that interfering with the very initial events after
device implantation targeting the cascades of secondary cell death due to glutamate
excitotoxicity seems to be an efficient approach to maintain neuronal networks in the
vicinity of an implant. Although reducing the microglial response and thereby the degree of
pro-inflammatory and neurotoxic molecules increases the neuronal survival in the vicinity of
an implant, targeting these delayed cascades does not maintain neuronal networks to the
same extent. Moreover, regarding the long-term results, glial scar formation is apparently
rather less influenced by the acute administration of substances during cannula
implantation, but instead seems to be primarily a consequence of the chronic presence of
the foreign body.
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3  General introduction
Over the past decades, growing interest emerged on the chronic implantation of electrodes
into the brain to restore mobility in patients that suffer from paralysis, amputations or from
a motor system or affective disorder (Lebedev and Nicolelis, 2006;Kringelbach et al.,
2007;Hochberg et al., 2012;Jackson, 2012). Research on brain-computer interfaces (BCIs) has
rapidly evolved accompanied by an ongoing debate about the acquisition of
electrophysiological signals from the brain by means of non-invasive or invasive BCIs
(Wolpaw et al., 2000). Signals recorded by electrodes are processed and translated into
commands that reflect the users’ intent. Non-invasive BCIs derive the users’ intent from
scalp-recorded electroencephalographic (EEG) activity, evaluated via sensorimotor cortex
rhythms, slow cortical potentials and P300 evoked potentials. Invasive BCIs record electrical
activity of the brain via intracranially implanted electrodes either from subdural or epidural
electrocorticographic (ECoG) activity or from single unit-based systems implanted into the
brain parenchyma. ECoG signals are derived from sensorimotor rhythms similar to EEG
signals but are much more robust and carry highly specific and anatomically focal
information about cortical processing. Best signals for BCI control are however achieved by
intracortically implanted electrodes that record neuronal action potentials or local field
potentials with multi-electrode single unit recordings providing best precision, accuracy and
speed. Depending on the patients’ insult or disease and actual needs, different device
outputs are required ranging from simple communication via cursor control, over the control
of a motorised wheel chair, to very fine control of a prosthetic limb (Fig. 3.1) (Wolpaw et al.,
2002;Leuthardt et al., 2006;Mak and Wolpaw, 2009). For fine-tuned, real-time control of
artificial devices or of the own limbs it is moreover essential to receive sensory feedback,
which is why long-term solutions include not only electrode recordings from motor cortices,
but also microstimulation of somatosensory cortices by means of brain-computer-brain
interfaces (Nicolelis and Lebedev, 2009).
3.1 Applications of chronic brain implants
3.1.1 Human diseases
BCIs provide a new means to restore mobility and independence in patients suffering from
amputations or paralysis due to spinal cord injury, brainstem stroke, amyotrophic lateral
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sclerosis, cerebral palsy or other disorders that involve the loss of movement control (Mak
and Wolpaw, 2009). Patients with long-standing tetraplegia have already been successfully
implanted with neural interface systems and were able to control complex devices such as a
robotic arm by recording neural signals from the primary motor cortex (M1). Even years
after an injury of the central nervous system (CNS), the application of BCIs has been
demonstrated to be feasible, indicating that M1-neuronal ensemble activity remains
functionally engaged despite subcortical damage of descending motor pathways (Hochberg
et al., 2006;Chadwick et al., 2011;Hochberg et al., 2012).
Fig. 3.1 Schematic representation of electrophysiological signal acquisition and processing from
non-invasive or invasive brain-computer interfaces into device commands. Brain signals are
acquired by electrodes non-invasively from scalp-recorded electroencephalographic (EEG) activity, or
invasively either from subdural or epidural electrocorticographic (ECoG) activity or from single unit-
based systems implanted into the brain parenchyma. Signals are digitised, processed and translated
into device commands ranging from simple to higher levels of control. Sensory feedback improves
the performance by altering electrophysiological signals (Leuthardt et al., 2006).
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Neural interface systems are however not solely intended to restore mobility, but
also to restore sensory information in blind or deaf people by means of sensory neuro-
prostheses. Cochlear implants (Loeb, 1990;Wilson et al., 1991), auditory brain stem implants
(O’Driscoll et al., 2011;Matthies et al., 2014) or midbrain implants (Lenarz et al., 2006) have
been developed as auditory prostheses, as well as visual prostheses that stimulate retinal
neurons, the optic nerve or the visual cortex (Pezaris and Eskandar, 2009).
Electrode implantation is also necessary for deep brain stimulation (DBS), which is of
remarkable therapeutic benefit in disorders such as chronic pain, Parkinson’s disease,
tremor and dystonia. DBS also proved useful for the treatment of affective and related
disorders, including depression, obsessive-compulsive disorder, Tourette’s syndrome,
chronic pain or cluster headache (Kringelbach et al., 2007).
Further potential applications of chronically implanted intracranial electrodes are in
epilepsy to monitor, detect and treat seizures by means of automatic seizure-prediction
algorithms that trigger automatic therapeutic interventions before convulsions and the loss
of consciousness occur (Nicolelis, 2001).
3.1.2 Animal models
In animal models microinjections via chronically implanted stainless steel guide cannulae
(Fig. 3.2) represent a common method in basic research to study transmitter systems and
receptor subtypes as well as drug effects on the behaviour (Krase et al., 1993;Koch et al.,
2000). The contribution of specific brain areas to certain behaviours or diseases by means of
permanent or reversible inactivation of that brain area is a further field of application for
chronic brain implants (Fendt et al., 1994;Koch et al., 1996;Feja et al., 2014). Reversible
inactivation differs from permanent inactivation by permitting an examination of functional
deficits immediately following the tissue inactivation without any “recovery of function”. In
permanent tissue inactivation the animal has to cope with the inactivated tissue
permanently and often develops compensatory strategies, or relies upon secondary cortical
circuits to accomplish the task which makes it more difficult to evaluate the results in
chronic settings. In reversible inactivation experiments no recovery of function takes place
since the inactivation lasts for limited time only (Lomber, 1999). In this work an initial
reversible inactivation study by means of the GABAA agonist muscimol was also conducted in
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order to examine the acute behavioural deficits in a skilled reaching task and the precise
function of the motor cortical area chosen for the follow-up experiments.
Fig. 3.2. Chronic cannula implantation in animal models. Guide cannulae are chronically implanted
by means of stereotactic devices to enable insertion of injection cannulae which are connected to a
microliter syringe via an injection tube. Substances can be precisely injected into specific brain areas,
as depicted here for the caudal forelimb area of the primary motor cortex in Lister Hooded rats on a
schematic drawing from the rat brain atlas (Paxinos and Watson, 1998).
However, chronic cannula implantations used for microinjections are not the only
application of chronic brain implants in animal models. Optical imaging via the insertion of
micro-optical probes into surgically implanted guide tubes works similarly and is a further
field of application that serves to examine brain processing or disease progression by
tracking neurons or gliomas, vasculature structures or microcirculatory speed (Barretto et
al., 2011).
Moreover, BCIs are not only of clinical relevance, but can also contribute to real-time
neurophysiological investigations of neural circuits in behaving animals and to quantification
of physiological changes that take place in learning of sensorimotor and cognitive tasks
(Nicolelis et al., 2003). Electrodes are also in use as biosensors in order to investigate
transmitter release and receptor activity in the absence and presence of pharmacological
Microliter syringe
Injection tube
Guide cannulaInjection cannula
Substance
(http://www.janvier-labs.com)
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agents (Nguyen et al., 2010) and are inevitably required in preclinical basic research for the
application of DBS therapies (Gong et al., 2015).
3.1.3 Obstacles for clinical application
Although there has been immense progress in the field of BCI research and some first human
trials were successful, several hurdles have yet to be overcome. A lot of basic research in
device implantation is still necessary to better understand and control the tissue response to
indwelling devices and to ensure that chronic electrode implantation in clinical application is
safe and beneficial enough to take the risk of the surgical intervention. Besides improving
electrode designs, microelectronics, power management, real-time computational modelling
and robotics, the biocompatibility of the implants remains a major problem for long-term
clinical applications (Nicolelis et al., 2003;Polikov et al., 2005). The tissue response that is
also referred to as “foreign body response” involves the formation of a glial scar around the
implant that is accompanied by progressive neurodegeneration. Both contributes to
inconsistent performance of recording electrodes in humans and results in a loss of recorded
electrical potentials (Polikov et al., 2005).
Previous attempts to minimise the foreign body response examined different
electrode designs and implantation techniques (Edell et al., 1992;Turner et al.,
1999;Szarowski et al., 2003;Nicolelis et al., 2003;Kim et al., 2004;Biran et al., 2005), as well
as different surface coatings with biocompatible (Ignatius et al., 1998;Kam et al., 2002;He et
al., 2006) or immunosuppressant molecules (Maynard et al., 2000;Shain et al., 2003;Kim and
Martin, 2006;He et al., 2007). However, a satisfactory control of the foreign body response is
still not available (Polikov et al., 2005;Griffith and Humphrey, 2006).
3.2 Cells involved in the immune response of the brain
The foreign body response is a protective mechanism by the immune system with different
cell types being involved. The CNS tissue consists of neurons, glial cells (oligodendrocytes,
astrocytes and microglia) and vascular-related tissue. Glial cells are evolutionarily conserved,
existing in similar forms in simple invertebrates as well as in vertebrates such as humans.
The proportion of glial cells to neurons seems to be correlated to the animal’s taxonomical
organisation, with the brain of fruit flies consisting to 25% of glia, of rodents to roughly 65%
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and of humans to about 90% (Allen and Barres, 2009). In post-mortem studies of human
cortices, a glia to neuron ratio of 1.32 and 1.49 for males and females, respectively, has been
observed, with males exhibiting a 28% higher number of cortical glial cells and a 19% higher
number of cortical neurons. For rats, the cortical glia to neuron ratio was suggested to be
slightly higher with about twice as much glial cells compared to neurons. The ratio of the
different types of glial cells was suggested to be about 75% oligodendrocytes, 20%
astrocytes and 5% microglia (Pelvig et al., 2008). The oligodendrocytes in the CNS are the
equivalent of the Schwann cells in the peripheral nervous system (PNS) and provide
mechanical support and electric insulation to neuronal axons. By extending processes
around multiple axons, they are metabolically coupled to neurons and form myelin sheaths
that are essential for saltatory conduction of action potentials (Simons and Nave, 2015).
However, the main effectors in the brain’s immune response are microglia and astrocytes.
3.2.1 Microglia
Microglial cells constitute the resident macrophages of the brain and constantly screen the
brain tissue in their “resting” state for pathologic events. They exhibit a ramified morphology
with highly mobile processes that are continually rebuilt (de novo formation) and retracted
in order to thoroughly scan the environment. The complete brain parenchyma is monitored
every few hours without translocation of microglial cell bodies. This high “resting mobility”
serves as housekeeping function to control the microenvironment and to clear the
parenchyma of metabolic products or deteriorated tissue components (Nimmerjahn et al.,
2005;Hanisch and Kettenmann, 2007). A transformation from their surveillant “resting” state
to an “activated” state takes place in response to disturbances of tissue homeostasis, such as
after microlesions or traumatic injuries as well as in neurodegenerative diseases, stroke or
brain tumors. The mediation of the rapid baseline dynamics of their processes as well as of
injury-induced chemotactic responses necessarily involves the nucleotide adenosine
triphosphate (ATP) (Davalos et al., 2005).
Four distinct morphological phenotypes of microglia can be distinguished according
to their degree of activation: ramified, primed, reactive and amoeboid. Ramified microglial
cells display a small but defined cell body with several highly branched processes that
correspond to resting microglia. Primed microglia cells have fewer higher-order branches
and wider cell bodies and are an intermediate phenotype. Reactive microglia are the next
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level of intermediate phenotypes in the sequence of complete activation with amoeboid-
shaped cell bodies and only few processes that are generally longer than the cell body. Fully
activated amoeboid microglia cells also have the characteristic amoeboid-shaped cell body
and are either devoid of processes or have a few unbranched processes within the length of
the cell body. Microglia can either transform into an intermediate phenotype and return to
the ramified morphology or transform into the amoeboid phenotype along the complete
activation sequence (Torres-Platas et al., 2014).
Activated microglia can be further distinguished according to their functionality into
“classically activated” pro-inflammatory (type-1) microglia or “alternatively activated” anti-
inflammatory (type-2) microglia. Depending on the type and extend of pathological event,
microglia shift from their homeostatic surveillant “resting” state into an “activated” state of
type-1 or type-2 (Kigerl et al., 2009). Upon tiny homeostatic disturbances, such as
microlesions of vessels or tissue, microglia rapidly respond with a directed reorganisation of
processes and the production of neurotrophic factors, like nerve growth factor (NGF), brain
derived neurotrophic factor (BDNF), glial-derived neurotrophic factor (GDNF) and
neurotrophin-3 (NT-3), to support endangered neurons and promote regenerative
processes, which are mediated by anti-inflammatory type-2 microglia (Fig. 3.3) (Hanisch and
Kettenmann, 2007). Under these acute conditions of minor disturbances, microglia cells are
able to limit further damage and restore normal homeostasis, which thus remains largely
unrecognised. However, after stronger insults to the CNS, such as infectious challenges or
significant tissue injury, more drastic changes are triggered in the functional phenotype,
which then surfaces overt symptoms. These stronger insults trigger the transformation of
microglia cells towards the type-1 phenotype that releases pro-inflammatory molecules
including excitatory amino acids, such as glutamate or aspartate, reactive oxygen
intermediates, such as hydrogen peroxide (H2O2) or superoxide anion (O2−), reactive nitrogen
intermediates, such as nitric oxide (NO), and diverse pro-inflammatory cytokines, such as
interleukin-1 (IL-1), IL-6 or tumor necrosis factor alpha (TNFα). Excessive acute, sustained or
maladaptive responses of microglia cause failure of protection and trigger neurotoxic
damaging cascades (Polikov et al., 2005;Hanisch and Kettenmann, 2007).
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Fig. 3.3. Activity states of microglia. Left, “resting” microglia actively scan their environment (1) for
signals released by neurons (2) or pathological events disturbing homeostasis. Perivascular
macrophages (3) also scan for disruption of blood vessels. Middle, tiny microlesions (4) trigger
microglial “activation” into anti-inflammatory type-2 microglial cells that are supported by
neighbouring astrocytes (5). Type-2 microglia release neurotrophic factors (6) in order to support
endangered neurons, which are recognised by a disruption of ongoing communication (7) or by
emission of signals indicating disturbed functions (8). Right, stronger insults trigger microglial
transformation into pro-inflammatory type-1 microglia (9) that actively contribute to neurotoxic
damaging cascades (Hanisch and Kettenmann, 2007).
3.2.2 Astrocytes
Astrocytes are the second cell type involved in the immune response of the brain and
contribute to homeostasis in the healthy brain by removing neurotransmitters from the
synaptic cleft and providing neurons with energy and substrates for neurotransmission. They
exhibit cellular extensions giving them a star-like appearance with end feet abutting capillary
walls serving the transfer of nutrients across the blood-brain-barrier (BBB). Astrocytes
provide mechanical support to neuronal networks and can be subdivided into
protoplasmatic astrocytes in the grey matter associated with cell bodies and synapses and
into fibrous astrocytes in the white matter associated with axons. When activated by an
injury or other pathological event, they transform into a “reactive” phenotype. They
proliferate, migrate to the site of injury and are characterised by hypertrophy and an up-
regulation of their intermediate protein GFAP (glial fibrillary acid protein). Astrocytes
possess many of the same neurotransmitter receptors as neurons, and neurotransmitter
release activates Ca2+-based signalling cascades between astrocytes. They interact and
communicate with neurons by means of feed-back loops and inhibit or enhance the
neuronal activity (Polikov et al., 2005;Allen and Barres, 2009). Astrocytes are coupled by gap
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junctions composed of two connexons (connexin hemichannels), by which they mediate
intercellular transfer of metabolites (e.g. adenosine diphosphate (ADP), glucose and
glutathione), second messengers (e.g. cyclic adenosine monophosphate (cAMP) and inositol
1,4,5-trisphosphate (IP3)) and ions (e.g. Na+, K+ and Ca2+). This formation of a functional
syncytium allows intercellular communication and spatial buffering of ions and metabolites
(Montero and Orellana, 2015).
Far reaching communication via Ca2+-wave propagation has been shown to depend
largely on extracellular release of ATP, which acts as an the intercellular messenger (Guthrie
et al., 1999) via purinergic pore-forming P2X7 receptors (Ballerini et al., 1996;Suadicani et al.,
2006) and to be independent in its propagation from intracellular Ca2+ and IP3 (Wang et al.,
2000). Extracellular ATP binds to purinergic P2 receptors on adjacent cells that can be
subdivided into P2X receptors, a family of ligand-gated ion channels selectively permeable to
Na+, K+ and Ca2+ with seven subtypes, and P2Y receptors, a family of G-protein-coupled
receptors (GPCRs) with eight subtypes. A second class of purinergic receptors are the P1
receptors, a family of GPCRs with four subtypes, that bind the metabolite adenosine (Fields
and Burnstock, 2006;Burnstock, 2008). Binding of extracellular ATP to purinergic P2
receptors on adjacent cells, results in Ca2+ transmembrane influx via the P2X receptor
channel and in cell depolarisation. Moreover, P2Y receptor activation triggers the production
of IP3 via a G-protein-mediated mechanism, which causes the release of Ca2+ from the
endoplasmatic reticulum (Goodenough and Paul, 2003;Fischer et al., 2009). ATP-induced ATP
release from astrocytes is required for the propagation of intercellular Ca2+-signals
(Anderson et al., 2004). Ca2+-wave propagation in astrocytic communication in response to
any kind of pathological event that causes disturbances of the homeostasis is indispensable
of ATP.
Since astrocytes express a large variety of neurotransmitter receptors, they sense
neuronal activity as well as microenvironmental changes. They respond to changes with the
release of ATP as the most important “gliotransmitter” in astrocyte communication, as well
as with the release of further bioactive molecules, such as glutamate, aspartate, adenosine,
GABA or D-serine (Montero and Orellana, 2015). The release of the excitatory amino acids
glutamate and aspartate from astrocytes is also dependent on Ca2+-release from internal
stores (Jeremic et al., 2001) which results in a non-vesicular efflux of glutamate and
aspartate through the pore-forming P2X7 receptor (Duan et al., 2003). However, glutamate
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release can additionally be mediated by reversal of uptake by plasma membrane glutamate
transporters, by volume-regulated anion channel opening induced by cell swelling, by
exchange via cystine-glutamate antiporter or by hemichannels on the cell surface as well as
by Ca2+-dependent vesicular exocytosis (Malarkey and Parpura, 2008). Since ATP release
from astrocytes has also been shown to be evoked by glutamate receptor activation
(Queiroz et al., 1997), there seems to be a positive feedback loop between the release of
glutamate and ATP by astrocytes (Jeremic et al., 2001).
3.3 The foreign body response
The immune response of the brain to a chronically implanted foreign body such as an
electrode array or a cannula can be subdivided into an acute phase that is caused by the
mechanical trauma of insertion and a chronic phase due to enduring inflammatory processes
at the interface (Polikov et al., 2005).
3.3.1 Mechanical trauma of insertion (acute phase)
The acute immune response of the brain is a one to three week process that is initiated by
the mechanical trauma due to device implantation and the release of cellular contents by
injured cells. In the acute phase of the wound healing response, especially resident microglia
and infiltrated macrophages are activated to clear cellular debris and excessive fluid, but also
reactive astrocytes start to insulate the implant and the damaged tissue from the
surrounding healthy tissue (Polikov et al., 2005). In addition to the release of cellular
contents from injured and dying cells, activated microglial cells release neurotoxic and pro-
inflammatory molecules, which causes secondary cell death to neurons and neuronal “die-
back” zones around implants (Biran et al., 2005;Potter et al., 2012). The neuronal cell loss is
accompanied by the formation of a glial scar that occurs faster than re-growth of neuronal
processes (Turner et al., 1999). Within two weeks after implant insertion, the formation of a
loosely organised glial sheath is observed with scattered reactive microglial cells and reactive
astrocytes that extend their processes towards the insertion site up to 500 µm from the
implant (Fig. 3.4A) (Turner et al., 1999;Szarowski et al., 2003).
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Fig. 3.4. Schematic representation of the acute and chronic tissue response following device
implantation. A) The acute tissue response is characterised by neuronal and glial cell injury and the
damage of blood vessels, which infiltrates macrophages and activates microglial cells and astrocytes.
B) The chronic response is characterised by “frustrated phagocytosis” of the microglial cells and
enduring inflammatory processes at the implant surface, accompanied by reactive astrocytes forming
a dense encapsulating layer to separate the healthy tissue from the enduring inflammation (Schwartz
et al., 2006).
3.3.1.1 Glutamate-mediated excitotoxicity
During the insertion of an implant into the brain, neurons and glial cells in the tract are
injured and blood vessels are damaged. The disruption of blood vessels in the implantation
tract impairs the oxygen and glucose supply of neurons, which results in energy-depletion
followed by ionic imbalance. Uncontrolled membrane depolarisation and massive changes in
the concentration gradients of Na+ and K+ across the cell membrane result in a sustained
release of the excitatory amino acid glutamate (Iadecola and Anrather, 2011;Bretón and
Rodríguez, 2012). Glutamate released from neurons is either Ca2+-dependently released
from neuronal vesicles, K+-dependently through swelling-activated anion channels or Na+-
dependently by a reversed operation of glutamate transporters (Rossi et al., 2000).
Moreover, the damage of neurons causes leakage of excitotoxic amounts of glutamate from
necrotic cells, which triggers a cascade of apoptotic and necrotic events (Bonfoco et al.,
1995). The accumulation of glutamate in the extracellular space results in an overstimulation
of glutamate receptors with the N-methyl-D-aspartate (NMDA) receptor playing a key role in
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excitotoxic cell death due to its high permeability for Ca2+ (Lipton and Rosenberg,
1994;Lynch and Guttmann, 2002).
The two major subtypes of NMDA receptors in the adult forebrain are the NR2A
subunit containing receptor (NR2AR) and the NR2B subunit containing receptor (NR2BR).
NR2ARs are primarily located at the synapse and are essential for synaptic transmission and
plasticity with its activation triggering intracellular processes resulting in neuronal survival.
NR2BR are primarily located at extrasynaptic sites and their activation triggers the activation
of downstream cascades that result in neuronal cell death (Hardingham et al., 2002;Lai et al.,
2011;Vizi et al., 2013). Hence, neurotoxicity is not solely mediated by the extent of NMDA
receptor activity and Ca2+-overload per se, but rather by the Ca2+-flow through
extrasynaptically located NR2BRs (Leveille et al., 2008). Although both receptor subtypes
cause Ca2+-increase in the neuron, they activate different intracellular pathways. Synaptic
NR2AR activation triggers the phosphorylation of the extracellular signal-regulated kinase
(ERK) and thereby the activation of the ERK pathway. Subsequent phosphorylation of the
cellular transcription factor cAMP response element-binding protein (CREB) induces the
transcription of genes linked to neuroprotection against apoptotic and excitotoxic insults,
such as the neurotrophin BDNF, which promotes neuronal survival, or activity-regulated
inhibitors of death (AID), that render mitochondria more resistant to stress and toxic insults.
Activation of extracellular NR2BRs has opposing effects and promotes ERK
dephosphorylation and thereby an inhibition of gene transcription by CREB, with the
extrasynaptic ERK “shut-off” signal being dominant over the synaptic “on” signal
(Hardingham and Bading, 2010). This causes a suppression of pro-survival pathways, and
instead triggers the expression of pro-apoptotic proteins (Fig. 3.5) (Ehrnhoefer et al., 2011).
The excessive rise in Ca2+-levels also triggers further processes involved in
neurotoxicity that include the production of excessive amounts of NO, which serves as
substrate for free radical production. NO is produced in neurons by the neuronal nitric oxide
synthase (nNOS) that catalyses the conversion of the amino acid L-arginine to L-citrulline by
oxidative deamination (Burgner et al., 1999). In the healthy brain, NO is involved in synaptic
plasticity and neuronal signalling. However, excessive amounts of NO that are produced by
NMDA receptor overactivation majorly contribute to glutamate-mediated neurotoxicity
(Dawson and Dawson, 1996;Habib and Ali, 2011). High levels of NO induce necrosis due to
cellular energy depletion via the inhibition of cytochrome C oxidase. This inhibition impairs
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the mitochondrial respiratory chain and ATP production via the formation of peroxynitrite
that induces mitochondrial permeability transition resulting in ATP-hydrolysis and via the
formation of reactive oxygen species (ROS) and reactive nitrogen species (RNS) that cause
DNA strand breaks. ATP depletion causes failure of ATP-driven Ca2+- and Na+-pumps and
results in osmotic rupture of the plasma membrane. Since caspase activation is also ATP-
dependent, its depletion prevents apoptosis and usually causes necrosis instead (Brown,
2010).
Fig. 3.5. Glutamate-mediated excitotoxicity. The accumulation of glutamate in the extracellular
space after tissue damage results in an overstimulation of glutamate receptors with opposing actions
of synaptically located NR2A subunit containing N-methyl-D-aspartate (NMDA) receptors and
extrasynaptically located NR2B receptors. Excessive activation and Ca2+-influx into the cells via
extrasynaptic NR2B receptors causes mitochondrial dysfunction and cell death via an overproduction
of reactive oxygen species (ROS), cell membrane rupture and DNA fragmentation. Moreover, NR2B
receptor activation promotes extracellular signal-regulated kinase (ERK) dephosphorylation and
inhibits the transcription factor cAMP response element-binding protein (CREB), which results in the
inhibition of pro-survival pathways and excitotoxic cell death of apoptotic or necrotic nature. These
cell death promoting effects can be counteracted by the low-affinity, open-channel blocker
memantine (from Ehrnhoefer et al., 2011).
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NMDA receptors in neurons have been shown to interact with multi-protein
complexes known as postsynaptic densities (PSDs) that contain several PDZ (postsynaptic
density-95/discs large/zonula occludens-1) protein interaction domains. The most prominent
protein component in the PDZ complex is the protein PSD-95, that contains three PDZ
domains, of which the first two (PDZ1 and PDZ2) interact with the NR2B subunit, that is
linked via these domains to nNOS. Activation and Ca2+-influx into the cells via this receptor
causes binding of the allosteric activator calmodulin to nNOS, which initiates complex
formation of NMDA receptor/PSD-95/nNOS. Under sustained conditions, this leads to the
production of excessive amounts of NO, which serves as substrate for highly free radical
production and is a major component of excitotoxicity (Bretón and Rodríguez, 2012).
Inhibition of PSD-95/nNOS interaction has also proven beneficial in reducing excitotoxic
damage (Zhou and Zhu, 2009;Zhou et al., 2010).
Moreover, the overstimulation of extrasynaptically located NR2BRs and the
concomitant rise in Ca2+-levels causes the activation and overstimulation of proteases,
lipases, phosphatases and endonucleases. Mitochondrial dysfunction, which is a
consequence of the excessive Ca2+-influx, results in the formation of ROS and caspase
activation, cell membrane rupture, cytoskeletal breakdown and DNA fragmentation that also
results in excitotoxic cell death (Bretón and Rodríguez, 2012). The necrotic cells release
further glutamate that spills over to nearby cells that had survived the original trauma. This
causes secondary damage to originally uninjured cells by consecutive depolarisation, cell
swelling, lysis and the further release of cellular contents, including glutamate, into the
parenchyma. This autodestructive cascade of progressive cell death mediated particularly via
extrasynaptically located NR2BR can continue for hours or even days after a severe insult
primarily by necrotic-like mechanisms (Lipton, 2004). Memantine, as an uncompetitive, low-
affinity, open-channel blocker with a preference for extrasynaptically located NR2BRs over
synaptically located NR2ARs, has been shown to be neuroprotective and to inhibit
glutamate-mediated excitotoxicity (Lipton, 2004;Lipton, 2006;Xia et al., 2010).
3.3.1.2 NO and ATP in glial cell activation
The primary damage of brain tissue after insertion of an implant is coupled to the release of
cellular contents that can either directly cause damage to the brain tissue or indirectly via
the activation of pro-inflammatory microglial cells. In addition to the release of cellular
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contents and nNOS activation, several further forms of NOS are up-regulated that produce
large amounts of NO (Conti et al., 2007).
In addition to nNOS, that is immediately up-regulated after cell injury, a second form
of constitutively expressed NOS is up-regulated, which is called endothelial NOS (eNOS)
according to its location in the endothelium of blood vessels (Alderton et al., 2001). Unlike
nNOS, eNOS which is activated by sheer forces has been suggested to have a
neuroprotective role. By promoting vasodilatation, it lowers the blood pressure in the
vessels and maintains local blood flow and nutrients supply. Moreover, it inhibits
microvascular aggregation, adhesion and vasospasm and is suggested to reduce neuronal
cell loss following ischemia. Compared to total brain NOS activity, eNOS contributes to only a
fraction of NO production (Wei et al., 1999;Gewaltig and Kojda, 2002;Conti et al., 2007).
A third form of NOS is the inducible form of NOS (iNOS) that is expressed in all cell
types in response to a pathological event including astrocytes and microglia. This inducible
form synthesises about 100-1000 times more NO than the constitutively expressed enzymes
(Alderton et al., 2001). After the first short toxic peak of NO production by nNOS that is
reached within one hour, there is a second increase of NO in damaged tissue that goes back
to the activation of iNOS. Its activation is induced by pro-inflammatory cytokines within two
hours after an injury and its amount grows progressively for a few days (Conti et al., 2007).
The expression of iNOS is regulated at the transcriptional level and does not require Ca2+ for
its activity. The enduring release of large amounts of NO is not only harmful for surrounding
neurons but has also been demonstrated to be an important chemoattractant for microglial
cells to migrate to the site of injury. However, it has also been shown that NO is only an
effective chemoattractant in the presence of ambient ATP (Dibaj et al., 2010).
An increase in extracellular ATP concentration has been shown to rapidly mediate the
microglial response towards the site of injury (Davalos et al., 2005). Initially released from
the damaged tissue, high levels of ATP persist in the peritraumatic zone for many hours after
an insult, thereby triggering irreversible increases of cytosolic Ca2+ and cell death of even
healthy neurons through purinergic receptor activation with an important role for the P2X7
receptor (Wang et al., 2004). Moreover, the high levels of extracellular ATP also trigger an
increase of Ca2+-levels in astrocytes (Wang et al., 2000), which results in the release of
regenerative ATP from internal pools (Anderson et al., 2004). This ATP-induced ATP release
from astrocytes is not only responsible for far reaching communication via Ca2+-wave
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propagation between astrocytes, but also enhances the directional chemotactic response of
microglial cells (Davalos et al., 2005). Microglial activation is accompanied by the release of
pro-inflammatory cytokines, which further amplifies the immune response resulting in a self-
perpetuating cycle of cell death after a severe insult (Fig. 3.6) (Bianco et al., 2005;Schwartz
and Shechter, 2010). In addition to ATP release, astrocytes also release glutamate in
response to ATP binding, which exacerbates the glutamate-mediated excitotoxicity and
further contributes to neuronal cell loss (Lipton and Rosenberg, 1994;Lynch and Guttmann,
2002). The ATP-induced ATP release from astrocytes is required for the activation and
migration of microglial cells to the site of injury, which exacerbates secondary cell death and
the immune response after severe tissue damage. This microglial activation has been shown
to be reduced by the enzyme apyrase, an ATPase that hydrolyses extracellular ATP and ADP
(Davalos et al., 2005).
Fig. 3.6. Self-perpetuating cycle of cell death. Neuronal damage results in the leakage of excitotoxic
glutamate and adenosine triphosphate (ATP) from injured cells. This induces the activation of
microglial cells (also referred to as reactive microgliosis). The activated microglia phagocytose
neuronal debris while concurrently releasing pro-inflammatory cytokines, such as interleukin (IL)-1,
tumor necrosis factor (TNF) and IL-6, and neurotoxic molecules, such as reactive oxygen species
(ROS), that contribute to a cycle of self-sustaining neurotoxicity involving the loss of surrounding
neurons and the activation of further microglial cells (from Schwartz and Shechter, 2010).
ATP
Glutamate
Self-perpetuating
neurotoxicity
Release of
pro-inflammatory
and neurotoxic
molecules
General introduction 26
3.3.1.3 Self-perpetuating cycle of cell death
The initial activation and migration of microglial cells is beneficial after tiny microlesions in
the protection against infectious agents and the repair of the damaged tissue by means of
producing neurotrophic substances and cell adhesion molecules, which support injured
neurons. Similar, the activation and proliferation of astrocytes helps to separate healthy
from necrotic tissue (Eddleston and Mucke, 1993;Marin and Fernandez, 2010). However,
under severe acute or chronic conditions an overactivation of microglial cells causes
secondary tissue damage due to the release of pro-inflammatory and neurotoxic molecules.
Also the activation of astrocytes that form a barrier hinders neuroregenerative processes,
such as neurite outgrowth, and instead, pushes neuronal cell bodies further away from the
implant surface (Turner et al., 1999;Leach et al., 2010).
The large amounts of cellular contents released after an injury contribute not only
directly to cell damage, but are moreover important chemoattractants for microglial cells.
The activation and migration of microglial cells in response to glutamate (Liu et al., 2009) is
accompanied by a fourfold increase in ATP-release of microglial cells. NO, that has been
demonstrated to be a chemoattractant for microglial cells as long as ambient ATP is
available, induces the immediate attraction of microglial cell processes, followed by cell
migration and subsequent morphological changes to amoeboid-like cells (Dibaj et al., 2010).
In severe acute as well as in chronic conditions, as it is the case for chronic cannula
implantation, microglia become a source of toxic factors due to an overproduction of pro-
inflammatory cytokines and free radicals that evoke a self-perpetuating cycle of
neurotoxicity (Schwartz and Shechter, 2010). Activated microglia cells phagocytose the
debris of dying and dead cells, but concurrently secrete pro-inflammatory cytokines, like IL-
1, IL-6 and TNFα, that contribute to the progressive activation of further microglial cells as
well as of astrocytes. Pro-inflammatory cytokines either stimulate the release of ROS and
RNS from microglial cells or are directly toxic to neurons and oligodendrocytes (Hanisch,
2002). The activation of microglial cells has been shown to be inhibited by the semi-
synthetic, second-generation tetracycline minocycline, an antibiotic with a broad range of
anti-inflammatory and anti-apoptotic properties that reduces the amount of activated glial
cells and thereby inhibits the release of neurotoxic and pro-inflammatory substances (Elewa
et al., 2006).
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3.3.2 Long-term inflammation (chronic phase)
Once the acute immune response subsides, a chronic response is initiated that is
characterised by enduring inflammatory processes at the interface between the implant and
the brain tissue (Fig. 3.4B). In contrast to stab wounds, the chronic foreign body response is
associated with persistent microglial activity around the implant that is accompanied by
neuronal cell loss (Biran et al., 2005). The inability of the microglia and of the infiltrated
macrophages to phagocytose the insoluble foreign body results in a state of “frustrated
phagocytosis” of the microglial cells (Polikov et al., 2005). This state is characterised by the
persistent release of pro-inflammatory and neurotoxic substances that causes microglia-
induced secondary cell death. The loss of neurons around chronic implants does not result
solely from the mechanical trauma of insertion, as no such loss is observed in stab wounds,
but rather in combination with the chronic inflammation at the interface (Biran et al., 2005).
Due to the persistent presence of the insoluble foreign body, the microglia cells
constitutively release neurotoxic substances trying to degrade the implant, thereby evoking
a self-perpetuating cycle of neurotoxicity and ongoing neuron damage (Block et al.,
2007;Schwartz and Shechter, 2010). The activated microglia adhere to the implant surface
and try to degrade the foreign material by secreting lytic enzymes and ROS, as well as pro-
inflammatory cytokines that activate further astrocytes that form a dense, organised sheath
around the implant and push surviving neurons even further away (Leach et al., 2010). For
optimal device function neuronal survival within the first 50 µm surrounding electrodes is
imperative to separate spike amplitudes of neurons (Buzsaki, 2004). The glial sheath
formation is suggested to be complete six weeks after foreign body implantation and to
remain stable thereafter, with reactive microglial cells constituting the first two layers
around the implant and reactive astrocytes extending only 50-100 µm around the insertion
site (Turner et al., 1999;Szarowski et al., 2003).
3.4 Neuronal substrates of skilled reaching
The impact of the inflammatory cascade and secondary cell death following the chronic
implantation of a foreign body into the motor cortex may also be measurable on the
behavioural level. In this regard, cannula implantation into the motor cortex may cause
motor deficits that can be measured by a task that is sensitive enough.
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Since the skilled reaching task has been shown to be very sensitive to disturbances of
the motor cortex, it has evolved into a model system to analyse the functionality of the
motor cortex by means of an elaborated movement scoring system (Alaverdashvili et al.,
2008). The hand shaping movements during skilled reaching for food have been shown to be
similar in rats and humans, and probably share a common origin in early tetrapods. Skilled
forelimb movements seem to derive from food-handling behaviour and are described as
homologous as they occur at the same spatial and temporal sequence (Iwaniuk and
Whishaw, 2000;Sacrey et al., 2009). Different brain regions, such as the corticospinal tract,
the sensorimotor cortex and the caudate-putamen, as well as nigrostriatal dopamine have
been demonstrated to be involved in skilled forelimb movement. Lesions in these brain
regions produce pronounced impairments in the use of the contralateral limb in skilled
motor performance, such as reaching for a food pellet, while relatively sparing unskilled
behaviours, such as walking, grooming, swimming and even holding a food pellet. This has
been suggested to result from a common underlying circuitry that is involved in the control
of independent limb use. This circuitry includes cortical motor areas and their projections to
the striatum, which in turn projects back to the motor cortex via the globus pallidus and the
thalamus. This pathway is considered to be the major route via which the basal ganglia
influence movements. The dopaminergic nigrostriatal projection from the substantia nigra
pars compacta to the dorsal striatum has also been shown to be particularly involved in the
production of movement as a further part of the basal ganglia motor loop. The substantia
nigra pars reticulata, which is also an important output nucleus of the basal ganglia to the
thalamus, moreover has modulatory efferents to the extrapyramidal system that also
contributes to the control of complex movements (Whishaw et al., 1986;Whishaw et al.,
1993). Cortical and subcortical lesions have not only been demonstrated to impair skilled
reaching for a food pellet, but also to impair skilled walking on a rung ladder (Metz and
Whishaw, 2002;Metz and Whishaw, 2009). The forelimb region of the motor cortex has
evolved into an important study target, since it has proven appropriate for the investigation
of neural plasticity and compensation strategies after stroke (Alaverdashvili and Whishaw,
2010), as well as for the investigation of cortical reorganisation of movement representation
and synaptogenesis during motor learning (Kleim et al., 2004). Moreover, it has proven as
interesting target to study strain-related differences in topographical mapping and
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behavioural, physiological and anatomical organisation of the motor system (VandenBerg et
al., 2002;Whishaw et al., 2003).
3.4.1 The motor cortex
The motor cortex, which is considered the main target for BCIs, is part of the frontal lobe and
is involved in planning, control and execution of voluntary movements. In primates and
humans, it can be subdivided into M1, which is the main contributor in the execution of
voluntary movements, the premotor cortex, which is mainly involved in the preparation for
movements and in the spatial and sensory guidance, and the supplementary motor area,
which is involved in the initiation, selection and planning of movements and the
coordination of both body sides. M1, also referred to as Brodmann area 4 in humans, is
located in the dorsal portion of the frontal lobe and works in association with the other
cortical areas to plan and execute movements. Inter- and intrahemispheric connections
between these motor areas ensure their coordination and interaction in the execution of
movements (Roland et al., 1980;Sadato et al., 1997).
The motor cortex in rats can be historically subdivided into a medial agranular zone
(Agm) and a lateral agranular zone (Agl) (Colechio and Alloway, 2009). Moreover,
topographical investigation of the motor cortex by means of intracortical stimulation studies
in rats demonstrated the existence of two separate forelimb areas: a rostral (RFA) and a
caudal forelimb area (CFA) (Neafsey and Sievert, 1982). The RFA is much smaller that the
CFA and is located in the Agm near the frontal pole. It is considered due to its location,
cellular organisation and projections to correspond to the premotor cortex in primates with
some overlap in function with the supplementary motor area. The CFA is larger and begins at
bregma. It is located in the Agl and largely corresponds to M1 of primates with a broader
layer V compared to the Agm and larger and denser distributed cells (Colechio and Alloway,
2009;Deffeyes et al., 2015). Both areas, however, are known to have direct corticospinal
projections, and have recently been demonstrated to exhibit a specialisation and
segregation of complex movement representation. In a detailed topographical investigation
of the forelimb movement representation, the RFA has been shown to primarily elicit
grasping movements, including digit flexion, while the CFA has been found to primarily elicit
reaching movements, including forelimb elevation, advance and retraction (Fig. 3.7). This
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functional and topographical dissociation suggests a conserved homology of independent
grasp and reach circuitries that are also found in primates (Brown and Teskey, 2014).
Fig. 3.7. The rostral (RFA) and the caudal forelimb area (CFA) of the primary motor cortex in rats.
Detailed topography of forelimb movement representation in reach-trained rats was recently derived
from a cortical deactivation study by a reversible cooling technique. Accordingly, grasping
representation, including digit flexion, is primarily localised in the RFA, while reaching
representation, including elevation, advance and retraction is primarily found in the CFA (Brown and
Teskey, 2014).
It has been shown that the size of the cortical representation of the different
forelimb areas can vary between rat strains as well as between different levels of
experience. Quantitative and qualitative differences have been described in reach
movements especially between pigmented and unpigmented strains, with pigmented strains
being most widely used for studies of the neuronal substrates of movements, while
unpigmented rats are most widely used for the study of movement impairments in
neurological diseases. The quality of movements of unpigmented rat strains has been
described to resemble the movement of pigmented rats after motor system injury
(VandenBerg et al., 2002;Whishaw et al., 2003).
3.4.2 Connectivities of the CFA
The CFA of M1 receives most of its cortical input from the ipsilateral primary somatosensory
area (S1), which is important for motor behavioural functions of the forelimbs that strongly
depend on somatosensory feedback. The feedback includes cutaneous input from the skin as
well as kinaesthetic inputs from joints and muscles. The second most cortical input, the CFA
RFA CFA
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receives via callosal connections from homotopic regions in the contralateral M1 that are
important for bilaterally coordinated forelimb movements (Colechio and Alloway, 2009).
Moreover, it has numerous reciprocal connections with the RFA and both regions project to
several common targets which allows them to interact at multiple levels, with a modulatory
influence of the RFA on CFA control of forelimb movements (Rouiller et al., 1993).
Furthermore, the CFA receives projections from the ipsilateral thalamus (Colechio and
Alloway, 2009), carrying cerebellar and basal ganglionic information (Weiler et al., 2008).
The posterior parietal cortex and the claustrum also send a few projections to the CFA
(Colechio and Alloway, 2009).
Major outputs from the CFA include the reciprocal corticocortical connections with
homotopic regions in the contralateral M1 as well as with the RFA, as described above.
Reciprocal connections also exist with the thalamus, with the CFA being mainly
interconnected with the ventromedial thalamic nucleus. Moreover, the CFA sends efferent
projections to the basal ganglia, with a very dense projection to the lateral portion of the
ipsilateral caudate putamen, but also to the substantia nigra and to the subthalamic nucleus.
The red nucleus, tectum, pontine nuclei, inferior olive, brain stem and spinal cord are also
innervated by CFA projections (Rouiller et al., 1993;Weiler et al., 2008). The projections to
the spinal cord are referred to as the corticospinal tract. This tract is the principle motor
system for controlling movements that require skill and flexibility (Martin, 2005).
3.4.3 Cellular organisation of M1
The mature rat motor cortex can be subdivided into the conventional six layers with
approximate thicknesses as estimated for lamina (L) 1 through 6: 210, 230, 180, 190, 520
and 550 µm (Skoglund et al., 1997). Most cortical neurons are excitatory glutamatergic
pyramidal cells (70-80%) which are the projection neurons of the cortex. The remaining
20-30% of cortical neurons are interneurons, that are mostly GABAergic and inhibitory in
nature (Markram et al., 2004). Excitatory glutamatergic pyramidal cells are located in all
layers except in L1. There is an upper-layer circuit from L2/3 to L5A/B that supplies feed-
forward excitation to lower-layer circuits that include corticospinal, corticothalamic,
corticostriatal and other subcortical projections. L5A also projects back to L2/3 representing
local circuits in rodent cortices that also exist within all laminae as intralaminar horizontal
connections (Weiler et al., 2008). Corticospinal neurons, also known as Betz cells in humans,
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are the largest pyramidal cells and are located exclusively in L5B in the motor cortex. They
have a large pyramidal cell body with a single apical dendrite extending toward L1 and
majorly branching within L2/3 with numerous basal dendrites and a very long axon that
constitutes a direct monosynaptic pathway from the cortex to the motor neurons of the
spinal cord (Terashima, 1995;Jara et al., 2014). However, only a fraction of the corticospinal
tract arises from M1 with further input arising from the premotor cortex and the
somatosensory cortex. As the tract courses from the cortex to the spinal cord, most axons
decussate to the contralateral side in the lower brain stem (medullary pyramid) and descend
in the contralateral white matter as the lateral corticospinal tract (Martin 2005). Less than
5% of the axons do not decussate in the medullary pyramid and descend in the ipsilateral
white matter as the ventral corticospinal tract, which is why muscles are largely innervated
by the contralateral side of the cortex (Carmel and Martin, 2014). Therefore, to measure
behavioural deficits that are caused by the chronic implantation of a foreign body into the
motor cortex, the motor performance of the contralateral body side has to be evaluated.
3.5 Aim of the thesis
The aim of this thesis was to further understand and control the foreign body response of
the brain to chronically indwelling devices such as electrodes, which is crucial for the
widespread clinical application of BCIs. For this purpose, the excitotoxic and inflammatory
cascades after cannula implantation in the motor cortex of Lister Hooded rats was further
investigated and intended to be suppressed at a very early stage to promote the survival of
neurons in the vicinity of the implant. The experiments in this work served as a proof-of-
principle investigation to mimic the implantation of a device, such as an electrode array, into
the cortex with all substances being applied during the implantation of the cannula to mimic
the local drug delivery from coated electrodes. Due to the high sensitivity of the skilled
reaching task to motor cortical disturbances, the impact of glial scar formation and neuronal
cell death following the chronic implantation of a foreign body into the CFA was suggested
to be also measurable on the behavioural level in this task. In this regard, a reversible
inactivation study by means of the GABAA agonist muscimol was initially conducted in order
to examine the acute deficits in the skilled reaching task and the precise function of the CFA
in Lister Hooded rats. Subsequently, cannula implantation was accompanied by local
substance administration, in order to antagonise the foreign body response. Regular
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behavioural investigations in the skilled reaching task, in a skilled walking task and in the
open field before and once weekly after cannula implantation, as well as immunohistological
tissue examination in the acute and chronic phase, served to examine the efficacy of the
substances.
Study 1 34
4 Suppression of excitotoxicity and foreign body response by
memantine in chronic cannula implantation into the rat brain
Linda Hayn and Michael Koch
4.1 Abstract
Chronic brain implants are accompanied by a tissue response that causes the loss of neurons
in the vicinity of the implant and the formation of a glial scar that is also referred to as
foreign body response. Despite immense progress in the field of brain-computer interface
(BCI) research the biocompatibility of chronic brain implants remains a primary concern in
device design. Excitotoxic overstimulation of NMDA-receptors by extrasynaptic glutamate
plays a pivotal role in cell death in the acute phase of the tissue response. In this study, we
examined the effect of the uncompetitive NMDA-receptor antagonist memantine locally
applied during cannula implantation in the caudal forelimb area (CFA) of the motor cortex
(M1) in Lister Hooded rats on their behavioural performance in a skilled reaching and a rung-
ladder task as well as in the open field. Moreover, the distribution of neurons and glial cells
in the vicinity of the implant were assessed. Memantine improved the performance in the
behavioural paradigms compared to controls and increased the number of surviving neurons
in the vicinity of the implant even above basal levels accompanied by a reduction in
astrocytic scar formation directly around the implant with no effect on the
microglia/macrophage activation two and six weeks after cannula implantation. These
findings suggest that memantine is a potential therapeutic agent in the acute phase of
chronic foreign body implantation in the motor cortex in terms of increasing the viability of
neurons adjacent to the implant and of improving the behavioural outcome after surgery.
4.2 Introduction
In the last decades, immense progress has been made in the field of BCI research.
Neuroprosthetic devices that restore mobility in patients suffering from paralysis or
amputations have been developed, and moreover, have demonstrated functionality even
years after an injury to the central nervous system (CNS) (Hochberg et al., 2012;Jackson,
2012). Despite this technological progress, the biocompatibility of these chronic brain
implants still remains a major problem and a demanding field of research. Different
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electrode designs as well as implantation techniques have been investigated (Edell et al.,
1992;Turner et al., 1999;Szarowski et al., 2003;Nicolelis et al., 2003;Kim et al., 2004;Biran et
al., 2005), complemented by different surface coatings with biocompatible (Ignatius et al.,
1998;Kam et al., 2002;He et al., 2006) or immunosuppressant molecules (Maynard et al.,
2000;Shain et al., 2003;Kim and Martin, 2006;He et al., 2007). However, a satisfactory
control of the foreign body response that may impair the functioning of the implants is still
not available (Polikov et al., 2005;Griffith and Humphrey, 2006).
The implantation into the brain of a chronically indwelling device, such as an
electrode array, is accompanied by two different phases of tissue response: an acute and a
chronic response (Turner et al., 1999;Szarowski et al., 2003). The acute response is caused by
the rupture of blood vessels in the implantation tract and the damage of neurons and glial
cells (Szarowski et al., 2003;Potter et al., 2012). Similar to stroke, the disruption of blood
vessels in the implantation tract impairs the oxygen and energy supply of neurons which
causes an ionic imbalance that is followed by sustained release of glutamate due to
uncontrolled membrane depolarisation (Iadecola and Anrather, 2011;Bretón and Rodríguez,
2012). Glutamate is suggested to be either Ca2+-dependently released from neuronal
vesicles, K+-dependently through swelling-activated anion channels from astrocytes or Na+-
dependently by a reversed operation of glutamate transporters (Rossi et al., 2000). The
accumulation of glutamate in the extracellular space overstimulates glutamate receptors
with N-methyl-D-aspartate (NMDA) receptors playing a pivotal role in excitotoxic cell death
(Lipton and Rosenberg, 1994;Lynch and Guttmann, 2002). The two major subtypes of NMDA
receptors in the adult forebrain are the NR2A subunit containing receptor that is primarily
located at the synapse activating intracellular processes resulting in neuronal survival, and
the NR2B subunit containing receptor that is primarily located at extrasynaptic sites
activating downstream cascades resulting in neuronal death (Hardingham et al., 2002;Lai et
al., 2011;Vizi et al., 2013). Excessive Ca2+-influx into the cells via extracellular NR2BRs induces
an overproduction of highly reactive free radicals, mitochondrial dysfunction, cell membrane
rupture and DNA fragmentation, which results in excitotoxic cell death of apoptotic or
necrotic nature depending on the severity of the insult (Bretón and Rodríguez, 2012).
Moreover, the injury of neurons causes further leakage of excitotoxic amounts of the amino
acid glutamate, enhancing the cascades of apoptotic and necrotic processes by NMDA
receptor overstimulation. The large amounts of glutamate spill over to nearby cells that had
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survived the original trauma and cause them to depolarise, swell, lyse and to release their
cellular contents into the parenchyma. This autodestructive cascade continues for hours or
even days (Bonfoco et al., 1995;Lipton, 2006). The necrotic brain tissue and the
accumulation of fluid in the acute phase accompanied by the release of early neuronal
“danger signals” like the nucleotide ATP by the injured cells activates microglia cells that
migrate to the site of injury in order to clear the necrotic tissue and to degrade the foreign
body by releasing pro-inflammatory molecules (Davalos et al., 2005;Iadecola and Anrather,
2011). This in turn activates astrocytes that extend their processes towards the implantation
site to separate the healthy tissue from the injured. These early reactive responses of the
glial cells are supposed to be complete about two weeks after the implantation (Turner et
al., 1999;Szarowski et al., 2003). In contrast to stab wounds though, these acute responses
are followed by long-term inflammatory processes around the implant in chronic settings
with microglia cells trying to degrade the foreign body by means of enduring release of
inflammatory mediators (Biran et al., 2005;Potter et al., 2012). About six weeks after the
implantation, the glial scar is highly compact and remains constant in size after this time
point to isolate the healthy brain tissue from the enduring inflammatory processes at the
interface (Turner et al., 1999;Szarowski et al., 2003). For optimal device function of brain
electrodes the survival of neurons within the first 50 μm around the implant is of special
importance (Buzsaki, 2004). However, device implantation followed by the neurotoxic
cascade and the enduring inflammation processes, results in a neuronal “kill zone” around
the implantation site (Edell et al., 1992;Biran et al., 2005), followed by the formation of a
glial scar that pushes the surviving neurons even further away. Moreover, the glial scar
prevents the regrowth of neuronal processes into the implantation site, since this process
takes longer than sheath formation itself (Turner et al., 1999).
The current study serves as a proof-of-principle investigation mimicking the
implantation of a device such as an electrode array into the motor cortex by means of a steel
cannula. We aimed to block the initial steps of the foreign body response and to counteract
the extent of neurotoxicity at the implantation site by a single local application of the
uncompetitive NMDA receptor antagonist memantine. The relatively low-affinity, open-
channel blocker memantine, is the first clinically successful NMDA receptor antagonist that is
used for the treatment of Alzheimer’s disease (Scarpini et al., 2003;Lipton, 2006;Wenk et al.,
2006) and also shows some potential therapeutic benefit in patients with Huntington’s
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disease (Fan and Raymond, 2007) with a more favourable side-effect profile than high
affinity uncompetitive NMDA receptor antagonists (Parsons et al., 1999). The progressive
cell death due to NMDA receptor overactivation gets inhibited by memantine without
affecting the physiological functions at the synapse due to its fast off-rate kinetics (Parsons
et al., 1999;Lipton, 2004) and its preference for extrasynaptically located NR2BRs over
synaptically located NR2ARs (Xia et al., 2010). In the context of this study, memantine
administration during cannula implantation may mimic the local drug delivery from coated
electrodes and is expected to facilitate the survival of neurons in the vicinity of the implant
and to suppress the density of the glial scar. We investigated the skilled reaching
performance of rats based on the behavioural paradigm of Whishaw and colleagues
(Whishaw et al., 1986;Whishaw and Pellis, 1990), the skilled walking performance on a rung
ladder in different conditions (Metz and Whishaw, 2002;Antonow-Schlorke et al., 2013) and
the locomotor behaviour of rats in an open field box before and after the implantation of a
cannula in the caudal forelimb area (CFA) of the motor cortex (M1). Moreover, the spatial
distribution of neurons, and glial cells was immunohistologically analysed at the
implantation site two weeks after cannula implantation when the glial sheath is supposed to
be less organised and extends furthest around the implantation site (acute phase), and six
weeks after implantation when the glial sheath is most densely organised and remains
constant for the duration of the implantation (chronic phase) (Polikov et al., 2005).
4.3 Materials and methods
4.3.1 Animals
A total of 60 naive adult male Lister Hooded rats (Charles River Laboratories, Germany)
weighing 200-220 g were used in this study. Rats were group-housed under standard
conditions in Makrolon cages (type IV) on a 12 h light/dark cycle (lights on at 7:00 a.m.) with
controlled temperature and humidity. All rats received tap water ad libitum and were
restricted to 12 g standard diet rodent chow (Altromin, Germany) per rat per day as soon as
the training started. The experiments were conducted in compliance with the ethical
guidelines of the National Institute of Health for the care and use of laboratory animals for
experiments and were approved by the local animal care committee (Senatorische Behörde,
Bremen, Germany).
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4.3.2 Timeline
The study was designed to assess the effects of acute memantine treatment locally
administered during the implantation of a foreign body in the CFA of M1. Therefore, the rats
were habituated and individually trained in the single-pellet boxes (Whishaw et al.,
1986;Whishaw and Pellis, 1990) at least four weeks before the experiments started. After
reaching a stable baseline of at least 75 % the rats were pseudo-randomly assigned to six
groups, receiving either artificial cerebrospinal fluid (aCSF) which served as the control or
memantine in a low dose (20 µg/µl) or in a high dose (50 µg/µl). Brains were removed for
histological analysis either two or six weeks after cannula implantation. All animals were
tested in the single-pellet reaching box and in the open field the day before cannula
implantation and once a week after the implantation. Moreover, the 2-week group was
tested on a ladder rung walking task for further analysis of the rats’ skilled walking ability
and received one week of previous training.
4.3.3 Single-pellet reaching task
The single-pellet reaching task was chosen to define the preferred forepaw of each rat and
to analyse the functionality of the motor cortex contralateral to this paw before and after
cannula implantation.
4.3.3.1 Single-pellet reaching boxes
The single-pellet boxes (Fig. 4.1A) were made of clear polycarbonate (40.0 cm long x 14.0 cm
wide x 31.0 cm high) with a vertical slot at the centre of the front wall, 1 cm wide extending
from 2 cm above the floor to a height of 15 cm. On a shelf in the front of the slot, 2.5 cm
above the floor, casein pellets (45 mg Dustless Precision Pellets, Bio-Serv®, UK) were placed
in one of two indentations. These indentations were located 2 cm from the inside of the wall
aligned with the edges of the slit in order to prevent the rats using the tongue to lap the
pellet and to ensure that they only reach the pellet in the indentation contralateral to the
preferred paw. After the habituation phase, two additional polycarbonate side walls were
inserted in the box with a distance of 6 cm to each other to ensure that the rats directly
approach the slot with their body postures always in a similar orientation (Fig. 4.1B).
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Fig. 4.1. Single-pellet box. Schematic representation of the skilled reaching box with additionally
inserted side walls (A). Photograph of a rat reaching for a pellet (Subelement: Pronate/Grasp) (B).
4.3.3.2 Training and testing
The first week of training in the skilled reaching box consisted of daily 10 min training
sessions per rat. After box habituation pellets were placed on the shelf to introduce their
retrieval. As soon as the rats successfully retrieved pellets from the shelf, these were moved
to the indentations to force the rats to use the paws for their retrieval. The paw that was
most often and most precisely used usually emerged to be the preferred paw of the rat and
was then trained by placing individual pellets into the indentation contralateral to that paw.
When demonstrating a paw preference, inter-trial intervals were introduced during which
the rats had to turn around and walk to the rear wall of the box to receive a further pellet as
a reward for every pellet they gained from the indentation in the front and to initiate a new
trial. After this habituation phase to the procedure two additional polycarbonate side walls
were inserted in the box to ensure that the rats directly approach the slot and avoid major
variations in their body posture when reaching for the pellets. The rats were trained to walk
to the rear wall of the box after every trial to initiate the next one, though, only the trials in
which they successfully reached a pellet in the first attempt were rewarded by the additional
pellet in the back. On semi-random trials pellets on the shelf were withheld to ensure that
the rats sniff for and orient to the pellet. Training sessions in the following weeks consisted
of daily 5-10 min sessions per rat for about 4-5 weeks until they reached a stable baseline of
at least 75% correct responses.
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The 2-week group with the cannula explantation two weeks post-surgery was tested
in the reaching box the day before the surgery and once weekly for two weeks post-surgery.
The 6-week group with cannula explantation six weeks post-surgery was also tested the day
before the surgery and then once weekly for six weeks post-surgery to investigate short- and
long-term effects of cannula implantation in the CFA of M1 on the behavioural performance.
4.3.3.3 Behavioural analysis
The reaching performance in the single-pellet boxes was recorded for 5 min on each test day
using a Panasonic NV-DS60 digital video camera (shutter speed 1/50 s) and a cold-light
source for improved subsequent frame-by-frame analysis (25 frames/s). All experiments
were performed with the experimenter being blind to the treatment protocol.
Quantitative analysis:
Hit-reach-ratio. The success rate of each rat was calculated from the total number of hits
compared to the total number of reaches. Reaching attempts were scored as long as the
pellet was in the respective indentation. A successful reach was scored as a hit (“1 hit”) when
the pellet was grasped and consumed in the first attempt. If the pellet was grasped, but
dropped in the box an incomplete hit (“0.5 hits”) was scored. An incomplete hit was also
scored when the rat had missed the pellet, which was scored as a miss (“1 miss”), but then
grasped the pellet from the indentation without priorly withdrawing the paw through the
slot. Repeated, unsuccessful attempts without paw withdrawal from the shelf were scored
as repeated misses (“0.5 misses”) with the first miss being scored as complete miss.
Moreover, attempts in which the rat approached the slot, but dropped the paw on the inner
edge of the slot, were scored as incomplete attempts (“0.5 misses”).
The hit-reach-ratio was calculated by the sum of hits and incomplete hits divided by
the total number of attempts. Each hit as well as each incomplete hit was counted as one
attempt as well as the complete misses which was hence scored as “1 reach”. Only repeated
misses and incomplete attempts were counted as half attempts and were hence scored as
“0.5 reaches”.
reachesofnumberTotal
hitsofnumberTotalratio-reach-Hit 
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Qualitative analysis:
Movement pattern analysis. Each forelimb movement during a successful hit in the single-
pellet box consists of 12 movement subelements (Alaverdashvili et al., 2008;Alaverdashvili
and Whishaw, 2010). When initiating a trial the rat moves from the back of the box to the
front where it sniffs for the pellet in the indentation contralateral to the preferred paw. This
element is referred to as orientation to locate the food pellet (1) with the head and the snout
targeting the pellet, accompanied by further postural adjustments and a raise of the head
when initiating the movement. As the rat begins to reach for the pellet by lifting the limb (2)
the tips of the digits are aligned with the midline of the body. The palm is supinated with the
digits semiflexed or closed (3). Aiming (4) at the food pellet involves the adduction of the
elbow to the midline of the body with the digits remaining positioned on the body midline.
As the paw advances (5) through the slot the digits extend and open (6) in the end of the
movement when the paw is over the pellet. In a pronation (7) movement over the pellet the
digits fully extend and open with the outer digit through the inner digit sequentially
contacting the shelf by an abduction of the elbow and a rotation of the wrist. Grasping (8)
consists of the flexion and closure of the digits around the pellet followed by an extension at
the wrist and the raise of the pellet. The supination movement of the paw consists of two
phases: Supination I (9) involves the rotation of the paw by 90 ° around the wrist as it is
withdrawn through the slot, followed by supination II (10), the rotation of the paw so the
palm with the pellet faces the mouth. By opening the digits the pellet is finally released (11)
into the mouth and the paw is replaced (12) on the floor or on the wall when rearing or
turning around to initiate the next trial.
The first five attempts on each test day before and after the surgery were analysed
for these 12 subelements and rated using a three-point scale. A successful normal
subelement was rated “0”, when the subelement was present but abnormal it was rated
“0.5”, and when it was absent or incomplete and resulted in a miss or of loss of the pellet it
was rated “1”. Scoring was achieved by means of frame-by-frame analysis.
4.3.4 Open field
The locomotor activity of the rats was analysed in infrared-controlled activity chambers
(44.7 cm x 44.7 cm x 44.0 cm; ActiMot-system, TSE, Bad Homburg, Germany) by the total
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distance travelled [m] that was measured from the rats’ horizontal activity for 30 min the
day before surgery and once weekly after surgery.
4.3.5 Ladder rung walking task
For further analysis of the rats’ preferred forelimb the skilled walking ability of the 2-week
group was tested on a ladder rung walking task in horizontal, upward and downward
conditions according to a modified version of Antonow-Schlorke et al. (2013) analysing the
rats’ preferred forelimb contralateral to the cannula implantation side.
4.3.5.1 Ladder rung walking test apparatus
The test apparatus was manufactured according to Metz and Whishaw (2002) by in-house
mechanics of the University of Bremen. The rung ladder was 1 m in length with metal rungs
3 mm in diameter linking the side walls that were made of clear polycarbonate with a height
of 25 cm and a distance of about 8 cm to each other. During the training phase the rungs
were placed at a regular arrangement with a distance of 2 cm between the rungs to
habituate the rats to the setting. In the horizontal condition the ladder was elevated about
1 m above the floor with a platform at both ends. The angle of inclination of the rung ladder
for the upward and the downward condition was about 38.32°, due to the one end of the
ladder being elevated about 62 cm. Rats were supposed to walk from a neutral platform
across the ladder to a platform on the other side with a small reward which were three
casein pellets in the horizontal condition and four pellets in the upward and downward
conditions.
4.3.5.2 Training and testing
After a short training phase of 2-3 days on the regular pattern single rungs were removed to
receive an irregular pattern with rung-to-rung distances of 2-6 cm (Fig. 4.2). The original
regular pattern with rungs spaced at 2 cm intervals was further applied for the last 20 cm on
each side of the ladder to enable the rats to enter and leave the alley, since they often
stopped in these regions for orienting behaviour. Two templates of irregular patterns,
pattern A and B, were applied for the middle part of 60 cm to prevent the rats from learning
the pattern. After the rats enabled to cross the ladder fluently, without too many stops, they
were video recorded the day before the surgery on pattern A for the horizontal and the
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upward condition and pattern B for the downward condition. One week after the surgery
the animals were tested on pattern B for the horizontal and the upward condition and on
pattern A for the downward condition. In the second post-surgery week the same patterns
from before the surgery were applied.
Fig. 4.2. Horizontal ladder. Arrangement of ladder rungs: regular and irregular pattern.
4.3.5.3 Foot fault scoring
The skilled walking performance was evaluated qualitatively by means of frame-by-frame
analysis using a seven-category scale according to previous studies (Metz and Whishaw,
2002;Antonow-Schlorke et al., 2013): a correct placement of the paw on the rung with full
weight support on its midportion was rated “6 points”; a partial placement of the paw on
the rung with the wrist or digits was rated “5 points”; a correction of the limb that aimed for
a rung, but was then quickly repositioned without touching the first rung was rated “4
points”; the replacement of the paw, touching a rung without weight bearing, being quickly
lifted and placed on another rung was rated “3 points”; a slight slip off a rung with the
animal maintaining its balance and a continued coordinated walk was rated “2 points”; a
deep slip off a rung due to weight bearing on the slipping paw was rated “1 point”; a total
miss of a rung that resulted in a fall was rated “0 points”. Only the forelimb that was
preferred in the reaching box and that was contralateral to the cannula implantation site
was rated. When different errors occurred at the same time, the lowest of the scores was
given. In case of a fall, the preferred forelimb was only rated when it initiated the fall
otherwise no score was given until the rat repositioned all limbs. The scores for the
preferred forelimb of each rat and of each treatment group were averaged for the
horizontal, for the upward and the downward condition respectively and compared within
and in between the treatment groups before and after the surgery.
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4.3.6 Cannula implantation and drug administration
Substances administered during the implantation of the cannula were either aCSF
(in mM: 133.3 NaCl, 3.4 KCl, 1.3 CaCl2, 1.2 MgCl2, 0.6 NaH2PO4, 32.0 NaHCO3 and 3.4 glucose;
with pH adjusted to 7.4) serving as vehicle or memantine in a low (20 µg/µl) or in a high dose
(50 µg/µl) dissolved in aCSF (with pH adjusted to 7.4). ACSF was aliquoted and stored in the
freezer. Memantine solutions were freshly prepared before cannula implantation. Substance
administration occurred in a pseudorandom order by a treatment-blind experimenter.
Rats of all groups were implanted with a blunted stainless steel 27 gauge injection
cannula (0.4 mm diameter, Braun, Melsungen, Germany) in the CFA of M1 contralateral to
the preferred forelimb. Drugs were administered during the implantation procedure. For this
purpose, animals were anesthetised by intraperitoneal (i.p.) injections of 60 mg/kg
pentobarbital (Sigma Aldrich, Steinheim, Germany) and 10 mg/kg xylazine (Rompun®; Bayer,
Leverkusen, Germany). To mitigate the respiratory depressive effects of pentobarbital
0.1 mg/kg atropine (Braun, Melsungen, Germany) were administered subcutaneously (s.c.).
Rats were fixed in a stereotaxic apparatus (Kopf Instruments, Tujunga, CA, USA) in a flat skull
position. After a midsagittal incision of the skin and removal of the periosteum, jeweler’s
screws were anchored in the skull to fix the cannula. A small hole was drilled above the
contralateral CFA and 0.5 µl of either aCSF or memantine in its low or high dose were
administered on the cortical surface from the injection cannula that was connected with a
microlitre syringe (SGE Scientific Glass Engineering, Darmstadt, Germany) via polyethylene
tubes. Subsequently, further 0.5 µl were administered during the implantation of the
injection cannula into the CFA (0.1 µl/30 s). Coordinates for implantation
(anteroposterior: +1.5 mm; mediolateral: ±2.3 mm; dorsoventral: -2.3 mm from bregma)
were derived from previous mapping studies (Neafsey et al., 1986;Hyland, 1998;Colechio
and Alloway, 2009) and further pretests of our workgroup using the
GABA (γ-aminobutyric acid)A-agonist muscimol (0.5 µg/0.3 µl and 1 µg/0.3 µl; Biozol, Eching,
Germany) to temporarily inactivate this region. After implantation the cannula was left in
place and was embedded in dental acrylic. The polyethylene tubes were removed as soon as
the cannula was fixed to the skull and then closed by the acrylic cap. After surgery the rats
were kept on a warming plate until recovered from anaesthesia.
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4.3.7 Perfusion and tissue collection
Upon completion of the last test, the rats were euthanised with a lethal dose of
pentobarbital (200 mg/kg; i.p.) and transcardially perfused with 250 ml PBS (phosphate
buffered saline; pH 7.4) followed by 250 ml 4% paraformaldehyde (PFA; Serva
Electrophoresis, Heidelberg, Germany) in 0.1 M phosphate buffer (pH 7.4). The brains were
removed from the skull and post-fixed for 24 h in PFA followed by cryoprotection in 30%
sucrose solution for 48 h. Subsequently, six series of horizontal 40 µm sections of the rats’
cortex including the implantation site in the CFA were cut on a cryostat (Jung CM 3000, Leica
Instruments GmbH, Nussloch, Germany).
4.3.8 Histology
Brain slices of the first series were used to visualise the injection site. They were mounted
onto gelatinised glass slides and Nissl-stained with thionin and coverslipped for subsequent
analysis of the implantation site using a light microscope (Zeiss; Göttingen, Germany) and a
rat brain stereotaxic atlas (Paxinos and Watson, 1998). The extent of inflammation and the
number of the neurons around the implantation site were analysed by immunohistological
staining of free-floating sections. The second series of sections was stained for neurons
(neuronal nuclei; NeuN), the third series for astrocytes (glial fibrillary acid protein; GFAP) and
the fourth series for microglia/macrophages (ionised calcium binding adaptor molecule 1;
IBA-1). Free-floating sections were rinsed three times (for 10 min each) at room temperature
in PBS, followed by 1 h tissue blocking at room temperature in 10% normal goat serum (NGS;
Linaris, Dossenheim, Germany) blocking buffer containing 0.05% Triton-X 100 (Sigma,
Steinheim, Germany) to rehydrate the tissue and to increase the permeability of the cell
membranes for the antibodies. Following blocking, the tissue sections were incubated in the
respective primary antibody dilutions for 72 h at 4 °C which were either mouse anti-NeuN
(1:1000; Millipore, Darmstadt, Germany), rabbit anti-GFAP (1:5000; DAKO, Hamburg,
Germany) or rabbit anti-IBA-1 (1:2000; WAKO, Neuss, Germany). Next, after 3 rinses in PBS
(10 min per rinse), followed by 1 h blocking at room temperature in PBS containing 0.2%
bovine serum albumin (PBSA; Sigma, Steinheim, Germany), sections were transferred to
their secondary antibody dilutions for 48 h at 4 °C. Secondary antibodies, which were either
biotinylated goat anti-rabbit IgG (1:2000; DAKO, Hamburg, Germany) for the astrocytes as
well as for the microglia/macrophages or Alexa Fluor 488 goat anti-mouse IgG (1:1000;
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Dianova, Hamburg, Germany) for the neurons, were diluted in PBSA blocking buffer. After
immunostaining with the secondary antibodies and 3 further rinses with PBS the tissue
sections stained for the neurons were mounted onto sodium azide-gelatinised glass slides
and dried in the dark for 3 days. The sections stained for astrocytes and
microglia/macrophages were treated again for 1 h with PBSA blocking buffer and were then
incubated in PBSA containing Cy3-labeled streptavidin (1:2000; Sigma, Steinheim, Germany)
for 24 h at room temperature. After 3 further rinses in PBS theses series were as well
mounted on microscope slides and dried in the dark.
To eliminate background immunofluorescence and autofluorescence of lipofuscin the
sections were treated for 20 min with 0.5% filtered Sudan Black (Acros, New Jersey, USA)
solution prepared in 70% ethanol. After 3 rinses in 0.2 M PB (10 min each), they were
coverslipped with fluorescence mounting medium (DAKO, Glostrup, Denmark) for imaging.
4.3.9 Image analysis
Fluorescent images of tissue sections from layers V of the cortex near the tip of the cannula
were taken using a Zeiss Axioskop fluorescent microscope (Göttingen, Germany) with
adequate band pass filter sets (excitation and emission peaks: Cy2 at 492 nm and 510 nm
(green); Cy3 at 550 nm and 570 nm (red)) and a digital camera RT Slider Spot connected to
the image analysis software Metamorph 4.6 (Visitron Systems GmbH, Puchheim, Germany).
Z-stack images were captured with a 20 x objective around the implantation site for the
neurons as well as for the microglia/macrophages to individually count the cells and with a
10 x objective for astrocytes to examine the distribution of the astrogliotic scar. Exposure
times and gamma values were held constant for each cellular marker. Quantification was
performed following the acquisition of 16-bit tagged image files (TIFs) using the image
processing software FIJI. The implant region was manually delineated and regions of interest
(ROIs) were defined in 50 µm concentric circles up to 300 µm from the interface for neurons
and microglia/macrophages and up to 500 µm for astrocytes. Large blood vessels or other
irregularities were excluded from the ROIs. To improve visual display images in this report
have been pseudo-coloured.
To quantify the neuronal population surrounding the implantation site the neurons in
each ROI around the implantation site were manually counted by means of the cell counter
plug-in and the average number of neurons [n] for bins of 50 µm² was calculated for each
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treatment. The same procedure was applied to the images of the microglia/macrophages.
The motor cortex of the hemisphere contralateral to the implantation site of aCSF-treated
animals served as the control and the average number of neurons and of
microglia/macrophages in the CFA was determined from the untreated hemispheres, with
the same ROI sets as used on the contralateral implantation site.
The distribution of the astrocytic scar was examined by converting the images into 8-
bit images to level them (enhancement of contrast: 0.3%), followed by the application of an
auto local threshold (method: median; radius: 80 pixel; correction value (c): -30) in order to
obtain binary images. The average area covered with astrocytes [%] was calculated for each
ROI. Again the motor cortex of the hemisphere contralateral to the implantation site of
aCSF-treated animals served as the control and the average area covered with astrocytes in
the CFA was determined from the untreated hemispheres with the same ROI sets as used on
the contralateral implantation site.
4.3.10 Statistical analysis
Descriptive statistics are based on means and variances indicated as standard error of the
mean (+S.E.M.). Statistical analyses were run using the statistical software SigmaStat
(version 2.03 for Windows) using a two-way repeated measures analysis of variance (2-way
RM ANOVA) for the behavioural tests with the factors treatment and test day within the
2-week group and within the 6-week group and for the immunohistological investigations
with the factors treatment and distance from the implantation site for each marker within
the 2-week group and within the 6-week group. Post-hoc pairwise comparisons using a
Tukey’s t-test were defined to be significant at P<0.05. Animals that did not reach a stable
baseline performance of 75% correct responses in the skilled reaching task or lost the acrylic
cap after cannula implantation were excluded from further analysis.
4.4 Results
4.4.1 Behavioural experiments
A total of eight animals were excluded from the experiments either due to a loss of the
acrylic cap (n=5) or due to not reaching a stable baseline of at least 75% correct responses in
the single-pellet reaching task (n=3). Data of all 52 participating animals (aCSF: n=16; Mem
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low: n=18; Mem high: n=18) are included in the bar plots and statistics of the 2-week group
for all behavioural experiments except for the ladder rung walking task that was exclusively
applied to the 2-week group and contains the data of the 26 animals that remained for two
weeks in the experiment. Bar plots and statistics of the 6-week group contain only the data
of 26 animals that remained in the experiment up to the sixth week with each treatment
group containing half of the animals. Start differences within the groups go back to
individual differences in different behavioural patterns of the animals.
4.4.1.1 Single-pellet reaching task
Hit-reach-ratio. Before cannula implantation into the CFA contralateral to the preferred
forelimb, rats of all treatment groups showed a stable baseline in the reaching boxes with a
hit-reach-ratio of at least 75%. Local vehicle treatment during cannula implantation
decreased the performance not only within the first two post-surgery weeks, but also at
later time points as shown by the 6-week group. Both doses of memantine reversed this
impairment to about baseline levels in the 6-week group. The statistical data analysis
revealed for the first two weeks (Fig. 4.3A) a significant main effect of drug treatment
(F2,98=3.549; P=0.036) and time point of measurement (F2,98=54.371; P<0.001), as well as a
significant interaction drug x time point of measurement (F4,98=4.973; P=0.001). Further
post-hoc comparisons showed that cannula implantation into the CFA caused a decrease of
the hit-reach-ratio within the first two weeks that was significant for all treatment groups
when compared to pre-surgery (P<0.01). Both doses of memantine significantly improved
the performance in the first post-surgery week compared to vehicle (P<0.01). In the second
post-surgery week the high dose of memantine also significantly increased the performance
compared to vehicle (P=0.014), although the effect of the low dose of memantine did not
reach statistical significance (P=0.096). Statistical data analysis of the hit-reach-ratio for the
6-week animals (Fig. 4.3B) also revealed a significant main effect of drug treatment
(F2,138=8.276; P=0.002) and time point of measurement (F6,138=12.254; P<0.001) as well as a
significant interaction drug x time point of measurement (F12,138=2.105; P=0.020). Post-hoc
comparisons revealed that vehicle treatment significantly decreased the hit-reach-ratio in all
post-surgery weeks compared to pre-surgery (P<0.001), in contrast to memantine treatment
that resulted in a decrease only in the second post-surgery week compared to pre-surgery
(P<0.05). Both doses of memantine improved the performance significantly in most post-
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surgery tests compared to vehicle treatment (P<0.05) and returned to about baseline levels
after the second post-surgery week, with the low dose of memantine significantly improving
the performance from the second to the sixth post-surgery week (P=0.045).
Fig. 4.3. Hit-reach-ratio. Quantitative data analysis of the rats’ performance in the skilled reaching
task before and once weekly after the implantation of a cannula into the CFA contralateral to the
preferred forepaw accompanied by either local vehicle treatment (aCSF) or local memantine
treatment in a low (20 μg/μl) or a high dose (50 μg/μl) two (n=52) (A) and six weeks (n=26) post-
surgery (B). Data are means +S.E.M. Asterisks denote a significant difference (Tukey’s t-test; P<0.05)
between pre- and post-surgery tests of a certain treatment. Significant differences on a certain test
day compared to vehicle are illustrated by circles. A significant postsurgery effect of a certain
treatment is illustrated by the triangle (here: from post-surgery week 2 to 6). Brackets () indicate a
trend of significance (Tukey’s t-test; P<0.1).
Movement pattern analysis. In addition to the quantitative hit-reach-ratio analysis, the
qualitative movement pattern analysis of the first five trials revealed that the subelements
most impaired were the advancing of the paw through the slot, the pronation of the paw
over the pellet, as well as the release of the pellet into the mouth. The other subelements
were unaffected by the surgery suggesting that advancing, pronation and release are most
vulnerable to the implantation-induced tissue damage. In compliance with the results of the
hit-reach-ratio-analysis, vehicle treatment caused the strongest increase in errors with the
highest error scores within the first two post-surgery weeks. Both doses of memantine
reduced these error scores.
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Fig. 4.4. Movement pattern analysis. Qualitative data analysis of the most impaired subelements
within the first five trials in the skilled reaching task before and once weekly after cannula
implantation accompanied by local vehicle or memantine treatments two (n=52) (A,C,E) and six
weeks (n=26) post-surgery (B,D,F). Data are means +S.E.M. Asterisks denote a significant difference
(Tukey’s t-test; P<0.05) between pre- and post-surgery tests of a certain treatment. Significant
differences on a certain test day compared to vehicle are shown by circles. A significant post-surgery
effect of a certain treatment is indicated by the triangle (here: from post-surgery week 1 to 2, 3 and
4). Brackets () denote a trend of significance (Tukey’s t-test; P<0.1).
The error rate of the subelement advance was increased after cannula implantation in all
treatment groups with the animals often advancing the paw not far enough through the slot
to reach the pellet or swept the pellet off the shelf when touching it only with the tips of the
digits. Vehicle treatment showed the strongest increase in errors up to four weeks post-
surgery. Memantine again amended this motor impairment. The statistical data analysis
revealed for the first two weeks (Fig. 4.4A) a significant main effect of time point of
measurement (F2,98=18.622; P<0.001) and of the interaction drug x time point of
measurement (F4,98=3.432; P=0.011). Further post-hoc comparisons showed that the
increase in the number of errors in this subelement was significant for vehicle treatment
(P<0.001) and the low dose of memantine (P=0.035) in the first post-surgery week compared
to pre-surgery. For vehicle treatment this increase remained significant in the second
post-surgery week compared to pre-surgery (P<0.001), in contrast to memantine that only
tended to increase the error rate in the low dose (P=0.057), although not in the high dose.
The high dose improved the performance significantly compared to vehicle in the first post-
surgery week (P=0.003). The decrease of errors with the low dose of memantine compared
to vehicle did not reach statistical significance (P=0.052) in the first post-surgery week. For
the 6-week animals (Fig. 4.4B) only a significant main effect of time point of measurement
was revealed (F6,138=4.284; P<0.001). Further post-hoc comparisons revealed that the
increase in errors continued to be significant for vehicle treatment for the first four post-
surgery weeks (P<0.05) with a significant decrease in the number of errors from the first to
the sixth post-surgery week (P=0.034). Memantine slightly improved motor performance
within the first four post-surgery weeks compared to vehicle, but reached statistical
significance only in the first post-surgery week in the high dose (P=0.044), although not in
the low dose (P=0.082).
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The error rate of the subelement pronate was not that pronounced, but increased
post-surgically with especially the vehicle-treated rats either not fully extending and opening
their digits or omitting the rotation of the wrist, and hence missing the pellet or grasping the
pellet with a lateral swipe of the paw. This effect was again most intense in the first two
post-surgery weeks and improved by memantine. Within these first two post-surgery weeks
(Fig. 4.4C) a significant main effect of drug treatment (F2,98=3.3341; P=0.044) and time point
of measurement (F2,98=8.307; P<0.001) was revealed as well as a significant interaction drug
x time point of measurement (F4,98=3.185; P=0.017). Further post-hoc comparisons revealed
a significant increase of errors in this subelement after vehicle treatment in both post-
surgery weeks (P≤0.001) as well as after the low dose of memantine in the second post-
surgery week (P=0.043) compared to pre-surgery. The high dose of memantine significantly
improved the performance in the first (P=0.005) as well as in the second post-surgery week
(P=0.027) compared to vehicle, similar to the low dose of memantine in the first post-
surgery week (P=0.011). An increase in the number of errors was also obvious in the 6-week
groups especially after vehicle treatment in the first post-surgery week (Fig. 4.4D), though
without reaching statistical significance.
The error rate of the subelement release also showed its strongest increase in the
first post-surgery week after vehicle treatment, with the animals often showing difficulties to
open their paw and release the pellet into the mouth. Statistical data analysis of the first two
weeks (Fig. 4.4E) including all animals  neither showed a significant main effect of drug
treatment or time point of measurement nor of their interaction for this subelement.
Though, for the 6-week group (Fig. 4.4F) data analysis revealed a significant main effect of
time point of measurement (F6,138=2.460; P=0.027). Post-hoc comparisons indicated a
significant increase in the number of errors after vehicle treatment in the first post-surgery
week compared to pre-surgery (P=0.033), but in post-surgery weeks 2-4 a significant
decrease of errors (P<0.01) occurred compared to the first post-surgery week. A significant
lower error rate was revealed after memantine treatment in both doses in the first post-
surgery week compared to vehicle (P<0.01) and a trend of decrease (P=0.072) with high dose
of memantine in the sixth post-surgery week.
The other subelements were not impaired within the first five trials. The subelement
replace exhibited a mean error rate of 41.09% (± 5.03%) already pre-surgery and revealed no
significant differences post-surgery.
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4.4.1.2 Open field
The analysis of the rats’ locomotor activity measured by the total distance travelled [m] in
30 min served as a control paradigm and did not reveal any treatment effects neither within
the first two weeks (Fig. 4.5A) nor within the 6-week group (Fig. 4.5B). Only a significant
main effect of the time point of measurement was revealed for the 6-week group
(F6,138=2.589; P=0.021), with further post-hoc comparisons revealing a significant overall
decrease in the total distance travelled in the first post-surgery week compared to pre-
surgery (P=0.017) and again a significant increase from the first to the sixth post-surgery
week (P=0.048) independent of the treatment. Further post-hoc comparisons revealed for
the low dose of memantine a significant increase in the distance travelled from the first to
the sixth post-surgery week (P=0.005), similar to the high dose that tended to increase
motor behaviour (P=0.072).
Fig. 4.5. Open field. Analysis of the rats’ total distance travelled [m] within 30 min on the day before
and once weekly after cannula implantation two (n=52) (A) and six weeks (n=26) post-surgery (B).
Data are means +S.E.M. Triangles denote significant post-surgery differences (Tukey’s t-test; P<0.05)
within a certain treatment (here: from post-surgery week 1 to 6). Brackets () indicate a trend of
significance (Tukey’s t-test; P<0.1).
4.4.1.3 Ladder rung walking task
The data analysis of the foot placement scores of the 2-week animals on the rung ladder
revealed the ladder’s diagonal conditions to be more difficult than the horizontal condition
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(Fig. 4.6A). Vehicle treatment caused a slight decrease of performance in the ladder’s
upward (Fig. 4.6B) as well as in the ladder’s downward condition (Fig. 4.6C) that was
improved by memantine. Statistical analysis revealed a significant main effect of the factor
treatment (F2,46=4.909; P=0.017) only for the ladder’s upward condition. Further post-hoc
comparisons indicated a significantly decreased locomotor activity in the first post-surgery
week after vehicle treatment compared to the low dose (P=0.002) or the high dose of
memantine (P=0.010). In the second post-surgery week vehicle-treated animals improved
again significantly compared to the first post-surgery week (P=0.036). No significant
impairments were observed in the horizontal and downward conditions. The results of the
vehicle treatment in the ladder’s downward condition indicate a stronger decline in the
animals’ post-surgery performance compared to memantine treatment, but this effect failed
to reach statistical significance.
Fig. 4.6. Ladder rung walking task. Analysis of the rats’ skilled walking ability on the rung ladder in
horizontal (A), upward (B) and downward (C) conditions on the day before and once weekly after the
implantation of a cannula two weeks post-surgery (n=26). Data are means +S.E.M. Circles denote a
significant difference (Tukey’s t-test; P<0.05) on a certain test day compared to vehicle. Significant
post-surgery differences within a certain treatment are indicated by triangles (here: from post-
surgery week 1 to 2).
4.4.2 Histology
The microscopic examination of the Nissl-stained sections revealed that all implantation sites
were located within the CFA. Data analysis for histological examination included at least 2-3
sections from 4-5 rats per treatment group and per time point.
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4.4.2.1 Neuronal distribution
The distribution of neurons in the CFA without (Fig. 4.7A) and with a cannula accompanied
by aCSF (Fig. 4.7B) or memantine treatment was assessed by immunostaining for NeuN, a
nuclear antigen found in neurons. Two as well as six weeks after the implantation of the
cannula a reduction in neuronal nuclei within a zone of 50 µm from the implant was
observed after vehicle treatment. In contrast, memantine treatment increased the number
of neurons within this zone reaching neuron numbers above baseline.
Statistical analysis revealed a significant main effect of the interaction drug x distance
(F15,70=5.932; P<0.001) for the number of neurons in the 2-week animals (Fig. 4.7C). Further
post-hoc comparisons for the vehicle treatment show a significant reduction in the average
number of neurons in the first 50 µm around the implantation site compared to all further
intervals up to 300 µm (P<0.001) as well as compared to the contralateral hemisphere with
no intervention (P=0.004) . The average number of neurons within the first 50 µm was
increased significantly with the low (P=0.001) as well as with the high dose (P<0.001) of
memantine compared to vehicle. Moreover, the high dose also revealed an increased
average number of neurons within this first interval compared to the interval 250-300 µm
from the implantation site (P=0.037). For the 6-week animals (Fig. 4.7D) a significant main
effect in the interaction drug x distance was also revealed (F15,65=2.995; P=0.001). Further
post-hoc comparisons indicated a significant reduction in the average number of neurons
within the first 50 µm compared to intervals from 150-300 µm after vehicle treatment
(P<0.05), although not when compared to the hemisphere with no intervention. Memantine
significantly increased the number of neurons within this interval in the low (P=0.009) and in
the high dose (P=0.003) with the high dose showing again a slight-to-significant increase in
the average number of neurons within these first 50 µm compared to the intervals further
away from the implantation site (150-200 µm, P=0.063; 200-250 µm, P=0.003; 250-300 µm,
P=0.052). Contralateral to the implantation site the average number of neurons was about
the same two and six weeks post-surgery.
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Fig. 4.7. Average number of NeuN+ nuclei. Representative immunohistological images showing NeuN
expression in the CFA of controls in the hemisphere without intervention (A) and with cannula
implantation illustrated with an appropriate set of ROIs (B) two weeks post-surgery. Quantification of
the average number of neuronal nuclei, as a function of distance from the implantation site, is shown
two (C) and six weeks post-surgery (D). Data are means +S.E.M. Asterisks denote a significant
difference (Tukey’s t-test; P<0.05) between the first interval of 50 μm and an interval further away
(up to 300 μm) of a certain treatment. Circles denote a significant difference within a certain interval
compared to vehicle. Scale bar = 100 μm.
4.4.2.2 Microglial/Macrophagial distribution
The distribution of microglia/macrophages in the CFA without (Fig. 4.8A) and with a cannula
accompanied by aCSF (Fig. 4.8B) or memantine treatment was assessed by immunostaining
for IBA-1, an antigen that is specifically expressed in microglia and macrophages, and is up-
regulated upon activation during inflammation. Two and six weeks after cannula
implantation, a strong increase in microglia/macrophages within the first 50 µm from the
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implant was observed independent of the treatment with an overall increase in the number
of microglia/macrophages two weeks compared to six weeks after the implantation.
Fig. 4.8. Average number of IBA-1+ cells. Representative immunohistological images showing IBA-1
expression in the CFA of controls in the hemisphere without intervention (A) and with cannula
implantation illustrated with an appropriate set of ROIs (B) two weeks post-surgery. Quantification of
the average number of microglia/macrophages, as a function of distance from the implantation site,
is shown two (C) and six weeks postsurgery (D). Data are means +S.E.M. Asterisks denote a significant
difference (Tukey’s t-test; P<0.05) between an interval close to the implantation site and any interval
further away (up to 300 μm) of a certain treatment. A significant difference of any treatment
compared to no intervention within a certain interval is indicated by a rhomb. Scale bar = 100 μm.
Statistical analysis revealed a significant main effect of drug treatment (F3,70=3.807; P=0.035)
and distance (F5,70=47.706; P<0.001) as well as of their interaction (F15,70=6.041; P<0.001) for
the microglia/macrophage distribution of the 2-week animals (Fig. 4.8C). Further post-hoc
comparisons indicated a significantly increased number of microglia/macrophages in the first
50 µm around the implantation site for all treatments (P<0.001) compared to all further
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distances and when compared to the hemisphere without interventions (P<0.001). The
interval of 50-100 µm comprised a significantly increased number of microglia/macrophages
for the high dose of memantine compared to 200-250 µm (P=0.018) and 250-300 µm
(P<0.001). Six weeks after cannula implantation (Fig. 4.8D) a significant main effect of drug
treatment (F3,65=7.440; P=0.004) and distance (F5,65=25.770; P<0.001) as well as of their
interaction (F15,65=3.397; P<0.001) was observed. Post-hoc comparisons revealed again a
significant increase in the number of microglia/macrophages in the first 50 µm for all
treatments compared to all further distances (P<0.001) and when compared to the
hemisphere without interventions (P<0.001). Moreover, within a distance of 50-100 µm
there was a significant increase of microglia/macrophages after the low dose of memantine
compared to the untreated hemisphere (P=0.016), that did not reach statistical significance
after vehicle treatment or the high dose of memantine. Moreover, a significant main effect
of the time point of measurement was evident in the untreated hemisphere (F1,35=8.453;
P<0.023) with an overall increase of microglia/macrophages two weeks compared to six
weeks post-surgery.
4.4.2.3 Astroglial distribution
The distribution of astrocytes in the CFA without (Fig. 4.9A) and with a cannula accompanied
by aCSF (Fig. 4.9B) or memantine treatment was assessed by immunostaining for GFAP, an
antigen that is expressed in the intermediate filaments of astrocytes, and is up-regulated
upon activation during inflammation. Two and six weeks after cannula implantation, an
increased astrocytic immunoreactivity around the implant was observed independent of the
treatment with an overall increase two weeks compared to six weeks after the implantation
and a further expansion of scar tissue two weeks post-surgery. Statistical analysis revealed
for the 2-week animals (Fig. 4.9C) a significant main effect of drug treatment (F3,126=7.288;
P=0.004) and distance (F9,126=213.097; P<0.001) as well as of their interaction (F27,126=29.817;
P<0.001). Further post-hoc comparisons show for the first 50 µm, that vehicle treatment
significantly enhanced astrocyte density compared to the low dose of memantine (P=0.002)
which also tended to be enhanced compared to the high dose (P=0.068). Within the first
100 µm all treatments caused significantly enhanced intensity profiles compared to no
intervention, with memantine exhibiting an enhancement up to 150 µm (P<0.05). Within the
50-100 µm interval the high dose of memantine revealed significantly enhanced GFAP
B
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immunoreactivity compared to vehicle (P=0.012) and within the 100-150 µm interval the low
dose of memantine significantly enhanced astrocyte density compared to vehicle (P=0.019),
similar to the high dose of memantine (P=0.076), which did not reach the level of
significance though. Moreover, a significant increase in fluorescent intensity was revealed
for the low dose of memantine up to 200 µm around the implantation site (P<0.01) and for
vehicle and the high dose of memantine up to 250 µm (P<0.05) compared to intervals
further away than 400 µm. 400-450 µm from the implantation site significantly less GFAP
immunoreactivity was found after vehicle treatment compared to the untreated hemisphere
(P=0.028), similar to the interval of 450-500 µm, which also tended to be decreased
(P=0.059). Statistical analysis of the 6-week animals (Fig. 4.9D) revealed a significant main
effect of distance (F9,117=240.016; P<0.001) and of the interaction drug x distance
(F27,117=28.021; P<0.001), as well as a trend for a significant main effect of drug treatment
(F3,117=3.346; P=0.053). Further post-hoc comparisons show that vehicle-treated animals
exhibited significantly enhanced astrocyte density within the first interval compared to the
low (P=0.044) or the high dose of memantine (P<0.001). Moreover, within the first 50 µm all
treatments revealed significantly enhanced GFAP immunoreactivity compared to no
intervention (P<0.001) with the high dose of memantine exhibiting this increase as well 50-
100 µm from the implantation site (P=0.008). A significant increase in GFAP
immunoreactivity was found up to 150 µm from the implantation site for memantine
(P<0.05) and up to 200 µm for vehicle (P<0.05) compared to intervals further away than
400 µm. 200-500 µm around the implantation site vehicle treatment either tended to
(P<0.1) or caused significantly less (P<0.05) fluorescent intensity compared to the
hemisphere without intervention. The low dose of memantine revealed a significant
decrease in GFAP immunoreactivity (P=0.009) only for the last interval of 450-500 µm
compared to no intervention. Moreover, again a significant main effect of the time point of
measurement was evident in the untreated hemisphere (F1,63=10.169; P=0.015) with an
overall increase of astrocytes two weeks post-surgery compared to six weeks post-surgery.
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Fig. 4.9. Average distribution of GFAP+ cells. Representative immunohistological images showing
GFAP expression in the CFA of controls in the hemisphere without intervention (A) and with cannula
implantation illustrated with an appropriate set of ROIs (B) two weeks post-surgery. Quantification of
the average distribution of astrocytes, as a function of distance from the implantation site, is shown
two (C) and six weeks post-surgery (D). Data are means +S.E.M. Asterisks denote a significant
difference (Tukey’s t-test; P<0.05) between an interval close to the implantation site and any interval
further away (up to 500 μm) of a certain treatment. A significant difference of any treatment
compared to no intervention within a certain interval is indicated by a rhomb. Circles denote a
significant difference within a certain interval compared to vehicle. Brackets () indicate a trend of
significance (Tukey’s t-test; P<0.1). Scale bar = 100 μm.
4.5 Discussion
This study demonstrates that local memantine treatment during cannula implantation in the
CFA increases the vicinity and the number of neurons adjacent to the implant accompanied
by an improved motor behaviour compared to controls. The effect on the glial scar
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formation is only minor revealing no effect on the microglia/macrophage activation, but a
slight reduction in astrocytic scar formation directly around the implant.
Glutamatergic NR2B subunit containing NMDA-receptors play a key role in the
neurodegeneration associated with glutamate-induced excitotoxicity, with memantine being
the only clinically approved drug that preferentially blocks this predominantly
extrasynaptically located NMDA receptor subtype (Vizi et al., 2013;Lopes et al., 2013). The
NR2BR has been found to contribute to a number of pathological events including
Alzheimer’s disease (Maher et al., 2014) and epilepsy (Zhu et al., 2015), as well as
Huntington’s disease, schizophrenia, hypoxia/ischemia and others as reviewed by (Loftis and
Janowsky, 2003;Waxman and Lynch, 2005). The neuroprotective properties of memantine
by blocking NR2B receptor induced excitotoxicity are supposed to be additionally enhanced
by an increased production of the glial cell line-derived neurotrophic factor (GDNF) from
astrocytes which promotes neuronal survival, as well as by an inhibition of microglia
activation and a reduction in production of pro-inflammatory molecules that exacerbate the
inflammation (Wu et al., 2009). Here, we report that memantine has also neuroprotective
potential when locally applied during cannula implantation into the CFA accompanied by an
improvement in motor behaviour.
Our results show that neuronal cell loss persists around an implant in rat motor
cortex over a 6-week period after vehicle treatment as measured by NeuN
immunoreactivity. Two as well as six weeks after cannula implantation a reduction in
neurons was observed that was restricted to an arc of 50 µm surrounding the cannula. These
findings have also been described in previous studies at these or similar time points
(Winslow and Tresco, 2010;Winslow et al., 2010;Potter et al., 2012) and indicate that the
loss of neurons is a locally restricted phenomenon. Neuronal cell loss seemed to be more
intense two weeks after the implantation compared to six weeks, suggesting that neurons
slightly re-approach the lesion after the acute phase of the foreign body response. Larger
neuronal “die-back” has also been observed by Potter and colleagues (Potter et al., 2012)
two weeks after electrode implantation recovering by four to eight weeks with another
relapse at 16 weeks though. The initial cell loss is in line with the results of the glial cells that
are spread further and more intense around the implantation site two weeks after the
implantation, with the sheath getting more compact after six weeks. Memantine, as an
uncompetitive NMDA-receptor antagonist, appears to effectively interrupt the cascade of
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progressive neurodegeneration given locally during the implantation of the cannula. Two as
well as six weeks post-surgery there is an increase in the average number of neurons close to
the implant when treated with memantine compared to vehicle, suggesting that neurons in
the implantation tract are pushed aside by the implant and survive this original trauma after
memantine treatment without getting implicated in and exacerbating the neurotoxic
cascade by secondary cell death.
We also provide evidence that the spatial distribution of glial cells does not increase
over time, but becomes denser and more organised six weeks compared to two weeks after
cannula implantation, indicating a contraction of the glial sheath around the implant at later
time points which has already been suggested previously (Winslow and Tresco, 2010;Potter
et al., 2012). Moreover, it was reported that the microglia/macrophages attach to the
implant as early as 6 h post-implantation, then increase in number and constitute a layer of
1-2 cells covering the length of the implant (Polikov et al., 2006). After the implantation of a
foreign body into the rat cerebral cortex a scattered distribution of reactive microglia and
hypertrophic astrocytes has been postulated in the initial wound healing response, followed
by an encapsulating sheath with clustering of microglia and hypertrophic astrocytes
extending in previous studies up to 500 µm from the implant two weeks after the
implantation (Turner et al., 1999;Szarowski et al., 2003). A continuous presence of microglia
in a tight cellular sheath has been observed six weeks after the implantation with a compact
astrocytic sheath extending 50-100 µm around the implant that remains constant after this
time point. The inability of the microglia/macrophages to clear the insoluble implant
material has been describes as “frustrated phagocytosis” that is characterised by persistent,
constitutive release of inflammatory products, surrounded by astrocytes in an encapsulation
layer to separate the region of enduring inflammation from the healthy tissue (Polikov et al.,
2005;Biran et al., 2005). These findings are in line with the results of our study with an
increase of microglia/macrophage activity two weeks after the implantation and clustering in
the first 50 µm around the implant. Six weeks after the implantation the number of
microglia/macrophages had slightly decreased. The hypertrophic astrocytes extended in our
study up to 100-200 µm from the implant two weeks after the implantation, surrounded by
a region of hypotrophy within a distance of 400-500 µm in controls. Six weeks after the
implantation the hypertrophic region seemed to be restricted to the first 50 µm surrounded
by a region of hypotrophy ranging from 250-500 µm. Staining for IBA-1 revealed a thin layer
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of microglia/macrophages cells that were irregularly distributed along the length of the
cannula providing further evidence that the microglia/macrophages constitute the most
inner layer and adhere to the implant, therefore being partly removed with the cannula by
implant extraction which also has been reported previously (Szarowski et al., 2003).
Memantine treatment resulted only in minor reductions in the glial scar formation around
the implant. There was a decrease of the astrocytic scar tissue in the first 50 µm around the
implant accompanied by a reduction of the hypotrophic regions surrounding the scar, but no
differences in the microglia/macrophage activation compared to vehicle. Hence, these
results are in line with the concept that the cell loss in the acute phase with a principally
beneficial immune response is to a large extend independent of the more adverse long-term
foreign body response with persistent inflammatory processes at the interface (Biran et al.,
2005;Marin and Fernandez, 2010). Although the astroglial response is only reduced by
memantine in the first 50 µm in our study, this may not be a major problem, since the
vicinity and the number of the neurons is increased above baseline adjacent to the implant
and moreover the reactive astrocytes are not predominantly harmful, but depend in their
function strongly on the type of injury. Astrocytes are supposed to exhibit primarily
beneficial, protective function after ischemia-related injuries expressing high levels of
neurotrophic factors and cytokines that help to repair and rebuild lost synapses, as well as
the blood-brain barrier and limit immune cell influx and neuronal death (Zamanian et al.,
2012). Furthermore, they are essential to remodel the extracellular space and to protect the
neurons from the enduring inflammatory processes at the interface and to restrict the
spread of inflammation into surrounding tissue serving as anti-inflammatory barrier
(Sofroniew, 2015).
Irrespective of the glia cell distribution adjacent to the implant we found an overall
increase of microglia/macrophages as well of astrocytes in the untreated contralateral
hemisphere of the vehicle-treated controls two weeks compared to six weeks post-surgery,
suggesting widespread inflammatory processes enduring during this time span. Activation of
microglia in the contralateral hemisphere has also been described in previous studies after
cerebral ischemia (Marks et al., 2001), and were suggested to be either due to far-ranging
signals sent from microglia around the site of damage stimulating the activation,
proliferation and migration to the site of damage, or become activated as a result of
diaschisis, i.e. functional changes in brain structures remote from, but connected to the site
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of brain damage (Seitz et al., 1999). The interhemispheric connectivity via transcallosal fibers
connecting the primary motor cortices (M1-M1) that is also important in motor recovery
after stroke (Lindenberg et al., 2012) may also induce the activation of microglia in the
contralesional CFA. Alternatively, contralateral microglia activation may be enhanced due to
enduring brain swelling causing physical deformation also of the contralateral hemisphere
(Loddick et al., 1998). In support of these assumptions is the finding that not only microglia
but also astrocytes are increased two compared to six weeks after cannula implantation.
Intensification of GFAP staining in the contralateral hemisphere following injury has also
been noted previously (Badan et al., 2003), with a peak of microglial and astrocyte activation
on average after one to two weeks.
In accordance with the neuronal cell loss after vehicle treatment in the vicinity of the
implant, that is even more severe two weeks after the implantation compared to six weeks,
the results of the behavioural experiments suggest the most severe decline in the rats’
performance in the first two post-surgery weeks and a slight recovery thereafter. The data
from the reaching box confirm that the increase in neurons around the implant after
memantine treatment positively influences the performance two as well six weeks after
cannula implantation. Although showing an increased number of neurons even above
baseline levels after memantine treatment, the performance is still significantly decreased
within the first two post-surgery weeks when compared to pre-surgery. It can be
hypothesised that the neurons in the vicinity of the implant, that are presumably pushed
aside during cannula implantation, survived the initial trauma due to memantine treatment,
but may have partly lost their synaptic connectivity and the neuronal networks they had
established. Four to six weeks after implantation the memantine-treated animals had
recovered to a large extent and reached baseline levels again, probably benefitting from the
surviving neurons and the repair of synapses and neuronal networks by astrocytes. In
general, after local brain injury, recovery occurs spontaneously also without rehabilitative
training due to behavioural compensations. Over the ensuing weeks a redistribution of the
representation of the affected area occurs by neuroanatomical changes such as local axonal
sprouting, dendritic spine expansion and synaptogenesis in the regions surrounding the
lesion. Neurite outgrowth into intact motor areas surrounding the lesion occurs as well as
remote cortical neurons that project to the lesion site contribute to a reassembly of inter-
and intra-areal cortical networks and functional recovery. The transfer of functional
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responsibility takes about 4-8 weeks, although still comprising significant deficits when not
undergoing rehabilitative training (Maldonado et al., 2008;Nudo, 2013). Since rats in our
study did not receive daily rehabilitative training after cannula implantation the slight
increase in performance during the six post-surgery weeks was most probably due to a
combination of spontaneous recovery and weekly testing as a form of rehabilitative training.
The subelement most impaired was the advancing of the paw through the slot with
the rats either reaching not far enough to hit the pellet or sweeping the pellet off the shelf
when touching it only with the tips of the digits. The strongest increase in errors was found
after vehicle treatment in the first post-surgery week enduring up to the fourth week.
Memantine amended this motor impairment. In the fifth and sixth post-surgery week the
increase in errors in this subelement was compensated or had recovered by the weekly
testing. As examined previously the cortical area for wrist and digit presentation is
predominantly the RFA, with the CFA being largely responsible for elbow and shoulder
movement and partly for wrist movement without being involved in digit coordination
(Neafsey and Sievert, 1982;Neafsey et al., 1986). After skilled reach training, the movement
representation in the CFA changes in responsibility to an increase in wrist representation
and, to some extend, as well to digit representation accompanied by a decrease in elbow
and shoulder representation (Kleim et al., 1998). Since the mere repetitive motor use of a
limb has been shown to result in no net change in movement topography, the increase in
wrist and digit representation in the CFA goes back to skill acquisition (Nudo et al., 1997).
The increase in wrist representation in the CFA might be responsible for the increase in error
rate in the subelements pronate and release which depend on wrist movement. That these
subelements are not as heavily impaired as the advancing and only in the first or the first
two post-surgery weeks is probably due to the fact that the CFA in which the cannula was
implanted is still primarily responsible for elbow and shoulder movement. According to
several previous studies (Neafsey and Sievert, 1982;Neafsey et al., 1986;Colechio and
Alloway, 2009) and unpublished preliminary inactivation experiments in our lab, using the
GABAA agonist muscimol, we decided for the actual coordinates used in this study.
Moreover, a recent microstimulation study (Brown and Teskey, 2014) suggests the
coordinates used in the present study to be majorly involved in the advancing of the paw,
which is perfectly in line with the results of our study.
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The results of the ladder rung walking task show, that the most difficult condition
was the upward walk followed by the downward walk with a decrease in performance
especially in the first week after vehicle treatment that was again mitigated by memantine.
Since according to the reaching box experiment the elbow and shoulder movements were
most impaired after vehicle treatment during surgery, this would suggest that the rats have
problems exactly coordinating the affected forepaw when reaching for the next rung, which
becomes obvious from a decline in the paw placement accuracy. The diagonal conditions of
the rung ladder have been described as more challenging by Antonow-Schlorke et al. (2013)
with forelimb motor impairments being reflected by enhanced error scores with challenging
requirements in foot placement accuracy, interlimb coordination and balance. Since the
impairments in this task were minor and only present in the first week, the animals in the six
week group were not tested in this task.
The open field test was used to assess the locomotor behaviour of the animals by the
total distance travelled pre-as well as post-surgery. The overall decrease in the distance
travelled in the first post-surgery week of the 6-week animals followed by an increase to the
sixth week is probably due to the preceding surgery and an incomplete overall behavioural
recovery at that time point, which would be in line with the behaviour of the animals in their
home cages sleeping or resting a lot the week after the surgery.
In summary, the results of the present study show that memantine has
neuroprotective potential when locally applied during cannula implantation by promoting
the survival of neurons in the vicinity of the implant. This effect is accompanied by a
reduction in astrocytic scar formation directly around the implant in the motor cortex with
no effect on the microglia/macrophage activation. Moreover, memantine mitigated the
lesion-induced behavioural deficits especially in the skilled reaching task. These findings
suggest that memantine treatment is effective in reducing the foreign body response in the
brain. It needs to be elucidated in further studies whether coating of electrodes with
memantine improves the biocompatibility and long-term recording quality of BCIs in a
similar way.
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5 Suppression of the foreign body response and neuroprotection
by apyrase and minocycline in chronic cannula implantation
Linda Hayn, Linda Deppermann, Michael Koch
5.1 Abstract
Chronic implantation of electrodes or cannulae into the brain is accompanied by a tissue
response that is referred to as foreign body response. Persistent inflammation at the
interface between the implant and the brain tissue enhances the formation of a glial scar
that involves reactive microglial cells and astrocytes. The constitutive release of pro-
inflammatory molecules and cytotoxic substances by microglial cells in chronic settings
exacerbates neuronal death and tissue damage. An important signal molecule released by
injured or dying cells is ATP that activates the microglial cells which exacerbates tissue
damage and the immune response. In this study, we examined the effect of the ATP-
hydrolysing enzyme apyrase and the antibiotic minocycline on the foreign body response,
when locally applied during cannula implantation in the caudal forelimb area (CFA) of the
motor cortex (M1) in Lister Hooded rats. The rats’ behavioural performance was assessed in
a skilled reaching and a ladder rung walking task as well as in the open field. Moreover, the
distribution of neurons and glial cells in the vicinity of the implant was examined.
Minocycline as well as apyrase increased the number of surviving neurons and reduced
microglia/macrophage activation. However, minocycline most effectively improved the
skilled motor performance and, moreover, caused a temporary reduction in astrogliosis.
Local minocycline application proved sufficiently beneficial to suggest it as a promising
therapeutic candidate for improving the biocompatibility of chronic brain implants.
5.2 Introduction
Rehabilitation of sensory or motor functions in patients suffering from neurological diseases
or brain injury has been pursued for several decades now (Lebedev and Nicolelis,
2006;Jackson, 2012). Brain computer interfaces that substitute motor, sensory or cognitive
functions by stimulating or recording the activity of individual or small populations of
neurons after electrode implantation have been developed to restore lost nervous system
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function and have demonstrated feasibility even years after an injury to the central nervous
system (CNS) (Hochberg et al., 2012;Jackson, 2012). However, the implantation of an
electrode device into the brain is accompanied by a tissue response, also known as foreign
body response, that impedes the maintenance of neuronal signals over time (Polikov et al.,
2005;Griffith and Humphrey, 2006).
The foreign body response that accompanies the implantation of an indwelling device
into the brain can be classified into an acute and a chronic response. The acute response is a
1 to 3-week long process and is initiated by the mechanical trauma caused by device
implantation which disrupts the BBB and injures neurons and glial cells in the implantation
tract. This in turn induces a wound healing response that includes activated microglia and
infiltrated macrophages to clear cellular debris and excessive fluid, as well as reactive
astrocytes to insulate the implant and the damaged tissue from the surrounding healthy
tissue (Polikov et al., 2005). Once the acute inflammatory response declines, a chronic
response ensues that is characterised by astroglial encapsulation of the implant
accompanied by chronic inflammation at the interface. This is exacerbated by the activated
microglia and infiltrated macrophages that are in a state of “frustrated phagocytosis” due to
their inability to remove the foreign body, which results in a persistent release of pro-
inflammatory molecules (Polikov et al., 2005;Biran et al., 2005). Biran et al. (2005) suggested
that a large amount of cell loss does not solely result from the mechanical trauma of
insertion, but from the interplay with the chronic inflammation at the interface, which was
confirmed by further studies (Winslow and Tresco, 2010;Potter et al., 2012). For optimal
device function neuronal survival within the first 50 µm surrounding electrodes is imperative
to separate spike amplitudes of neurons (Buzsaki, 2004). The glial sheath formation is
suggested to be complete six weeks after foreign body implantation and remains stable
thereafter (Turner et al., 1999;Szarowski et al., 2003).
In the acute phase of trauma injured and dying cells release early neuronal “danger
signals” like the nucleotide adenosine triphosphate (ATP) which increases within minutes
after an injury, due to neuronal and glial depolarisation or simply due to leakage through
damaged cell membranes (Davalos et al., 2005;Kono and Rock, 2008;Iadecola and Anrather,
2011). ATP and its metabolite ADP are important activators of glial cells (Davalos et al., 2005)
by binding to purinergic P2 receptors (Fields and Burnstock, 2006;Burnstock, 2008).
Astrocytes as well as microglia contain diverse subtypes of purinergic receptors which
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depend in their activation on the amount of released ATP (Inoue, 2002;Hanisch and
Kettenmann, 2007). Activated microglia proliferate and migrate to the site of injury to clear
cellular debris, with ATP inducing the chemotaxic response of their processes and the
movement of these cells to the site of injury (Haynes et al., 2006;Burnstock, 2008). On the
one hand, after microinjury and homeostatic disturbances, such as tiny vascular or tissue
damages, microglia are known to phagocyte foreign material and cellular debris and to
secrete predominantly neurotrophic factors, that promote neuronal growth and survival.
However, under excessive acute or chronic conditions, such as at an interface, they
persistently release pro-inflammatory molecules as well as of cytotoxic factors due to their
enduring activity and their inability to degrade the foreign material (Inoue, 2002;Polikov et
al., 2005;Hanisch and Kettenmann, 2007).
Initially released from the damaged tissue high levels of ATP persist in the
peritraumatic zone for many hours after an insult which triggers cell death of even healthy
neurons by irreversibly increasing cytosolic Ca2+-levels and neuronal degeneration (Wang et
al., 2004). Extracellular ATP also triggers intercellular Ca2+-levels in astrocytes (Wang et al.,
2000) and the release of regenerative ATP from internal pools (Anderson et al., 2004). In
turn, astrocytes release ATP through regulated pathways to mediate intercellular Ca2+-wave
propagation to distant cells. This ATP-triggered ATP release from astrocytes was suggested
to be an important mediator of the directional chemotactic response of the microglia
(Davalos et al., 2005) that is followed by the release of pro-inflammatory cytokines such as
IL-1β, IL-6 and TNFα (Bianco et al., 2005). Moreover, in addition to ATP release from
astrocytes, they also release the excitatory transmitter glutamate. Glutamate-mediated
excitotoxicity further contributes to neuronal cell loss especially via the overstimulation of
extrasynaptically localised N-methyl-D-aspartate (NMDA) receptors (Lipton and Rosenberg,
1994;Lynch and Guttmann, 2002). The contribution of glutamate-mediated excitotoxicity to
the foreign body response has previously been investigated using the uncompetitive NMDA
receptor antagonist memantine (Hayn and Koch, 2015).
Since ATP, and to a lesser extent also ADP, are able to induce a rapid microglial
response (Davalos et al., 2005), in the present study we decided to use the ATP/ADPase
apyrase that hydrolyses extracellular nucleoside triphosphates as well as diphosphates. We
intended to suppress the extent of immune response by interrupting the inflammatory
cascade at a very early stage to also promote the survival of neurons. Moreover, we used
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the semi-synthetic second-generation tetracycline minocycline with a broad range of anti-
inflammatory, anti-apoptotic and glutamate-antagonist properties (Elewa et al., 2006). Time-
points chosen for tissue examination were two and six weeks constituting the end of the
acute and of the chronic phase of the immune response.
The present study aimed to further understand and control the foreign body
response and serves as a proof-of-principle investigation mimicking the implantation of a
device such as an electrode array into the motor cortex by means of a steel cannula. The
initial steps of the foreign body response are considered to be of particular relevance and
were intended to be blocked to counteract the extent of neurotoxicity and inflammation at
the implantation site by a single local application of either apyrase or minocycline during
cannula implantation in order to mimic local drug delivery from coated electrodes. The
extent of tissue damage in M1 of rats was investigated on the behavioural level using the
skilled reaching task (Whishaw et al., 1986;Whishaw and Pellis, 1990), the ladder rung
walking task (Metz and Whishaw, 2002;Antonow-Schlorke et al., 2013) and the open field
box. Rats were tested before and once a week after the implantation of a cannula into the
CFA of M1. Moreover, the spatial distribution of neurons and glial cells was
immunohistologically analysed at the implantation site two weeks as well as six weeks after
cannula implantation.
5.3. Materials and Methods
The materials and methods used in this study have already been described in detail
previously (Hayn and Koch, 2015) and are only briefly addressed here.
5.3.1 Animals
A total of 60 naive adult male Lister Hooded rats (Charles River Laboratories, Germany)
weighing 200-220 g were used in this study. Rats were group-housed under standard
conditions in Makrolon cages (type IV) on a 12 h light/dark cycle (lights on at 7:00 a.m.) with
controlled temperature and humidity. All rats received tap water ad libitum and were
restricted to 12 g standard diet rodent chow (Altromin, Germany) per rat per day as soon as
the training started. The experiments were conducted in compliance with the ethical
guidelines of the National Institute of Health for the care and use of laboratory animals for
experiments and were approved by the local animal care committee (Senatorische Behörde,
Bremen, Germany).
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5.3.2 Timeline
The study was designed to assess the effects of acute apyrase (grade VII apyrase from
potato; A 6535; Sigma Aldrich, Steinheim, Germany) treatment with an ATPase/ADPase ratio
of approximately 1 as well as minocycline (minocycline hydrochloride; M 9511; Sigma
Aldrich, Steinheim, Germany) treatment locally administered during the implantation of a
cannula into the CFA of M1. For this purpose, the rats were habituated and individually
trained in the single-pellet reaching boxes (Whishaw et al., 1986;Whishaw and Pellis, 1990)
at least four weeks before the experiments started. After reaching a stable baseline with a
hit-reach-ratio of at least 75 % the rats were pseudo-randomly assigned to six groups,
receiving either artificial cerebrospinal fluid (aCSF), which served as the control,
apyrase (0.3 U/µl) or minocycline (20 µg/µl). Brains were removed for histological analysis
either two or six weeks after cannula implantation. All animals were tested in the single-
pellet reaching box and in the open field the day before cannula implantation and once a
week after the implantation. Moreover, the 2-week group was tested on a ladder rung
walking task for further analysis of the rats’ skilled walking ability and received one week of
previous training for this task.
5.3.3 Single-pellet reaching task
The single-pellet reaching task was chosen to define the preferred forepaw of each rat and
to analyse the functionality of the motor cortex contralateral to this paw before and after
cannula implantation.
5.3.3.1 Single-pellet reaching boxes
The single-pellet boxes (Fig. 5.1) had a vertical slit at the centre of the front wall, and a shelf
in the front of the slit, on which casein pellets (45 mg Dustless Precision Pellets, Bio-Serv®,
UK) were placed in one of two indentations. These indentations were located 2 cm from the
inside of the wall aligned with the edges of the slit in order to prevent the rats using the
tongue to lap the pellet and to ensure that they only reach the pellet in the indentation
contralateral to the preferred paw. After the habituation phase, two additional
polycarbonate side walls were inserted in the box to ensure that the rats directly approach
the slot with their body postures always in a similar orientation.
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Fig. 5.1. Single-pellet reaching box. Photograph of the skilled reaching box with additionally inserted
side walls.
5.3.3.2 Training and testing
Training sessions in the skilled reaching box consisted of a habituation phase in which the
preferred paw was identified. The rats were trained to walk to the rear wall of the box after
every trial to initiate the next one, however, only trials in which they successfully reached a
pellet in the first attempt were rewarded by an additional pellet in the back. Training
sessions consisted of daily 5-10 min sessions per rat for about 4-5 weeks until they reached a
stable baseline of at least 75% correct responses.
5.3.3.3 Behavioural analysis
The reaching performance in the single-pellet boxes was recorded for 5 min on each test day
using a Panasonic NV-DS60 digital video camera (shutter speed 1/50 s) and a cold-light
source for improved subsequent frame-by-frame analysis (25 frames/s). All experiments
were performed with the experimenter being blind to the treatment protocol.
Quantitative analysis:
Hit-reach-ratio. The success rate of each rat was calculated from the total number of hits
compared to the total number of reaches. Reaching attempts were scored as long as the
pellet was in the respective indentation. A successful reach was scored as a hit (“1 hit”) when
the pellet was grasped and consumed in the first attempt. If the pellet was grasped, but
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dropped in the box an incomplete hit (“0.5 hits”) was scored. An incomplete hit was also
scored when the rat had missed the pellet, which was scored as a miss (“1 miss”), but then
grasped the pellet from the indentation without previously withdrawing the paw through
the slot. Repeated, unsuccessful attempts without paw withdrawal from the shelf were
scored as repeated misses (“0.5 misses”) with only the first miss being scored as complete
miss. Moreover, attempts in which the rat approached the slot, but dropped the paw on the
inner edge, were scored as incomplete attempts (“0.5 misses”).
The hit-reach-ratio was calculated by the sum of hits and incomplete hits divided by
the total number of reaches. Each hit as well as each incomplete hit was counted as one
attempt as well as the complete misses and was hence scored as “1 reach”. Only repeated
misses and incomplete attempts were counted as half attempts and were hence scored as
“0.5 reaches”.
Qualitative analysis:
Movement pattern analysis. Each forelimb movement during a successful hit in the single-
pellet box consists of 12 movement subelements: Orientation, limb lift, digits flexion, aim,
advance, digits extension and opening, pronation, grasp, supination I, supination II, release
and replace (Alaverdashvili et al., 2008;Alaverdashvili and Whishaw, 2010;Hayn and Koch,
2015). The first five attempts on each test day before and after the surgery were analysed
for these 12 subelements and rated using a three-point scale. A successful normal
subelement was rated “0”, when the subelement was present but abnormal it was rated
“0.5”, and when it was absent or incomplete and resulted in a miss or of loss of the pellet it
was rated “1”. Scoring was achieved by means of frame-by-frame analysis.
5.3.4 Open field
The locomotor activity of the rats was analysed in infrared-controlled activity chambers
(44.7 cm x 44.7 cm x 44.0 cm; ActiMot-system, TSE, Bad Homburg, Germany) by the total
distance travelled [m] that was measured from the rats’ horizontal activity for 30 min the
day before cannula implantation and once weekly after the implantation.
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5.3.5 Ladder rung walking task
For further analysis of the rats’ preferred forelimb, the skilled walking ability of the 2-week
group was tested on a ladder rung walking task in a horizontal condition (Metz and
Whishaw, 2002), and additionally, in a diagonal condition according to a modified version of
Antonow-Schlorke et al. (2013) to further analyse the performance of the rats’ preferred
forelimb contralateral to the cannula implantation site.
5.3.5.1 Ladder rung walking test apparatus
The test apparatus was manufactured according to Metz and Whishaw (2002) by in-house
mechanics of the University of Bremen. The rung ladder was 1 m in length with metal rungs
linking the side walls. During the training phase the rungs were placed at a regular
arrangement with a distance of 2 cm between the rungs. In the horizontal condition
(Fig. 5.2A) the ladder was elevated about 1 m above the floor with a platform at both ends.
The angle of inclination of the rung ladder for the upward and the downward condition
(Fig. 5.2B) was about 38.32°. Rats crossed the ladder from a neutral platform to a platform
on the other side with casein pellets as reward.
Fig. 5.2. Ladder rung walking test apparatus. Irregular arrangement of rungs in horizontal (A) and
diagonal directions (B).
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5.3.5.2 Training and testing
After a short training phase on the regular pattern single rungs in the middle part of 60 cm
were removed to receive an irregular pattern with rung-to-rung distances of 2-6 cm. Two
templates of irregular patterns, pattern A and B, were applied to prevent the rats from
learning the pattern. After the rats accomplished to cross the ladder fluently, they were
video recorded the day before the surgery and once a week for two weeks after the surgery.
5.3.5.3 Foot fault scoring
The skilled walking performance was evaluated qualitatively by means of frame-by-frame
analysis using a seven-category scale: Correct placement, partial placement, correction,
replacement, slight slip, deep slip and total miss (Metz and Whishaw, 2002;Antonow-
Schlorke et al., 2013;Hayn and Koch, 2015). Scores from 6 to 0 points were given and only
the forelimb that was preferred in the reaching box was rated. When different errors
occurred at the same time, the lowest score was given. In case of a fall, the preferred
forelimb was only rated when it initiated the fall.
5.3.6 Cannula implantation and drug administration
Substances administered during the implantation of the cannula were either aCSF which
served as control, or apyrase or minocycline dissolved in aCSF (with pH adjusted to 7.4).
Substances were freshly prepared before surgery and administration occurred in a
pseudorandom order by a treatment-blind experimenter.
Rats of all groups were anesthetised by intraperitoneal (i.p.) injections of 60 mg/kg
pentobarbital (Sigma Aldrich, Steinheim, Germany) and 10 mg/kg xylazine (Rompun®; Bayer,
Leverkusen, Germany). To mitigate the respiratory depressive effects of pentobarbital
0.1 mg/kg atropine (Braun, Melsungen, Germany) were administered subcutaneously (s.c.).
Rats were fixed in a stereotaxic apparatus (Kopf Instruments, Tujunga, CA, USA) and were
implanted with a blunted stainless steel 27 gauge injection cannula of 0.4 mm in diameter
(Braun, Melsungen, Germany) into the CFA of M1 contralateral to the preferred forelimb.
Drugs were administered during the implantation procedure with 0.5 µl being applied to the
cortical surface and further 0.5 µl being administered during the implantation of the
cannula. Coordinates for implantation according to bregma (AP: +1.5 mm; ML: ±2.3 mm;
DV: -2.3 mm) were derived from previous mapping studies (Neafsey et al., 1986;Hyland,
1998;Colechio and Alloway, 2009) and additional pre-tests of our workgroup using the
GABA (γ-aminobutyric acid)A-agonist muscimol to temporarily inactivate this region.
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5.3.7 Perfusion and tissue collection
Upon completion of the last test, the rats were euthanised with a lethal dose of
pentobarbital (200 mg/kg; i.p.) and transcardially perfused with 4% PFA. The brains were
removed from the skull and post-fixed for 24 h followed by cryoprotection in 30% sucrose
solution for 48 h. Subsequently, six series of horizontal 40 µm sections of the cortical
implantation site were cut on a cryostat (Jung CM 3000, Leica Instruments GmbH, Nussloch,
Germany).
5.3.8 Histology
Brain slices of the first series were Nissl-stained to control the coordinates of the
implantation site by means of a rat brain stereotaxic atlas (Paxinos and Watson, 1998). The
extent of inflammation and the number of the neurons around the implantation site were
analysed by immunohistological staining for neurons (neuronal nuclei; NeuN) with mouse
anti-NeuN (Millipore, Darmstadt, Germany), for astrocytes (glial fibrillary acid protein; GFAP)
with rabbit anti-GFAP (DAKO, Hamburg, Germany) and for microglia/macrophages (ionised
calcium binding adaptor molecule 1; IBA-1) with rabbit anti-IBA-1 (1:2000; WAKO, Neuss,
Germany). Secondary antibodies were biotinylated goat anti-rabbit IgG (DAKO, Hamburg,
Germany) followed by Cy3-labeled streptavidin (Sigma, Steinheim, Germany) for the
astrocytes as well as for the microglia/macrophages and Alexa Fluor 488 goat anti-mouse IgG
(Dianova, Hamburg, Germany) for the neurons. Sections were mounted on microscope slides
and counterstained with Sudan Black (Acros, New Jersey, USA) to eliminate background
immunofluorescence and autofluorescence before being coverslipped for imaging.
5.3.9 Image analysis
Fluorescent images of tissue sections from layers V of the cortex near the tip of the cannula
were taken using a Zeiss Axioskop fluorescence microscope (Göttingen, Germany). Z-stack
images were captured with a 20 x objective around the implantation site for neurons and for
microglia/macrophages to individually count the cells and with a 10 x objective for
astrocytes to examine their distribution. Exposure times and gamma values were held
constant for each cellular marker. Quantification was performed using the image processing
software FIJI (ImageJ). The implantation region was manually delineated and regions of
interest (ROIs) were defined in 50 µm concentric circles up to 300 µm from the interface for
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neurons and microglia/macrophages and up to 500 µm for astrocytes. Large blood vessels or
other irregularities were excluded from the ROIs. In order to improve visual display images in
this report have been pseudo-coloured (Fig. 5.3).
Quantification of the neuronal population surrounding the implantation site
(Fig. 5.3A) was accomplished by manually counting the neurons in each ROI around the
implantation site and by calculating the average number of neurons [n] for bins of 50 µm²
for each treatment. The same procedure was applied to the images of the
microglia/macrophages (Fig. 5.3B). The motor cortex of the hemisphere contralateral to the
implantation site of aCSF-treated animals served as the control.
The distribution of the astrocytic scar (Fig. 5.3C) was examined by an enhancement
of contrast by 0.3%, followed by the application of an auto local threshold (method: median;
radius: 80 pixel; correction value (c): -30) in order to obtain binary images. The average area
covered with astrocytes [%] was calculated for each ROI. Again the motor cortex of the
hemisphere contralateral to the implantation site of aCSF-treated animals served as the
control.
Fig. 5.3. Image analysis. Fluorescent images of tissue sections from layers V of the CFA two weeks
after cannula implantation. ROIs were defined in 50 µm concentric circles up to 300 µm from the
interface for neurons (A) and microglia/macrophages (B) and up to 500 µm for astrocytes (C).
Horizontal and vertical lines in indicate the bins of 50 µm² for which the average number of cells was
calculated. Scale bar = 200 µm.
5.3.10 Statistical analysis
Descriptive statistics are based on means and variances indicated as standard error of the
mean (+S.E.M.). Statistical analyses were run using the statistical software SigmaStat
(version 2.03 for Windows) using a two-way repeated measures analysis of variance (two-
way RM ANOVA) for the behavioural tests with the factors treatment and test day, and for
the immunohistological investigations with the factors treatment and distance from the
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implantation site for each marker and time point. Post-hoc pairwise comparisons using a
Tukey’s t-test were defined to be significant at P < 0.05. Animals that did not reach a stable
baseline performance of 75% correct responses in the skilled reaching task or lost the acrylic
cap after cannula implantation were excluded from further analysis.
5.4 Results
5.4.1 Behavioural experiments
A total of six animals were excluded from the data analysis either due to a loss of the acrylic
cap (n=2) or due to not reaching a stable baseline of at least 75% correct responses in the
single-pellet reaching task (n=4). Data of all 54 participating animals (vehicle: n = 18;
apyrase: n = 17; minocycline: n = 19) are included in the bar plots and statistics of the first
two weeks for all behavioural experiments except for the ladder rung walking task that was
exclusively applied to the 2-week animals and contains the data of 28 animals that remained
for two weeks in the experiment. Bar plots and statistics of the 6-week group contain the
data of 26 animals that remained in the experiment up to the sixth week. Each treatment
group accordingly contains eight to ten animals.
5.4.1.1 Single-pellet reaching task
Hit-reach-ratio. Before cannula implantation into the CFA contralateral to the preferred
forelimb, rats of all treatment groups had reached a stable baseline in the reaching boxes
with a hit-reach-ratio of at least 75%. Local vehicle treatment during cannula implantation
decreased the performance at all time points measured. Apyrase and minocycline amended
the performance with a stronger effect for minocycline which increased the performance at
all time points measured compared to controls. The statistical data analysis revealed for the
first two weeks (Fig. 5.4A) a significant main effect of drug treatment (F2,102 = 6.148;
P = 0.004) and time point of measurement (F2,102= 50.218; P < 0.001), as well as a significant
interaction drug x time point of measurement (F4,102 = 3.634; P = 0.008). Post-hoc
comparisons showed that the decrease of the hit-reach-ratio within the first post-surgery
week was significant for vehicle and apyrase (P < 0.001) as well as for minocycline (P = 0.001)
compared to pre-surgery. The performance decrease in the second post-surgery week was
only significant for vehicle (P < 0.001) and apyrase (P = 0.001) compared to pre-surgery, but
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not for minocycline. After minocycline treatment the performance was significantly
improved compared to controls in both post-surgery weeks (P ≤ 0.001), which was also the
case for apyrase in the second post-surgery week (P = 0.027). Statistical data analysis of the
hit-reach-ratio for the 6-week animals (Fig. 5.4B) also revealed a significant main effect of
drug treatment (F2,138 = 9.706; P < 0.001) and time point of measurement (F6,138 = 17.997;
P < 0.001) with post-hoc comparisons revealing a significantly decreased the hit-reach-ratio
after cannula implantation in all six post-surgery weeks compared to pre-surgery for vehicle
(P ≤ 0.001). Performance decrease was also significant for apyrase and minocycline in the
first post-surgery week (P < 0.001) compared to pre-surgery, but exhibited constant recovery
thereafter that reached statistical significance (P < 0.05) in the fourth week for apyrase and
already in the third week for minocycline. Performance was significantly improved compared
to vehicle in the sixth post-surgery week for apyrase (P = 0.029) and in all post-surgery weeks
for minocycline (P < 0.05).
Fig. 5.4. Hit-reach-ratio. Quantitative data analysis of the rats’ performance in the skilled reaching
task before and once weekly after the implantation of a cannula into the CFA contralateral to the
preferred forepaw accompanied by either local vehicle (aCSF), apyrase or minocycline treatment two
weeks (n = 54) (A) and six weeks (n = 26) post-surgery (B). Data are means +S.E.M. Asterisks denote a
significant difference (Tukey’s t-test; P < 0.05) between pre- and post-surgery tests of a certain
treatment. Significant treatment differences on a certain test day compared to vehicle are indicated
by circles. A significant post-surgery effect of a certain treatment is indicated by the triangle (here:
compared to the first post-surgery week).
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Movement pattern analysis. In addition to the quantitative hit-reach-ratio analysis, the
qualitative movement pattern analysis of the first five trials on each test day revealed that
the subelements most impaired after cannula implantation were advancing and pronation of
the paw. Minor impairments were detected in the subelements grasp and release. In
compliance with the results of the hit-reach-ratio-analysis, vehicle treatment caused the
strongest increase in errors within the first post-surgery week with especially minocycline
reducing these error scores.
The subelement advance revealed the most increased error rates after cannula
implantation in all treatment groups with the animals often advancing the paw not far
enough through the slot to reach the pellet or sweeping the pellet off the shelf when
touching it only with the tips of the digits. The strongest increase in errors occurred with
vehicle and apyrase treatment with minocycline amending these motor impairments. The
statistical data analysis revealed for the first two weeks (Fig. 5.5A) a significant main effect
of drug treatment (F2,102 = 5.480; P = 0.007) and time point of measurement (F2,102 = 32.718;
P < 0.001) as well as of the interaction drug x time point of measurement (F4,102 = 3.097;
P = 0.019). Post-hoc comparisons showed that the increase in the number of errors in this
subelement was significant for vehicle treatment (P < 0.001) in both post-surgery weeks
compared to pre-surgery. For apyrase (P < 0.001) and minocycline (P = 0.013) the increased
error rate only reached statistical significance in the first post-surgery week compared to
pre-surgery. Minocycline decreased the error rate in the first (P < 0.011) and second
(P < 0.001) post-surgery week compared to vehicle treatment. For the 6-week animals
(Fig. 5.5B) there was also a significant main effect of drug treatment (F2,138 = 17.319;
P < 0.001) and time point of measurement (F2,138 = 15.044; P < 0.001) with post-hoc
comparisons revealing a significant increase in errors for vehicle within the first five post-
surgery weeks (P < 0.05) with a significant decrease in errors from the first to the fifth and
sixth week (P < 0.05). For apyrase the increase in errors was significant in the first (P < 0.001)
and in the third post-surgery week (P = 0.038) compared to pre-surgery, with a significant
decrease in errors after the first week (P < 0.05). Minocycline amended the motor
performance and decreased the error rate statistically significant (P < 0.05) within the first
five post-surgery weeks compared to vehicle and only resulted in a significant increase in
errors in the first week (P = 0.015) with a significant decrease in post-surgery weeks three to
five (P < 0.05).
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Fig. 5.5. Movement pattern analysis. Qualitative data analysis of the most impaired subelements
within the first five trials in the skilled reaching task before and once weekly after cannula
implantation accompanied by local vehicle, apyrase or minocycline treatment two (n = 54) (A,C) and
six weeks (n = 26) post-surgery (B,D). Data are means +S.E.M. Asterisks denote a significant
difference (Tukey’s t-test; P < 0.05) between pre- and post-surgery tests of a certain treatment.
Significant treatment differences on a certain test day compared to vehicle are shown by circles. A
significant post-surgery effect of a certain treatment is indicated by the triangle (here: compared to
the first post-surgery week).
The error rate of the subelement pronate was not that pronounced, but vehicle-
treated rats often not fully extended and opened their digits or omitted the rotation of the
wrist, hence missing the pellet or grasping the pellet with a lateral swipe of the paw. This
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effect was again most intense within the first two post-surgery weeks and was improved by
apyrase and minocycline. Within these first two post-surgery weeks (Fig. 5.5C) a significant
main effect of drug treatment (F2,102 = 5.524; P = 0.007) and time point of measurement
(F2,102 = 9.641; P < 0.001) was revealed. Further post-hoc comparisons showed that the
increase of errors in this subelement was significant after vehicle treatment in both post-
surgery weeks (P < 0.01) compared to pre-surgery. Apyrase as well as minocycline improved
the performance within both post-surgery weeks reaching statistical significance in the first
post-surgery week for minocycline (P = 0.004) and in the second post-surgery week for
apyrase as well as minocycline (P < 0.05). Within the 6-week group (Fig. 5.5D) there was also
a significant main effect of drug treatment (F2,138 = 4.816; P = 0.018) and time point of
measurement (F2,138 = 2,758; P = 0.015). Post-hoc comparisons did not reach statistical
significance for the increase in errors after the surgery when treated with vehicle, though,
the decrease in errors after minocycline treatment was significant in the first and fifth post-
surgery week (P < 0.01) compared to vehicle.
The subelements grasp and release revealed only minor impairments, and are hence,
not further illustrated. The error rate of the subelement grasp was only slightly enhanced
after the surgery with the rats from time to time either pulling the pellet instead of properly
grasping and lifting it or grasping the pellet in a deviant way with only one or two digits.
Statistical analysis did not reveal a significant main effects for the first two weeks, however
for the 6-week group a significant main effect of the drug treatment (F2,138 = 6.087;
P = 0.008) was revealed, with the apyrase-treated animals exhibiting a significantly
decreased error rate (4.69% ± 3.29) in this subelement compared to vehicle (20.37% ± 7.10)
in the third post-surgery week (P = 0.041). The subelement release also slightly increased
after cannula implantation with the animals from time to time showing difficulties to open
their paw to release the pellet into the mouth. However, statistical data analysis revealed no
significances.
The other subelements were even less or not at all impaired within the first five trials.
The subelement replace was difficult to examine, since the rats often turned around in the
box to walk to the back without replacing the paw pre- as well as post-surgery and hence,
often no scores could be given and the subelement had to be excluded.
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3.1.2. Open field
The analysis of the rats’ locomotor activity measured by the total distance travelled [m] in
30 min served as a control paradigm and revealed no significant main effects of the
interaction drug x time point of measurement. Within the first two weeks (Fig. 5.6A) only a
significant main effect of the time point of measurement (F2,102 = 4.989; P = 0.009) was
revealed with post-hoc comparisons indicating a significant increase in the total distance
travelled from the first to the second post-surgery week for minocycline (P = 0.005),
however without any significant differences compared to pre-surgery or compared to
vehicle. For the 6-week group (Fig. 5.6B) a significant main effect of the drug treatment was
revealed (F2,138 = 3.473; P = 0.048), with post-hoc comparisons indicating a significant
increase in the distance travelled for the apyrase-treated animals in the fourth (P < 0.013)
and the sixth post-surgery week (P < 0.015) compared to vehicle-treated animals, however,
this increase was not significant compared to pre-surgery and a more detailed data analysis
indicated that this increase goes back to two outliers.
Fig. 5.6. Open field. Analysis of the rats’ total distance travelled [m] within 30 min on the day before
and once weekly after cannula implantation two (n = 54) (A) and six weeks (n = 26) post-surgery (B).
Data are means +S.E.M. Significant treatment differences on a certain test day compared to vehicle
are shown by circles. The triangle denotes a significant post-surgery difference (Tukey’s t-test;
P < 0.05) within a certain treatment (here: compared to the first post-surgery week).
5.4.1.3 Ladder rung walking task
The data analysis of the foot placement scores of the 2-week animals on the rung ladder
revealed the ladder’s diagonal conditions to be more difficult than the horizontal. Vehicle
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treatment during cannula implantation caused a slight decrease of performance in the
ladder’s horizontal condition (Fig. 5.7A) and a more intense decrease in the ladder’s upward
(Fig. 5.7B) and downward conditions (Fig. 5.7C) that could be improved by both, apyrase and
minocycline. Statistical analysis by means of a two-way RM ANOVA revealed only a
significant main effects for the ladders’ downward condition (F2,50 = 4.325; P = 0.024) with
further post-hoc comparisons indicating that the performance decrease was significant in
the first post-surgery week after vehicle treatment compared to pre-surgery (P = 0.004) as
well as compared to apyrase (P = 0.002) and minocycline (P = 0.013). The apparent
performance decrease in the ladder’s upward condition after vehicle treatment compared to
apyrase and minocycline in the first post-surgery reached statistical significance when
applying a one-way ANOVA. This analysis revealed a significant main effect between the
treatment groups (F2,25 = 6.224; P = 0.006) within the first post-surgery week with post-hoc
comparisons revealing a significantly improved performance after apyrase (P = 0.010) and
minocycline treatment (P = 0.020) compared to vehicle.
Fig. 5.7. Ladder rung walking task. Analysis of the rats’ skilled walking ability on the rung ladder in
horizontal (A), upward (B) and downward (C) conditions on the day before and once weekly for two
weeks after the implantation of a cannula (n=28). Data are means +S.E.M. The asterisk denotes a
significant difference (Tukey’s t-test; P < 0.05) between pre- and post-surgery tests using a two-way
RM ANOVA. Circles denote a significant difference on a certain test day compared to vehicle. The plus
symbolises a significant difference (Tukey’s t-test; P < 0.05) on a certain test day compared to vehicle
using a one-way ANOVA.
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5.4.2 Histology
The microscopic examination of the Nissl-stained sections revealed that all implantation sites
were located within the CFA. Some of the implantation sites were tattered after cannula
removal and hence had to be excluded from further histological analysis. Six weeks post-
surgery more brains with well preserved implantation sites and intact glial sheath were
obtained compared to two weeks post-surgery obviously due to a stronger and more
compact cellular sheath around the cannula that was less easily damaged at this time point.
Data analysis for histological examination included 2-3 sections from 4-7 rats per treatment
group and per time point.
5.4.2.1 Neuronal distribution
The distribution of neurons in the CFA around the cannula was assessed by immunostaining
for NeuN, a nuclear antigen found in neurons. As control tissue served the CFA contralateral
to the implantation site of the vehicle-treated animals. Two as well as six weeks after the
implantation of the cannula a reduction in neuronal nuclei within a region of 50 µm from the
implant was observed after vehicle treatment. Apyrase as well as minocycline was able to
increase the number of neurons within this distance. Statistical analysis revealed a
significant main effect of distance to the implantation site (F5,80 = 5.569; P < 0.001) and of the
interaction drug x distance (F15,80 = 2.964; P < 0.001) for the number of neurons within the
2-week group (Fig. 5.8A). Further post-hoc comparisons indicated a significant reduction in
the average number of neurons in the first 50 µm around the implantation site after vehicle
treatment compared to all further intervals up to 300 µm (P < 0.001) as well as compared to
the contralateral control hemisphere (P < 0.001). The average number of neurons within the
first 50 µm was significantly increased with apyrase (P = 0.015) as well as with minocycline
(P = 0.015) compared to vehicle. For the 6-week animals (Fig. 5.8B) no significant main effect
was revealed with the two-way RM ANOVA. Since the first interval still implies an enduring
loss of neurons in the vehicle group after six weeks a one-way ANOVA was applied that
revealed a significant main effect of drug treatment within these first 50 µm (F3,18 = 5.343;
P = 0.008). Post-hoc comparisons indicated an enduring significant reduction in the average
number of neurons after vehicle treatment compared to the control tissue (P = 0.021).
Moreover, apyrase was able to significantly increase the number of neurons within this
distance (P = 0.008), with minocycline also indicating a trend towards an increase (P = 0.097).
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The average number of neurons contralateral to the implantation site was about the same
two and six weeks post-surgery.
Fig. 5.8. Average number of NeuN+ nuclei. Quantification of the average number of neuronal nuclei,
as a function of distance from the implantation site, is shown two (n = 14) (A) and six weeks (n = 17)
post-surgery (B). Data are means +S.E.M. The asterisks denotes a significant difference (Tukey’s t-
test; P < 0.05) between the first interval of 50 μm and an interval further away (up to 300 μm) of a
certain treatment. Circles denote a significant difference within a certain interval compared to
vehicle. The plus symbolises a significant difference (Tukey’s t-test; P < 0.05) on a certain test day
compared to vehicle using a one-way ANOVA. Brackets () indicate a trend of significance (Tukey’s t-
test; P<0.1).
5.4.2.2 Microglial/Macrophagial distribution
The distribution of microglia/macrophages in the CFA around the cannula was assessed by
immunostaining for IBA-1, an antigen that is specifically expressed in resting and activated
microglia and macrophages, and is up-regulated upon activation during inflammation. Two
as well as six weeks after cannula implantation, a strong increase in microglia/macrophages
within the first 50 µm from the implant was observed independent of the treatment.
Moreover, an overall increase in the number of microglia/macrophages two weeks
compared to six weeks after the implantation was revealed as assessed by means of the
control tissue. Apyrase as well as minocycline was able to decrease the total number of
microglia/macrophages within the first 50 µm two weeks after the implantation, which
remained consistently lower up to six weeks post-surgery for minocycline. Statistical analysis
revealed a significant main effect of drug treatment (F3,80 = 7.959; P = 0.002) and distance
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(F5,80 = 39.765; P < 0.001) as well as of their interaction (F15,80 = 7.181; P < 0.001) for the
microglia/macrophage distribution of the 2-week animals (Fig. 5.9A). Further post-hoc
comparisons indicated a significantly increased number of microglia/macrophages in the first
50 µm around the implantation site for all treatments (P ≤ 0.001) when compared to all
further distances as well as when compared to the control tissue. The interval of 50-100 µm
comprised a significantly increased number of microglia/macrophages compared to 200-
300 µm from the implantation site only after vehicle treatment (P < 0.001). The intervals of
50-100 µm and 150-200 µm also exhibited significantly increased numbers of
microglia/macrophages compared to control tissue (P < 0.05) after vehicle treatment.
Apyrase as well as minocycline was able to significantly diminish this increase in
microglia/macrophages that was present after vehicle treatment within the first 50 µm
(P < 0.05).
Fig. 5.9. Average number of IBA-1+ cells. Quantification of the average number of microglia/
macrophages, as a function of distance from the implantation site, is shown two (n = 14) (A) and six
weeks (n = 17) post-surgery (B). Data are means +S.E.M. Asterisks denote a significant difference
(Tukey’s t-test; P < 0.05) between an interval close to the implantation site and any interval further
away (up to 300 μm) of a certain treatment. Circles denote a significant difference within a certain
interval compared to vehicle. A significant difference of any treatment compared to no intervention
within a certain interval is indicated by a rhomb. Brackets () indicate a trend of significance (Tukey’s t-
test; P<0.1).
Six weeks after cannula implantation (Fig. 5.9B) a significant main effect of drug treatment
(F3,90 = 4.135; P = 0.021) and distance (F5,90 = 64.886; P < 0.001) as well as of their interaction
(F15,90 = 9.112; P < 0.001) was observed. Post-hoc comparisons also revealed for this time
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point a significant increase in the number of microglia/macrophages in the first 50 µm for all
treatments (P < 0.001) when compared to all further distances as well as when compared to
the control tissue. Within a distance of 50-100 µm the number of microglia/macrophages
was also significantly increased for all treatments (P < 0.05) when compared to distances
further away than 150 or 200 µm. The number of microglia/macrophages within 50-100 µm
from the implantation site was again only significantly increased after vehicle treatment
compared to the untreated hemisphere (P = 0.018). With minocycline the number of
microglia/macrophages within the first 50 µm persisted to be significantly diminished
compared to vehicle (P = 0.006) with a trend towards a significantly diminished number with
apyrase compared to vehicle (P = 0.061). Moreover, there was a significant main effect of
the time point of measurement evident in the control tissue (F1,45= 5.512; P < 0.043) with an
overall increase of microglia/macrophages two weeks compared to six weeks post-surgery.
5.4.2.3 Astroglial distribution
The distribution of astrocytes in the CFA was assessed by immunostaining for GFAP, an
antigen that is expressed in the intermediate filaments of immature and mature resting or
activated astrocytes, and is up-regulated upon activation during inflammation. Two as well
as six weeks after cannula implantation, an increased astrocytic immunoreactivity around
the implant was observed independent of the treatment with a further expansion of the scar
tissue in all treatment groups two weeks post-surgery. Moreover, an overall GFAP-
upregulation was observed two weeks compared to six weeks after the implantation as
assessed by means of the control tissue. Statistical analysis revealed for the 2-week animals
(Fig. 5.10A) a significant main effect of distance (F9,144 = 490.832; P < 0.001) as well as of the
interaction drug treatment x distance (F27144 = 65.870; P < 0.001). Further post-hoc
comparisons indicated for the first 100 µm, that cannula implantation increased astrocyte
density significantly independent of the treatment when compared to the untreated control
hemisphere (P ≤ 0.001). Astrocyte levels were moreover significantly enhanced (P < 0.05) up
to 300 µm from implantation site for vehicle, up to 250 µm for apyrase, and up to 200 µm
for minocycline compared to distances further away (measured up to 500 µm). At distances
further away than 300 µm for apyrase and further away than 350 µm for vehicle and
minocycline astrocyte levels were significantly decreased compared to control tissue
(P < 0.05). Within the first 50 µm minocycline was able to significantly decrease the GFAP up-
B
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regulation around the cannula (P < 0.001). Statistical analysis of the 6-week animals
(Fig. 5.10B) revealed a significant main effect of drug treatment (F3,162 = 3.937; P = 0.025)
and distance (F9,162 = 367.472; P < 0.001) as well as of their interaction (F27,162= 39.187;
P < 0.001). Further post-hoc comparisons indicated for the first 50 µm, that cannula
implantation increased astrocyte levels significantly independent of the treatment when
compared to the control tissue (P ≤ 0.001) and to distances further away (P < 0.05). At
distances further away than 150 µm for minocycline and further away than 250 µm for
vehicle and apyrase (P < 0.05; with a few exceptions for apyrase) astrocyte levels were
significantly decreased compared to control tissue. Moreover, a significant main effect of the
time point of measurement was evident in the control tissue (F1,81 = 8.095; P = 0.019) with an
overall increase of astrocytes two weeks compared to six weeks post-surgery.
Fig. 5.10. Average distribution of GFAP+ cells. Quantification of the average distribution of
astrocytes, as a function of distance from the implantation site, is shown two (n = 14) (A) and six
weeks (n = 17) post-surgery (B). Data are means +S.E.M. Asterisks denote a significant difference
(Tukey’s t-test; P < 0.05) between an interval close to the implantation site and any interval further
away (up to 500 μm) of a certain treatment. A significant difference of any treatment compared to
no intervention within a certain interval is indicated by a rhomb. Circles denote a significant
difference within a certain interval compared to vehicle.
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5.5 Discussion
The results of the present study demonstrate that the chronic implantation of a steel
cannula into the CFA of M1 causes a foreign body response that involves glial scar formation
and neuronal cell death, accompanied by a deterioration of skilled motor performance. Local
apyrase and minocycline administration during cannula implantation improved the skilled
motor performance, with minocycline being most effective. Moreover, both substances
increased neuronal survival and reduced microglia/macrophage activation within the first
50 µm around the cannula two and six weeks after the implantation, with minocycline also
reducing astrogliosis after two weeks.
Neuronal cell death around a chronically indwelling cannula is found frequently (Hayn
and Koch, 2015) and is in line with other studies that revealed neuronal “die-back” zones
around an implant (Biran et al., 2005;Potter et al., 2012). The decreased neuronal density
within the first 50 µm around the implant in controls in this study is accompanied by the
formation of a glial scar, which is suggested to occur faster than the re-growth of neuronal
processes (Turner et al., 1999). Neuronal cell loss around an implant has not been found to
such an extent in stab controls and has been suggested to be to a large degree associated
with the foreign body response and the persistent inflammation at the interface(Biran et al.,
2005;Winslow and Tresco, 2010;Potter et al., 2012).
The further expanded distribution of microglia/macrophages as well as astrocytes
two weeks compared to six weeks post-implantation supports the notion of a more diffuse,
loosely organised scar tissue around the implant in the acute phase of the immune response
that becomes tighter and more compact in the chronic phase. Previous studies at similar
time points (Turner et al., 1999;Szarowski et al., 2003;Potter et al., 2012) underline this
assumption which is further buttressed by our finding that more implantation sites were
tattered after cannula removal at two weeks compared to six weeks. Turner et al. (1999)
also found the cellular structure of the scar tissue better preserved six weeks post-
implantation compared to earlier time points at which the scar tissue was often disturbed
after probe removal and filled the space that was previously occupied by the probe. The
reduction in astrocyte density in distances further away from the implantation site suggests,
that astrocyte communication is far-reaching and that even far away cells are activated and
migrate towards the implant to help separate the healthy tissue from the inflammatory
processes around the implant.
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The results of the behavioural tests revealed remarkable impairments in skilled
motor performance after cannula implantation in controls. Deficits were most pronounced
in the skilled reaching task, which indicates a higher sensitivity of this task to damages of the
CFA compared to the rung ladder task. Performance in the skilled reaching boxes was
decreased at all time points after vehicle treatment with the subelement advance being
most sensitive. Since the CFA has been shown to be largely responsible for elbow and
shoulder movement and only partly for wrist movement without being involved in digit
coordination (Neafsey and Sievert, 1982;Neafsey et al., 1986) our findings are well-founded
and further supported by a recent microstimulation study (Brown and Teskey, 2014) and
unpublished preliminary inactivation experiments in our lab. The impairment of the
subelement pronate may indicate changes in cortical movement representation towards an
increase in wrist representation in the CFA (Kleim et al., 1998) that goes back to skill
acquisition during training (Nudo et al., 1997). An expansion of this area into the coordinates
of cannula implantation may be responsible for the impairments in this subelement.
Impairments in the ladder rung walking task were most severe in the ladders’
diagonal conditions which appeared more challenging than the horizontal condition. The
diagonal condition, introduced by Antonow-Schlorke et al. (2013), increased the demands
and the sensitivity of the task. Upward walking was suggested to impose a need for a higher
level of motor performance than horizontal walking, due to a higher load on the forelimbs
for maintaining balance and grip. Impairments in forelimb use during downward walking
even exceeded those discovered for horizontal and upward walking which underlines the
demands of downward locomotion. The results of the present study also demonstrates the
ladders’ downward condition to be most sensitive to impairments of the CFA, followed
directly by the upward condition, with only slight impairments in the horizontal condition.
The general locomotor behaviour of the rats as assessed in the open field revealed
not to be sensitive to the fine-tuned motor impairments. In contrast to long-term
impairments in the skilled reaching or walking tasks following motor system lesions (Metz
and Whishaw, 2002;Whishaw and Metz, 2002;Alaverdashvili and Whishaw, 2010), complete
movement recovery within one week has been observed when walking on a flat surface
even after severe insults (Muir and Whishaw, 1999;Norrie et al., 2005). The difficulties in
skilled compared to unskilled motor performance have been suggested to be related to
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differences in motor control, with locomotion on a smooth horizontal surface being
adequately achieved by subcortical motor systems (Metz and Whishaw, 2002). Spontaneous
and functional recovery due to daily exercise and locomotion in their home cages, may
additionally cover potential deficits of the rats in the open field test, without rats’ majorly
benefitting from this general exercise in the skilled motor performance tasks, since specific
motor skill training seems to be mandatory for skill recovery (Maldonado et al., 2008;Nudo,
2013).
Apyrase and minocycline have both proven beneficial in amending behavioural
deficits after cannula implantation, with minocycline being more effective than apyrase
especially in the skilled reaching task. Likewise, immunohistochemistry revealed increased
neuronal survival together with reduced microglia/macrophage activation around the
cannula with apyrase and minocycline, with the latter one also reducing the astrocytic scar
tissue two weeks post-implantation. Davalos et al. (2005) suggested the extracellular ATP
released by damaged cells and surrounding astrocytes to be primarily involved in microglial
branch dynamics and their migration towards the site of injury. This is in line with the results
of the present study that demonstrates a reduction of microglia/macrophages within the
first 50 µm around the implant after apyrase treatment. Apyrase has also previously been
shown to decrease the level of microglial cytokine secretion (Verderio and Matteoli,
2001;Bianco et al., 2005). The increased number of neurons around the implantation site
after lowering extracellular ATP concentrations with apyrase indicates that the inhibition of
microglia/macrophage activation that is accompanied by a reduction of released neurotoxic
and pro-inflammatory molecules, moreover, supports the neuronal survival. This effect was
suggested to be additionally accompanied by an increased release of neurotrophic factors
that promote neuronal growth and survival at lower ATP concentrations (Inoue,
2002;Polikov et al., 2005;Hanisch and Kettenmann, 2007). Astrocytic glutamate release has
also been shown to further contribute to neuronal death under pathological conditions, but
could be antagonised by P2 receptor blockade (Jeremic et al., 2001). Hydrolysing ATP by
means of apyrase may have contributed to neuronal survival in a similar way. The ATP
metabolites ADP, AMP and adenosine have been reported to be less potent in microglia
activation and to require priming with ATP (Chakfe et al., 2002;Farber and Kettenmann,
2006), although some potential has also been demonstrated for ADP itself (Davalos et al.,
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2005). Likewise, nitric oxide (NO) has been shown to be insufficient as a chemoattractant to
microglia without extracellular ATP (Dibaj et al., 2010). The density of astrocytes around the
implantation site was not significantly decreased at any time point after cannula
implantation with apyrase compared to vehicle. Although, apyrase was demonstrated to
inhibit the ATP-mediated Ca2+-wave propagation (Davalos et al., 2005), a wide range of
different types of molecules has been suggested to trigger reactive astrogliosis and also
involves astrocyte proliferation (Sofroniew, 2009).
It is to be emphasised that astrogliosis is not primarily harmful, but also exerts
numerous beneficial functions that improve the outcome after implantation of a foreign
body. Astrocytes are essential in wound closure and BBB repair, in the restriction of CNS
inflammation, and hence, in neuronal protection by forming functional barriers to separate
the healthy tissue from the enduring inflammation at the interface. Experimental disruption
of astrogliosis has been shown to be associated with a spread of neurotoxic inflammation
and increased lesion sizes (Sofroniew, 2015). The initial activation and migration of microglial
cells is also to some extent partly beneficial by clearing cellular debris and excess fluid.
However, their long-term response is largely adverse due to the enduring inflammatory
events at the implant interface that result in neuronal damage and “die-back” zones,
preventing neurons to be recorded or stimulated (Polikov et al., 2005;McConnell et al.,
2009;Marin and Fernandez, 2010). Hence, it is important to only reduce the glial cell
activation to a minimum, with the focus on the microglial cells.
Minocycline was even more effective than apyrase and did not only improve the
skilled motor performance more efficiently after cannula implantation, but additionally
reduced astrogliosis in the acute phase. Although exhibiting similar levels of surviving
neurons around the implant as well as of microglia/macrophages, minocycline seems to be
more effective than apyrase in preserving neuronal vitality and networks according to the
behavioural data, which probably arises from its much broader range of anti-inflammatory,
anti-apoptotic and glutamate-antagonist properties (Elewa et al., 2006). In a previous study
of Rennaker et al. (2007) minocycline was administered via the drinking water and resulted
in reduced astrogliosis around a chronic multi-channel microwire compared to controls
especially in the first week post-surgery, with only minor differences between the groups
four weeks post-surgery. The reduction in astrogliosis was accompanied by improvements in
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quality and longevity of neural recordings from the interfaces at both time points. In the
present study, local minocycline application also resulted in a reduction of astrogliosis two
weeks post-surgery with only a minor effect being maintained at six weeks. Moreover, the
reduced microglia/macrophage activation and the enhanced neuronal distribution in implant
vicinity in this study as well as of the improved behavioural outcome underline the
neuroprotective and anti-inflammatory characteristics of minocycline. Several previous
studies also suggested minocycline to be not only neuroprotective, but also to be
neurorestorative, via the inhibition of inducible NO-synthase (Yrjanheikki et al.,
1998;Yrjanheikki et al., 1999;Hewlett and Corbett, 2006), the reduction of pro-inflammatory
molecules such as TNFα, IL-1β or NO and the increase of anti-inflammatory molecules such
as TGF-β or IL-10 (Yang et al., 2015b), as well as via a decrease of glutamatergic neurotoxicity
by inhibiting the NMDA-induced activation of p38 MAPK in microglial cells, which
subsequently inhibits the microglial activation and provides neuroprotection (Tikka and
Koistinaho, 2001;Tikka et al., 2001). Moreover, minocycline ameliorates BBB integrity and
reduces edema following hemorrhage (Wasserman and Schlichter, 2007;Yang et al.,
2015a;Yang et al., 2015b). Besides being neuroprotective in stroke minocycline has also been
suggested to be an effective therapeutic in traumatic brain injury (Sanchez Mejia et al.,
2001), spinal cord injury (Wells et al., 2003), amyotrophic lateral sclerosis (Zhu et al., 2002),
Huntington disease (Bonelli et al., 2004), Parkinson disease (Du et al., 2001) and Alzheimer’s
disease (Ryu et al., 2004) and its neuroprotective and anti-inflammatory potentials are
further supported by the present study, which suggests it as an effective therapeutic in the
suppression of the foreign body response.
In conclusion, our results suggest that reducing the microglial response to a minimum
and thereby the degree of pro-inflammatory and neurotoxic molecules seems to be an
effective approach to increase the neuronal survival in the vicinity of an implant. Apyrase
and minocycline were shown to have neuroprotective and anti-inflammatory potential by
improving the neuronal survival and skilled motor performance accompanied by a reduction
of the inflammatory response mediated by microglia/macrophages. Minocycline was
however considerably more effective than apyrase in improving the behavioural
performance after cannula implantation into the CFA and, moreover, reduced the
astrogliosis in the acute phase. The local application of minocycline proved sufficiently
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beneficial to suggest it as a promising therapeutic candidate in the acute phase of chronic
foreign body implantation without any need for systemic applications. Further studies on the
efficacy of minocycline-coated electrodes will be however needed to evaluate the
biocompatibility and long-term recording quality.
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6 General discussion
For the widespread clinical application of BCIs it is of particular interest to understand and
control the foreign body response of the brain to chronically indwelling devices. Since a few
patients with long-standing tetraplegia have already successfully been implanted with neural
interface systems, an initial proof of concept is provided that recording of neuronal spiking
activity enables the execution of complex tasks such as controlling a robotic arm. However,
the foreign body response that involves glial scar formation and neuronal cell loss continues
to represent a major obstacle that disturbs neuronal signal acquisition and causes signal loss
over time. A reliable extraction of movement commands needs to be achieved to verify a
consistent functional outcome and to obtain the highest possible benefit from these
systems. Cannula implantation and local substance application during the implantation
procedure of a cannula in this work aimed to mimic the local drug delivery from coated
electrodes and served as a proof-of-principle investigation for different pharmacological
approaches.
6.1 Implications after foreign body implantation into the CFA
In order to investigate behavioural differences caused by the foreign body response after
cannula implantation into the CFA, the skilled reaching task, that has evolved into a model
system to analyse the functionality of the motor cortex, has also proven instrumental during
this work. Impairments in the skilled reaching movement after cannula implantation could
be measured by means of an elaborated movement scoring system (Alaverdashvili et al.,
2008) and assigned to specific subelements. A preceding reversible inactivation study
allowed for an easier discrimination of behavioural deficits in the follow-up experiments.
6.1.1 Behavioural deficits after reversible inactivation of the CFA by muscimol
The reversible inactivation study by means of the GABAA agonist muscimol permitted the
examination of acute deficits in the skilled reaching task and the precise function of the CFA
in rats. Since permanent tissue inactivation possibly entails potential functional
compensatory mechanisms by adjacent brain areas or compensatory strategies by the
animal itself, this makes it more difficult to evaluate the results in chronic settings. In
reversible inactivation no recovery of function can take place since the inactivation only lasts
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for limited time, which allows the examination of the true function of the inactivated tissue
(Lomber, 1999). Moreover, reversible inactivation has the advantage that the animals’
behaviour can be examined immediately after injection and the same animal can be
repeatedly tested with and without functional inactivation during multiple experimental
sessions. This enables within-subject designs that exclude any possible side-effects of the
surgery, since the guide cannula is implanted above the actual area that is examined and
animals are trained post-surgically until they re-establish their pre-surgical baseline level
(Martin and Ghez, 1999;Majchrzak and Di Scala, 2000;Jarrard, 2002;Arikan et al., 2002).
Muscimol is a potent agonist for the GABAA receptor and also a weak agonist for the GABAB
receptor and a partial agonist at the GABAC receptor as well as a specific neuronal and glial
GABA uptake inhibitor (Martin and Ghez, 1999;Chebib and Johnston, 1999;Krogsgaard-
Larsen et al., 2000). In this work, muscimol could be precisely injected into the CFA by means
of a chronically implanted guide cannula that was located 2 mm above the intended
injection site. Substance administration after recovery and re-training was enabled by means
of an injection cannula that was connected to a microliter syringe via an injection tube
(Fig. 3.2). Since the GABAA receptor has a ubiquitous distribution throughout the CNS,
muscimol administration causes neuronal hyperpolarisation of the respective area
(Beaumont et al., 1978;Goetz et al., 2007;Jacob et al., 2008). In contrast to GABA, the effects
of muscimol persist much longer for up to 12-24 h, with a maximal effect within the first
hour following injection (Martin and Ghez, 1999;Arikan et al., 2002).
In this work, muscimol was used in a dose of 0.5 µg/0.3 µl and 1.0 µg/0.3 µl to
temporarily inactivate this region, with PBS as the control. Deficits in the reaching
movements 45 min after local muscimol application were much more pronounced compared
to the chronic injection cannula implantation in the follow-up experiments, in which the
foreign body response was evaluated. According to a one-way RM ANOVA (F3,39=18.239;
P<0.001), there was a significant effect in the hit-reach-ratio between the different
treatments with post-hoc Tukey’s t-test revealing the hit-reach-ratio to be significantly
reduced (P<0.001) in both muscimol-treated groups compared to pre-surgery as well as
compared to PBS application (pre-surgery: 76.90% ± 1.71%; PBS: 76.25% ± 2.61%; low dose
of muscimol: 53.86% ± 4.41%; high dose of muscimol: 53.59% ± 4.02%; n = 10). Deficits in the
reaching behaviour after muscimol application were strongly exposed, with individual
animals even being unable to lift their paws to reach for the pellet during their first trials and
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instead turning around in the box to check for the reward pellet in the back that was
however omitted after unsuccessful attempts. Some animals also tried instead to reach for
the pellet with the unaffected paw without hitting the pellet that was thus located in the
ipsilateral indentation or tried to lick the pellet from the shelf without being able to reach it
(Fig. 6.1A, B). After several complete fails, rats usually continued to exhibit strong
impairments in advancing the paw towards the pellet as well as in paw pronating and
accordingly dropped the paw instead in an uncoordinated manner on the shelf (Fig. 6.1C, D).
In case they hit the pellet, they showed further difficulties to lift the paw with the pellet
from the shelf and the paw dropped from the shelf onto the floor of the box during
retraction (Fig. 6.1E, F). Moreover, during pellet release they often used the second paw to
support paw lifting and to direct the paw towards the mouth with the head turning towards
the paw with the pellet in order to release it into the mouth (Fig. 6.1G, H).
This reversible inactivation study in the initial phase of this work confirmed the
appropriateness of the coordinates chosen according to more previous stimulation and
tracer studies (Neafsey and Sievert, 1982;Neafsey et al., 1986;Hyland, 1998;Colechio and
Alloway, 2009) that either differentiate only between the RFA and CFA without further
assigning concrete functions to these areas or only roughly assign functions to both areas
without a clear functional and topographical dissociation of the RFA as a grasping area and
the CFA as a reaching area (Brown and Teskey, 2014). Acute deficits in the reaching
movement after reversible inactivation were revealed in a much more exposed manner than
in the chronic settings of the follow-up experiments. On the one hand this was due to the
unmasking characteristics of this reversible inactivation technique, but on the other hand
muscimol diffusion was certainly more widespread compared to the tissue loss caused by
chronic implantation of the injection cannula. Nevertheless, due to the preceding
inactivation study, deficits in the follow-up experiments were yet easier to identify.
Acute deficits in forelimb movement also resulted in locomotor impairments in the
open field with a significant effect on the distance travelled [m] between the treatment
groups according to a one-way RM ANOVA (F3,39=18.239; P<0.001). Post-hoc Tukey’s t-test
revealed a significant decrease of the total distance travelled (P<0.001) for both muscimol-
treated groups compared to pre-surgery as well as compared to PBS application
(pre-surgery: 218.66 m ± 16.44 m; PBS: 215.44 m ± 12.48 m; low dose of muscimol:
130.32 m ± 13.14 m; high dose of muscimol: 127.27 m ± 18.13 m).
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Fig. 6.1. Behavioural deficits in the skilled reaching task after reversible inactivation of the CFA.
Reversible inactivation of the CFA caused deficits such as: the change of the preferred paw and the
use of the unaffected paw instead, or rats trying to lick the pellet from the shelf (A, B); strong
impairments in advancing the paw towards the pellet as well as in paw pronation (C, D); difficulties
to lift the paw with the pellet from the shelf with the paw dropping from the shelf during
retraction (E, F); support by the second paw during pellet release with the head turning towards the
paw in order to release the pellet into the mouth (G, H).
A B
C D
E F
G H
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Since animals demonstrated strong impairments in the use of the forepaw
contralateral to the inactivated CFA in the reaching box, deficits in the total distance
travelled were accordingly, expected, because the animals had no opportunity to cope with
their deficits or to rely on secondary circuits or on compensatory strategies. It has been
suggested that many cortical or subcortical lesions result only in minor or transitory deficits
in forelimb or hindlimb locomotor performance with total recovery within a few days after
surgery (Muir and Whishaw, 1999;Metz and Whishaw, 2002). Since rats were tested with
muscimol within the first hour after inactivation, a reduction in locomotion is in line with this
assumption. Moreover, it has been suggested that forebrain motor circuits are not
necessarily required for locomotion on a horizontal surface, which can be adequately
achieved by subcortical motor systems. Only more complex tasks that are sufficiently
challenging and require forebrain control reveal subtle chronic impairments in forelimb and
hindlimb use (Metz and Whishaw, 2002). Likewise, corticospinal-lesioned animals show only
transient locomotor deficits 24-48 h after lesioning and exhibit complete recovery after this
time suggesting that the corticospinal tract does not play an essential role in normal
overground locomotion in the open field. Transient changes in gait and locomotion were
suggested to be the result of temporary general locomotor compensations after unilateral
CNS injury in quadrupeds that quickly recover thereafter (Muir and Whishaw, 1999).
The ladder rung walking task had not been introduced before the follow-up
experiments started and the animals were accordingly not tested in this paradigm after
muscimol administration.
6.1.2 Behavioural deficits after foreign body implantation
Behavioural deficits after guide cannula implantation in order to examine the foreign body
response were less exposed than after muscimol application. However, the hit-reach-ratio
continued to be significantly reduced during the course of the 6-week test period with no
significant recovery. The most impaired subelement was the advancing of the paw through
the slot towards the pellet with the animals often advancing not far enough to reach the
pellet or sweeping the pellet off the shelf when touching it only with the tips of the digits.
The recent inactivation study of Brown and Teskey (2014) confirmed that the coordinates
used during this work are primarily involved in paw advancing. They assigned grasping and
digit flexion representations to the RFA and forelimb elevation, advance and retraction to
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the CFA. They were first assigning a clear functional and topographical dissociation of the
RFA as the grasping area and the CFA as the reaching area. Deficits in paw pronation and
pellet release were less exposed than advancing of the paw. The more previous
microstimulation mapping study of Neafsey and Sievert (1986) specifically assigned
pronation and supination movements also to the CFA, with the associated regions being
slightly more caudally located within the CFA and the region for supination also more
laterally. Deficits in paw pronation were also more exposed than in paw supination in the
preceding inactivation study. This suggests a closer association of the area responsible for
paw pronation to the area responsible for advancing compared to the area responsible for
paw supination. According to Brown and Teskey (2014), the area topographically bordering
laterally and caudally on the area responsible for advancing within the CFA is responsible for
elbow flexion. The coordinates used in this work for cannula implantation slightly overlap
with this area, since the injection cannula had a diameter of 0.4 mm that was additionally
surrounded by an area of neuronal cell loss and glial scar formation that extended even
further into the surrounding tissue. The slight impairments in pellet release may go back to
the deficits in elbow flexion. Disrupted interconnections and dissection of the projections of
surrounding neuronal networks bordering on the area responsible for paw advancing
probably also contribute to the impairments in additional subelements. Paw elevation was
however only impaired after muscimol application and not during injection cannula
implantation, which further supports the assumption of a more widespread diffusion of
muscimol. According to Brown and Teskey (2014), movement representation for paw
elevation is also located within a small area located medially/caudally to the representation
of elbow flexion. It is difficult to compare the impairments in reaching in this work with
those of other inactivation studies, since motor cortical lesions in other studies generally
extend much further into the surrounding tissue and include most parts of the motor cortex
with both forelimb areas as well as the hindlimb area. For example, in the study of
Alaverdashvili and Whishaw (2010) the skull was removed from 1 mm posterior to 4 mm
anterior to bregma and 1-4 mm lateral to the midline to induce motor cortical stroke by
means of devascularisation. Also, Whishaw et al. (2004) impacted the brain with a 3 mm and
a 5 mm diameter piston to produce cortical contusion injuries. Hence, impairments in their
work are usually more pronounced and include a much broader spectrum of impaired
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subelements, additionally involving e.g. the subelements supination I/II, which could not be
identified as significantly impaired in this work.
The skilled reaching task proved to be more sensitive to cannula implantation in the
CFA than the ladder rung walking task. The results of the ladder rung walking task
demonstrated that the skilled walking performance strongly depended on the walking
direction along the ladder. Walking along an inclined rung ladder turned out to be more
difficult for the rats and to be more sensitive to motor cortical disturbances than walking
along a horizontal ladder. Motor impairments in forelimb use after cannula implantation
were reflected by a reduction in the average score in the walking performance. After cannula
implantation, rats more often placed the impaired paw on the rung with only the wrist or
the digits, repositioned the paw or replaced it, slipped off the rung or also totally missed it.
Average scores, however, revealed only a decline in the first post-surgery week and had
recovered by the second post-surgery week, which is why this test was only applied to the
2-week groups. In the skilled reaching task, rats had particularly impairments in advancing
the paw, which involves forward displacement of the elbow and shoulder as well as wrist
extension and hand opening. Since upward and downward walking was more demanding
and accordingly more impaired than horizontal walking, the impairments in advancing may
also account for the increase in errors in the performance in the first post-surgery week.
Since step sizes still varied in a normal range without demanding the rat to especially stretch
its legs to reach the subsequent rung performance had already recovered by the second
week. In a motor cortical lesion study of Antonow-Schlorke et al. (2013), deficits are more
exposed than in this work which is obviously again a result of the much broader cortical
photothrombotic lesion size. They applied light transmission within a rectangular area
limited by the coordinates −2.5 mm to +4.52 mm anteroposterior and +0.5 mm to +4.5 mm
mediolateral from bregma which hence included again both forelimb areas as well as the
hindlimb area. Although deficits are more exposed in their study and include forelimb as well
as hindlimb use, only the contralateral side is impaired without any significant effect on the
ipsilateral side. In line with this are the results of a study of Whishaw and Metz (2002) that
suggested the ipsilateral portion of the corticospinal tract to make no contribution to skilled
movements of the kind made by the contralateral portion of the corticospinal tract, which
further supports the assumption that deficits are particularly present in the contralateral
side, since only 5% of corticospinal projections do not cross and descend on the ipsilateral
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side into the spinal cord. Moreover, the results from the lesion study of Antonow-Schlorke et
al. (2013) further demonstrated that contralateral forepaw use is more impaired during
upward and downward walking than during horizontal walking, with downward walking
exhibiting most errors. Interestingly, despite the larger lesion size in their study deficits are
also only present at post-ischemic day 7 and recover at day 28, which was the second test
day in their study. This is in agreement with the smaller lesion size in this work and
performance recovery within two weeks post-surgery.
Performance in the open field did not reveal any significant differences between pre-
and post-surgical test days. The total distance travelled was often slightly reduced in the first
post-surgery week, but increased again in the following weeks. Individual animals that did
not like to be kept in the open field boxes showed an intense increase in the total distance
travelled in later post-surgery weeks which increased the average as well as the error bars,
but also seemed to be treatment-independent and to be caused by only a few outliers. As
already suggested above, impairments in walking on a horizontal surface are only transient
in nature with forebrain motor circuits not being required for locomotion on a horizontal
surface. Accordingly, no significant reduction in the total distance travelled [m] could be
revealed after one week of recovery or during the subsequent weekly test sessions.
Complete movement recovery within one week after motor cortical injury in
unskilled motor tasks has not only been observed in this work, but also in other studies
(Muir and Whishaw, 1999;Norrie et al., 2005). In contrast to this short-term recovery in
unskilled motor tasks, long-term impairments have been demonstrated in skilled motor
tasks, including skilled reaching as well as skilled walking (Metz and Whishaw, 2002;Whishaw
and Metz, 2002;Alaverdashvili and Whishaw, 2010). The ability of skilled walking on the rung
ladder had already recovered two weeks after cannula implantation. However, skilled
reaching deficits persisted up to six weeks and had not recovered by the end of the test
period. Hence, the time span of recovery apparently correlates with the complexity and the
skill demands of the task. Spontaneous and functional recovery due to daily locomotion in
the home cages only contributes to cover deficits of the rats’ locomotion in the open field,
without rats majorly benefitting from this general exercise in the skilled motor tasks. For skill
recovery especially during skilled reaching, specific motor skill training seems to be
mandatory.
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The transfer of functional responsibility has been suggested to take about 4-8 weeks,
with animals still comprising significant deficits when not undergoing daily rehabilitative
training. The redistribution of cortical representation occurs by neuroanatomical changes
such as local axonal sprouting, dendritic spine expansion and synaptogenesis in the regions
surrounding the lesion. Neurite outgrowth occurs into intact motor areas surrounding the
lesion. Moreover, remote cortical neurons that project to the lesion site contribute to a
reassembly of cortical networks and functional recovery (Maldonado et al., 2008;Nudo,
2013). Since animals in this work did not undergo daily training, deficits in skilled reaching
were still obvious six weeks after cannula implantation.
In contrast to true functional recovery, movement compensation is mediated by
spontaneous recovery that also occurs without rehabilitative training. Young as well as aged
rats have been demonstrated to preserve a remarkable ability to compensate for motor
impairments due to the plastic properties of the brain. Although aged rats display a decline
in motor ability and are more affected by brain injuries, plastic properties are preserved and
aged rats display a similar recovery rate as young rats. Compensatory motor behaviour
following injury to the motor cortical forelimb region is suggested to be mediated especially
by the peri-lesional regions of the cortex (Alaverdashvili and Whishaw, 2010).
Movement compensation after cannula implantation into the CFA has particularly
been observed in the first test session after cannula implantation in the skilled reaching task,
during which the animals had to cope with their deficits for the first time. After several
misses usually due to impairments in paw advancing, which became obvious from the high
error scores within the first five trials of each session, they learned to cope with these
deficits and compensated for them. This compensation is reflected by the hit-reach-ratio
performance that was not as badly decreased as would have been expected after these first
trials. Especially within the 6-week group, the error score within the first 5 trials in the
subelement advance increased from 22.22% ± 4.94% pre-surgery to 66.67% ± 6.24% in post-
surgery week one. However, the hit-reach-ratio only decreased from 81.35% ± 1.90% pre-
surgery to 59.49% ± 2.29% in post-surgery week one, which indicates that rats quickly
compensated their deficits to a large extent within the first test session. Six weeks post-
surgery rats only exhibited an error rate in advancing of 42.22% ± 6.62% and a slight non-
significant increase in the hit-reach-ratio performance to 66.82% ± 3.09%, which indicates
that some functional recovery most probably occurred due to the weekly training sessions.
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Although rehabilitative training seems to be essential for true functional recovery
after an injury especially in skill requiring tasks, it has to be mentioned that early training
may exacerbate brain damage and functional outcome after brain injury. Activity-induced
increases in brain temperature and excitatory neurotransmitter release is suggested to
further contribute to the loss of vulnerable tissue surrounding the site of injury (Humm et
al., 1999;Risedal et al., 1999). This finding is in line with the assumption in this work that
excessive glutamate release after cortical brain injury induces a cascade of glutamate-
mediated excitotoxicity, which causes neuronal cell death of apoptotic and necrotic nature
that accordingly exacerbates behavioural outcome. Accordingly, Humm et al. (1999)
suggested neuronal tissue to be susceptible to the effects of intensive rehabilitation targeted
at the impaired limb within a post-surgical time interval of two weeks.
6.1.3 Brain tissue response to foreign body implantation
The immunohistological investigation of the foreign body response suggests that deficits in
the rats’ behavioural performance after injection cannula implantation particularly correlate
to the amount of neuronal cell loss around the implantation site. Neuronal cell loss around
the implanted cannula was most significant after two weeks with about one third less
neurons within the first 50 µm around the implant (data for control tissue response after
cannula implantation are derived from the second study, since this group has been
complemented by additional animals compared to the first study). By six weeks, cell loss
within the first 50 µm was also significant, but was not exacerbated. Neuronal cell loss
around chronic implants has been suggested to not solely result from the mechanical trauma
of insertion, but rather from the chronic inflammation at the interface, since in stab controls
no such loss was demonstrated (Biran et al., 2005;Winslow and Tresco, 2010;Potter et al.,
2012). Although reductions in neurofilament were also observed in stab wounds in the study
of Biran et al. (2005) at two weeks, the extent of reduction was much smaller compared to
chronically indwelling devices. Since, in their study, the microglial activity inversely
correlates to the neuronal cell loss, they concluded that the large amount of secondary cell
death is microglial-induced. However, in this work, neuronal cell loss has not been observed
to be exacerbated after six weeks compared to two weeks, which suggests that microglial
cell activation particularly contributes to neuronal cell loss within the vulnerable phase
within the first one to two weeks after implantation.
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Since cannula implantation into the brain is accompanied by damage and loss of
neurons in the implantation tract and by the disruption of blood vessels, the oxygen and
energy supply of surrounding neurons gets impaired, which results in an ionic imbalance that
is followed by sustained release of glutamate due to uncontrolled membrane depolarisation
(Iadecola and Anrather, 2011;Bretón and Rodríguez, 2012). Glutamate is suggested to be
released via numerous mechanisms after an injury and to induce a cascade of glutamate-
mediated excitotoxicity that exacerbates neuronal cell loss and tissue damage (Lipton and
Rosenberg, 1994;Lynch and Guttmann, 2002). The degree to which extent neurons die by
apoptosis or necrosis depends on the severity of the insult and the amount of glutamate
released (Bretón and Rodríguez, 2012), but presumably also on the number of microglial
cells activated during this vulnerable phase. The increased vulnerability of neurons after
cannula implantation presumably makes them unable to cope with the additional amount of
neurotoxic substances released by the microglial cells, which accordingly further contributes
to an exacerbation of the cascade of glutamate-mediated excitotoxicity.
In electrode implantation, it has been suggested that the survival of neurons within
the first 50 µm surrounding the electrode is imperative for optimal device functioning
(Buzsaki, 2004). The loss in signal strength has been suggested to be either a result of the
formation of a neuronal kill zone around the implant or to be a result from slow neuronal
regression from the electrode due to glial scar formation that pushes cell bodies away from
the electrode site. The number of neurons within this work has been shown to be
significantly reduced by about one third within the first 50 µm. This cell loss is most probably
accountable for the inconsistent performance of electrode arrays in chronic applications that
report a drop in the number of functional electrodes and recorded signals over time as
summarised by Polikov et al. (2005). Recorded signals were reported to either grow in
stability and to remain stable after a few weeks or to degenerate from high stability to
nearly no signals with day-to-day changes over the first 1-2 weeks and week-to-week
changes for 1-2 months (Liu et al., 1999;Nicolelis et al., 2003). This inconsistency in electrode
performance has also been characterised at the cellular level with strong variability in gliosis
and neuronal kill zones around electrodes with identical characteristics (Stensaas and
Stensaas, 1976;Edell et al., 1992). During this work variances in neuronal kill zones and
gliosis around the implantation site have also been observed. However, it has to be
mentioned, that it is of particular importance to minimise disturbances during implant
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removal since lateral movements of the implant or an inclination during removal causes
most devastating variances and pushes neurons not only further away from the implantation
site, but also causes enormous tattering of the scar tissue (Fig. 6.2.A, B). Whether cannula
removal was successful could be derived from the shape of the implantation site with oval or
tattered sites being excluded from further analysis. Since more implantation sites were
tattered two weeks compared to six weeks after implantation, this buttresses the
assumption that the scar tissue is tighter and more compact after six weeks. A further point
that most probably affects a homogenous tissue analysis and contributes to considerable
variances in neuronal kill zones and gliosis around the implant is the dependence on blood
vessels (Fig. 6.2.C, D). Rupture of large blood vessels during the implantation procedure has
been observed to cause a stronger neuronal loss and more pronounced gliosis compared to
no haemorrhage during implantation. Brains, in which haemorrhage was evident during
cannula implantation, were notated and were also excluded from histological analysis.
Fig. 6.2. Cannula implantation sites with factors affecting a homogeneous tissue analysis. Tattered
implantation site due to lateral cannula movement or cannula inclination during removal (A, B).
Approved implantation site with two medium-sized blood vessels in the vicinity of the implantation
tract as indicated by the arrows (C, D). Neuronal nuclei are depicted in (A, C) and astrocytes in (B, D).
Scale bar = 400 µm.
A B
C D
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In the initial wound healing response reactive microglial cells and infiltrated
macrophages exhibit a scattered distribution, followed by clustering in a reactive sheath
around the implant after two weeks (Polikov et al., 2005). In this work,
microglia/macrophage clustering was also observed after two weeks with an increased
number of microglial cells up to 200 µm around the implantation site compared to control
tissue. Six weeks after cannula implantation, microglial cells formed a tight cellular sheath
around the implant and exhibited an increased number only within the first 100 µm.
Additionally, microglia/macrophages were not only increased in the vicinity of the implant
two as well as six weeks after cannula implantation, but also two weeks after implantation in
the hemisphere contralateral to the implantation site. Glial cell up-regulation in the
contralateral hemisphere was not only the case for the microglia/macrophages, but also for
the astrocytes and has already been described previously (Marks et al., 2001) as well as in
this work. The increase in glial cells was suggested to either result from far ranging signals of
the glial cells (Marks et al., 2001), from functional changes due to interhemispheric
connectivity (Lindenberg et al., 2012) or from enduring brain swelling (Loddick et al., 1998).
Since the formation of the glial scar resulted in a tight cellular sheath around the cannula at
six weeks, it became difficult to distinguish between the four different morphological
phenotypes of microglial cells that have been introduced by Torres-Platas et al. (2014) and
were suggested to be classified into ramified, primed, reactive and amoeboid cells according
to their degree of activation. Cell bodies close to the implantation site were too closely
packed and merged with the processes, which made it impossible to distinguish the different
types. Nevertheless, it can be assumed that the largest degree of cells close to the
implantation site had transformed into the amoeboid type that is fully “activated” and
devoid of any processes, and that cells further away from the implantation site constitute
the ramified morphology which are highly branched and correspond to the “resting”
microglia. Cells in between can also transform into an intermediate phenotype that is either
primed or reactive and can return to ramified or further transform to amoeboid. Persistent
microglial activity at the interface between the implant and the brain tissue has also been
described previously and is founded in the inability of microglial cells and infiltrated
macrophages to phagocytose the insoluble foreign body (Polikov et al., 2005;Biran et al.,
2005).
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Cannula removal during this work revealed especially microglia/macrophages to
adhere to the implant, but rarely astrocytes, which could be demonstrated by cannula
immunostaining and subsequent microscopic investigations (Fig. 6.3.A, B). Persistent
microglia/macrophage activation at the implant surface of explanted microelectrodes has
also been found by Biran et al. (2005). The rare amounts of GFAP+ material found on the
surface of retrieved electrodes by them were attached to the layer of
microglia/macrophages rather than directly to the electrode surface. They also suggested
the persistent up-regulation of microglia/macrophages around the implant to be associated
with the chronic implantation of the foreign body, since in stab wounds only a temporary up-
regulation was observed that had significantly declined by four weeks.
Fig. 6.3. Cannula immunostaining two weeks after implantation. Immunostaining revealed almost
no GFAP reactivity (astrocytes) (A), but persistent IBA1 reactivity (microglia/macrophages) at the
implant surface of explanted cannulas (B). Scale bar = 400 µm.
Since cannula implantation causes significant tissue injury and persistent microglia
up-regulation, these cells are most probably transformed into the “classically activated” pro-
inflammatory (type-1) microglia that release pro-inflammatory and neurotoxic molecules
including excitatory amino acids, reactive oxygen and nitrogen intermediates, and diverse
cytokines, including IL-1, IL-6 or TNFα (Kigerl et al., 2009). Due to their inability to
phagocytose the insoluble foreign body they remain in this state of “frustrated
phagocytosis” (Polikov et al., 2005;Biran et al., 2005). The enduring release of neurotoxic
substances causes a self-perpetuating cycle of cell death due to further activation of
microglial cells that release even more pro-inflammatory and neurotoxic substances (Block
et al., 2007;Schwartz and Shechter, 2010). Hence, as a consequence, neuronal cell loss
A B
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around a chronically implanted foreign body is likely an interplay of the initial acute damage
triggering a cascade of glutamate-mediated excitotoxicity and the persistently enhanced
microglial activation around the implant.
The persistent release of pro-inflammatory substances by the microglial cells also
induces astrocyte activation that separate the healthy neuronal tissue from the enduring
inflammatory processes at the implant (Schwartz et al., 2006). In this work, astrocyte
activation also extended furthest around the implantation site at two weeks after cannula
implantation, with a significant increase within the first 100 µm compared to control tissue
and within the first 300 µm compared to distances further away from the implantation site.
After six weeks, this increase had reduced to the first 50 µm around the implantation site
compared to control tissue and to the first 200 µm compared to distances further away from
the implantation site. This supports the assumption that the glial scar gets more compact
and forms a tight cellular sheath around the implant after six weeks. A reduction in astrocyte
levels at distances further away than 350 µm at two weeks and further away than 250 µm at
six weeks compared to control tissue suggests that astrocytes migrate to the site of injury.
Since astrocyte levels are reduced up to 500 µm at two as well as six weeks compared to
control levels and most probably even further away, the assumption of far reaching
communication and activation of astrocytes can be herewith supported. This far reaching
astrocyte communication has been suggested to be mediated via Ca2+-wave propagation
that largely depends on the extracellular release of ATP (Guthrie et al., 1999). Previous
studies of Turner et al. (1999) and Szarowski et al. (2003) revealed reactive astrocyte regions
that even extend 500-600 µm around the implant at two weeks and become also more
compact thereafter, extending only 50-100 µm around the insertion site at six weeks and
remaining constant at later time points.
The dense, organised sheath around the implant formed by the astrocytes, in order
to separate the healthy tissue from the ongoing inflammatory processes around the implant,
protects the surrounding neurons from the neurotoxic substances released by the
microglia/macrophages, but also prevents re-growth of neuronal processes into the
implantation site. Since the process of neuronal re-growth is suggested to be slower than
sheath formation, surviving neurons are prevented to re-approach and contact the implant
with the glial scar forming a high resistance barrier between the probe and the implant
(Turner et al., 1999). However, the astroglial response, in contrast to the persistent
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microglial response, has been suggested to exhibit primarily beneficial, protective function
after ischemia-related injuries expressing high levels of neurotrophic factors and cytokines
that help to repair and rebuild lost synapses, as well as the blood-brain barrier and to limit
immune cell influx and neuronal death (Zamanian et al., 2012). Although shielding
surrounding neurons from the implant, they are essential to remodel the extracellular space
and to restrict the spread of inflammation into surrounding tissue serving as anti-
inflammatory barrier (Sofroniew, 2015). Accordingly, it seems important that the glial scar is
reduced to a minimum in a way that neurons are still protected from the ongoing
inflammation at the implant. Preventing neuronal cell death and excitotoxic cascades around
the implant in the acute phase after foreign body implantation was presumed in this work to
also reduce the amount of glial cells activated.
6.2 Pharmacological influence on the foreign body response
In order to block the initial steps of the foreign body response and to promote neuronal
survival in the vicinity of the implant, the excitotoxic and inflammatory cascades after device
implantation were aimed to be suppressed at a very early stage. For this purpose, in a first
approach the uncompetitive NMDA receptor antagonist memantine with a preference for
extrasynaptically located NR2BRs was locally applied during cannula implantation in order to
reduce the glutamate-induced excitotoxic cascade induced by the initial trauma. The second
approach aimed to counteract the extent of glial cell activation by means of the ATP/ADP-
hydrolysing enzyme apyrase in order to decrease the self-perpetuating cycle of microglial-
induced secondary cell death. The third approach with minocycline combined both
strategies due to its broad range of anti-inflammatory and anti-apoptotic properties. The
local substance application during cannula implantation aimed to mimic the local drug
delivery from coated electrodes, since the experiments in this thesis served as a proof-of-
principle investigation mimicking the implantation of a device such as an electrode array into
the cortex.
6.2.1 Memantine
In order to reduce the glutamate-induced excitotoxic cascade caused by the initial trauma of
cannula implantation, the uncompetitive NMDA receptor antagonist memantine was locally
applied during cannula implantation. Since extrasynaptically located NR2BRs are suggested
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to be key in mediating excitotoxic cell death (Bonfoco et al., 1995), the preference of
memantine for extrasynaptic over synaptic NMDA receptors together with its fast off-rate
kinetics, sparing physiological functions at the synapse (Lipton et al., 2004;Lipton et al.,
2006;Xia et al., 2010), makes it an ideal candidate for neuroprotection in the acute phase of
brain injury as caused by device implantation.
The excessively increased glutamate concentrations for hours or even days in the
acute phase after an injury to the CNS (Lipton, 2004), allow memantine to gain its full
potential in this work. Both applied doses were able to increase the number of neurons in
the vicinity of the implant even above baseline, indicating that neurons in the implantation
tract must not only have survived the original trauma, but that moreover neurons in the
implantation tract must have been pushed aside during the implantation procedure without
getting implicated in and exacerbating the neurotoxic cascade of progressive cell death. As
an uncompetitive antagonist, memantine binds to a separate allosteric binding site within
the channel pore of the NMDA receptor and hence requires prior activation of the receptor
by its agonist. NMDA receptors have a complex structure with a binding site for its agonist
NMDA or glutamate at the NR2-subunit, a binding site for its co-agonist glycine or D-serine
at the NR1-subunit and a central ion channel that is blocked by Mg2+. When agonist and co-
agonist bind to the receptor and the cell is depolarised by cation influx through α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, the Mg2+-block is removed
and the channel opens and allows influx of Ca2+ and Na+. The allosteric binding site of
memantine is the same as the Mg2+-binding site within the channel and requires receptor
activation and the relief of the Mg2+-block. The dwell-time of memantine within the channel
is much shorter compared to conventional channel blocker, such as MK-801 or phencyclidine
(Angel Dust), which is why it does not cause psychotropic side-effects. However, memantine
still has a slower off-rate than the Mg2+-block and preferentially blocks NMDA receptors
when excessively open. The higher the concentration of an agonist the better works the
channel block with memantine, while relatively sparing normal neurotransmission (Parsons
et al., 1999;Lipton, 2004;Lipton, 2006;Parsons et al., 2007;Chen and Lipton, 2006). Since
NR2BR activation by excessive amounts of glutamate promotes ERK dephosphorylation and
inhibits the transcription factor CREB, which results in the inhibition of pro-survival pathways
and excitotoxic cell death of apoptotic or necrotic nature, memantine’s preference for
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extrasynaptic NR2BRs counteracts these cell death promoting effects and promotes
neuronal survival (Ehrnhoefer et al., 2011).
In addition to memantine’s neuroprotective effects, a further neurotrophic effect has
been suggested, with memantine inducing astrocytes to produce neurotrophic factors such
as GDNF and most likely also BDNF and TGF-β, which further promote neuronal survival (Wu
et al., 2009). Glial scar formation around the cannula in this work was only slightly reduced
and affected only the astrocyte levels. The slight decrease of astrocytic scar tissue in the
vicinity of the implant was coupled to a reduction of the hypotrophic regions surrounding
the glial scar that was observed in controls. Since memantine primarily inhibited the
progressive cell death in the acute phase, the presumption that preventing neuronal cell
death reduces the amount of glial cells activated was herewith supported. Due to the
shielding and neuroprotective function of astrocytes, only a slight reduction in astrocytic scar
tissue was desired as it was the case for memantine. A reduction of microglial activation
after memantine treatment accompanied by a reduction of released pro-inflammatory
molecules, such as NO, TNFα or ROS, has also been suggested previously (Wu et al., 2009),
however could not be revealed in this work. In conflict to this is a further study of Liu et al.
(2009) that demonstrated the chemotactic response of microglial cells to glutamate to be
especially mediated by AMPA, kainate and metabotropic glutamate receptors, but not by
NMDA receptors, which buttresses the finding in this work. Moreover, the microglial
response has been suggested to primarily result from the persistent presence of the foreign
body and to be to a lesser extent caused by the initial trauma of device implantation. Hence,
the mere prevention of cell death in the acute phase does not reduce the persistent
microglial activation in chronic settings.
The increased number of neurons within the vicinity of the implant also improved the
behavioural performance, except for a slight performance decrease within the first two post-
surgery weeks in the skilled reaching task. This suggests that, although neurons in the
vicinity of the implant had survived, originally existing neuronal networks were most
probably nonetheless disturbed and many of the neurons originally located in the
implantation tract were lost. These neuronal networks, that most probably needed to be re-
established, nevertheless appeared beneficial in amending behavioural performance. Since
both applied doses of memantine resulted in comparable behavioural and immunhistological
outcomes, tissue saturation may be assumed. It has been suggested, that too high doses of
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memantine also target synaptic NMDARs (Ehrnhoefer et al., 2011). This however is not
expected to result in severe side-effects, due to memantine’s fast off-rate kinetics sparing
physiological functions anyway. Since there is only poor evidence of local memantine
application and previous studies only examined systemic administration, it is difficult to
exactly classify the doses used in this study. However, since the dilution of the high dose was
almost saturated, it can be assumed that it was rather high.
With a half-life time of memantine of approximately 12 h in rat brain (Rao et al.,
2001), this time span seems to be particular important to interrupt the cascade of
glutamate-induced progressive cell death. Glutamate uptake from the extracellular space is
achieved by different glutamate transporters present in the plasma membranes of neurons
and glial cells, especially astrocytes, and represents the only effective mechanism for
glutamate removal (Danbolt, 2001). Due to memantine’s lipophilic nature, it can also easily
cross the BBB, which is why it is also administered orally in patients suffering from
Alzheimer’s disease (Robinson and Kreating, 2006). Memantine, that is generally well
tolerated when administered systemically with a favourable side-effect profile, has only
occasionally been reported to cause dizziness or restlessness at high doses (Lipton 2004;
Parsons et al., 1999). This made it the first clinically successful NMDA receptor antagonist
that is approved for the treatment of moderate-to-severe Alzheimer’s disease (Scarpini et
al., 2003;Lipton, 2006;Wenk et al., 2006), with also some potential therapeutic benefit in
patients with Huntington’s disease (Fan and Raymond, 2007). Further therapeutic potential
has also been suggested for a broad spectrum of CNS disorders ranging from acute disorder
like stroke and trauma, over further chronic neurodegenerative disorders like Parkinson’s
disease and amyotrophic lateral sclerosis, to the symptomatic treatment of epilepsy,
depression, multiple sclerosis and further diseases (Parsons et al., 1999;Lipton, 2006).
Beyond this, according to the results of this work, memantine also seems to be a promising
candidate in the acute phase of chronic foreign body implantation to enhance the vicinity of
neurons to the implant.
6.2.2 Apyrase
In order to counteract the extent of glial cell activation and thereby decrease the self-
perpetuating cycle of microglial-induced secondary cell death, the ATP/ADP-hydrolysing
enzyme apyrase was locally applied during the implantation procedure. Since ATP is
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suggested to be key in mediating the microglial response towards the site of injury and also
in astrocyte communication, apyrase was assumed to reduce the glial cell activation in the
acute phase of brain injury as well as the microglial-induced secondary cell death.
After an insult, high levels of ATP have been shown to persist in the peritraumatic
zone for many hours, triggering irreversible increases of cytosolic Ca2+ via the activation of
purinergic receptors, and causing cell death of even healthy neurons (Wang et al., 2004).
Since ATP and also to a lesser extent its metabolite ADP are important activators of glial cells
(Davalos et al., 2005) by binding to purinergic P2 receptors (Fields and Burnstock,
2006;Burnstock, 2008), the ATPase apyrase, that hydrolyses ATP as well as ADP, was chosen
in this work. Here, apyrase was able to reduce the extent of microglial activation by about
one third particularly after two weeks, accompanied by a reduction of neuronal cell death
particularly after six weeks with the neuronal population having recovered to a large extent
at this later time point. Since microglial activation is accompanied by the release of pro-
inflammatory cytokines that further amplify the immune response and cause a self-
perpetuating cycle of cell death (Bianco et al., 2005;Schwartz and Shechter, 2010), the
assumption that a decrease in microglial cell activation causes an increase in surviving
neurons can be further supported by this work. Interestingly, although sheath formation was
suggested to occur faster than the re-growth of neuronal processes (Turner et al., 1999), our
findings indicate that some degree of neuronal re-approach towards the implantation site
seems to be possible, most probably as a result from glial scar contraction.
While apyrase was able to increase the neuronal density in the vicinity of the implant
back to baseline levels after six weeks, performance in the skilled reaching task was only
slightly increased compared to controls, without re-establishing baseline levels within this
time. Especially in the first week after cannula implantation, performance was almost as
reduced as that of the vehicle-treated animals. Since apyrase does not interfere with the
excitotoxic cascade of glutamate-induced progressive cell death, but instead aims at
interfering with the subsequent cascade of microglial-induced cell death, this may account
for a larger acute cell loss that may be more harming than the subsequent events. Inhibition
of the self-perpetuating cycle of microglial-induced cell death proved also to be beneficial in
promoting neuronal survival, however to a later time point and accordingly less effectively.
Moreover, due to the performance decrease, it is debatable in which condition surviving
neurons are, and it can be assumed that at least neuronal networks are majorly affected and
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need to be rebuilt as derived from the initial decrease in neuronal population around the
implant.
In contrast to the reduction in the number of microglial cells, the astrocytic scar
revealed no obvious reduction at either time point. Since astrocytes respond to changes in
tissue homeostasis with the release of Ca2+ from the endoplasmatic reticulum (Goodenough
and Paul, 2003;Fischer et al., 2009), which results in the release of regenerative ATP from
internal pools (Anderson et al., 2004), they seem to be independent in their communication
from the initially released ATP by injured cells. ATP-induced ATP release from astrocytes has
been suggested to be not only responsible for the far reaching communication via Ca2+-wave
propagation between astrocytes with ATP as an intercellular messenger (Guthrie et al.,
1999), but to be also required for the activation and migration of microglial cells to the site
of injury (Davalos et al., 2005). Hence, the astrocytic ATP release may be responsible for a
delayed activation of microglial cells in this work. Since Dibaj et al. (2010) suggested other
messenger molecules, such as NO, to be only effective chemoattractants for microglial cells
in the presence of ambient ATP, and initial amounts of ATP are most probably hydrolysed by
apyrase, this further supports the assumption that microglial cells depend in their activation
to a large extent on ATP released by astrocytes (Davalos et al., 2005). In addition to ATP
release, astrocytes moreover release glutamate in response to ATP binding, which
exacerbates the glutamate-mediated excitotoxicity (Lynch and Guttmann, 2002;Lipton,
2004) and may further account for existing performance deficits in this work.
Due to the rather transient nature of nucleotides with short half-life times of about
5-10 min for ATP and about 45-60 min for ADP, they are under normal conditions quickly
metabolised by ectonucleases from ATP to ADP and AMP that is subsequently transformed
to adenosine. The large amounts of ATP and ADP that are released after severe injuries,
however induce microglial cell activation that constitutes the first line in defence (Buvinic et
al., 2007). Since the plasma half-life time of apyrase has been suggested to be about 1 h
(Moeckel et al., 2014), this time span is most probably only sufficient to inhibit the first surge
of ATP and ADP released by the injured cells, however not to inhibit the massive amounts of
ATP that are subsequently released by the astrocytes. The metabolite adenosine has been
suggested to be beneficial after an injury by exhibiting anti-inflammatory, anti-thrombotic
and cardioprotective properties, which makes apyrase also a target candidate to treat
arterial thrombosis (Moeckel et al., 2014). An optimised version of apyrase has recently been
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engineered by Moeckel et al. (2015) with a 50 times longer plasma half-life time compared
to native apyrase. This optimised form completely prevents thrombotic re-occlusion and
significantly decreases infarction sizes after thrombotic occlusion of a coronary artery and
induced fibrinolysis in a canine model and also decreases infarct size in a murine model of
myocardial reperfusion injury when injected intravenously (Moeckel et al., 2014). It would
be interesting, how the tissue and behavioural response would turn out when ATP gets
effectively hydrolysed for a much longer period of time, as suggested for this optimised
version of apyrase.
6.2.3 Minocycline
In order to combine both strategies to reduce neuronal cell death as well as microglial
activation in the acute phase after foreign body implantation the antibiotic minocycline with
anti-apoptotic and anti-inflammatory properties was locally applied during the implantation
procedure in the third approach. Since the cascades of enduring cell death induced by the
initial trauma are accompanied by persistent microglial cell activation that further
contributes to the self-perpetuating cycle of cell death, minocycline seems to be an ideal
candidate to antagonise both these concerns.
Secondary cell death of neurons, induced by the initial release of cellular contents
from injured and dying cells such as glutamate and ATP, causes neuronal “die-back” zones
around implants, that are further exacerbated by subsequent persistent microglial activation
(Biran et al., 2005;Potter et al., 2012). The release of pro-inflammatory and neurotoxic
substances by injured neurons and glial cells causes secondary damage to originally
uninjured cells and the release of further cellular contents (Polikov et al., 2005). The
broad-spectrum antibiotic minocycline was intended to interrupt the neurotoxic as well as
the inflammatory cascade at a very early stage. Minocycline not only enhanced the number
of neurons in the vicinity of the implant at both time points in this work, but also decreased
the number of microglial cells, which was moreover accompanied by a decrease in astrocyte
density around the implant at two weeks. This inhibition of the foreign body response was
accompanied by an increase in performance that was only significantly reduced in the first
post-surgery week in the skilled reaching box and had recovered by post-surgery week three,
with rats having regained their baseline performance level. Although acting through a broad
range of mechanisms, minocycline’s neuroprotective effects result to a large extent from the
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inhibition of the p38 MAPK pathway in neurons and microglia, that is an important regulator
of immune cell function and cell death (Stirling et al., 2005). The activation of p38 MAPK
pathways in neurons due to NMDA receptor activation by glutamate is involved in apoptosis
and is directly inhibited by minocycline. The PI3-K/Akt (phosphatidylinositol 3-kinase/protein
kinase B) pathway that inhibits apoptosis and promotes cell survival is however maintained
by minocycline (Pi et al., 2004). Additionally, minocycline also inhibits p38 MAPK in microglial
cells, in which the p38 MAPK pathway induces the activation and proliferation of these cells
and the release of NO and IL-1β (Tikka and Koistinaho, 2001).
Minocycline’s neuroprotective and neurorestorative effects have also been
demonstrated in ischemic stroke accompanied by a prevention of microglia activation
(Yrjanheikki et al., 1998;Yrjanheikki et al., 1999;Hewlett and Corbett, 2006). Moreover, a
reduction of neurotoxic and pro-inflammatory molecules including NO, TNFα and IL-1β, as
well as an increase of anti-inflammatory molecules such as TGF-β or IL-10 was revealed
(Yang et al., 2015b). Both effects are beneficial for neuronal survival after foreign body
implantation and are further supported by this work. Furthermore, minocycline has been
demonstrated to effectively decrease neurotoxicity of glutamate by inhibiting the NMDA-
induced activation of p38 MAPK in microglial cells, thereby inhibiting microglial activation
and providing neuroprotection (Tikka and Koistinaho, 2001;Tikka et al., 2001). Due to
minocycline’s further attribute to ameliorate BBB integrity and edema following
haemorrhage (Wasserman and Schlichter, 2007;Yang et al., 2015a;Yang et al., 2015b),
surrounding neurons are protected from oxygen and glucose deprivation and ionic
imbalances that is accompanied by a loss in energy supply. A study by Rennaker et al. (2007),
in which minocycline is administered via the drinking water, also demonstrated reduced
astrogliosis and improvements in quality and longevity of neural recordings from the
interfaces. The local application of minocycline in the present study further supports their
approach and demonstrates that local minocycline administration mimicking electrode
coating is also effective in enhancing neuronal vicinity to the implant and in reducing glial
scar formation.
Compared to first-generation tetracyclines, minocycline has a longer half-life time
that is approximately 17 h in humans, but only about 3 h in rats. It is highly lipophilic and can
easily pass the BBB when administered orally. Being rapidly and completely absorbed, CSF
concentrations of 11-56% of plasma concentrations are achieved (Elewa et al., 2006).
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Although minocycline is well-tolerated in humans with a good safety record when used
chronically, most common side-effects when administered systemically include nausea,
vertigo and mild dizziness (Garrido-Mesa et al., 2013). Besides being neuroprotective in
stroke minocycline has also been suggested to be an effective therapeutic in traumatic brain
injury (Sanchez Mejia et al., 2001), spinal cord injury (Wells et al., 2003), amyotrophic lateral
sclerosis (Zhu et al., 2002), Huntington’s disease (Bonelli et al., 2004), Parkinson’s disease
(Du et al., 2001) as well as Alzheimer’s disease (Ryu et al., 2004). In the context of this work,
minocycline’s neuroprotective and anti-inflammatory potential is further supported,
suggesting it as an effective local therapeutic in the suppression of the foreign body
response.
6.3 Conclusion and further direction
Taken together, trying to reduce the foreign body response by interfering with the very early
events after device implantation seems to be a good approach to inhibit the induced
cascades of enduring cell death and persistent microglial activation. The uncompetitive
NMDA receptor antagonist memantine, with a preference for extrasynaptically located
NR2BRs, seems to be most effective in reducing the glutamate-induced excitotoxic cascade
induced by the initial trauma, by increasing the number of neurons in the vicinity of the
implant as well as the behavioural performance. The ATP/ADP-hydrolysing enzyme apyrase,
that aimed to reduce the self-perpetuating cycle of microglial-induced cell death, was least
effective in terms of maintaining the behavioural performance. Despite a rather temporary
decrease of microglial cells in the vicinity of the implant, neuronal populations had quickly
recovered, which however did not automatically result in an equivalent recovery of
behavioural performance. The broad-spectrum antibiotic minocycline, with anti-
inflammatory and anti-apoptotic properties, had the broadest spectrum of effects, ranging
from a permanent increase in neurons and behavioural performance to a permanent
decrease in microglial cells accompanied by a temporary decrease in astrocyte density.
Nevertheless, compared to memantine, neuron levels after minocycline treatment were
lower and performance in the skilled reaching box exhibited an obvious initial performance
drop.
This suggests that interfering with the very initial events after device implantation
targeting the cascades of secondary cell death due to glutamate excitotoxicity seems to be
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an efficient approach to maintain neuronal networks in the vicinity of an implant. Although
reducing the microglial response and thereby the degree of pro-inflammatory and
neurotoxic molecules increases the neuronal survival in the vicinity of an implant, targeting
these delayed cascades does not maintain neuronal networks to the same extent. Moreover,
regarding the long-term results, glial scar formation is apparently rather less influenced by
the acute administration of substances during cannula implantation, but instead seems to be
primarily a consequence of the chronic setting.
Fig. 6.4. Vision of a fully-implantable wireless brain-computer interface. Deriving signals from
thousand of neurons by means of a fully-implantable electrode array, could restore limb mobility in
paralysed subjects or amputees via wireless telemetry, being equipped with touch and position
sensors and the functionality of a human limb in terms of accuracy and power (Lebedev and Nicolelis,
2006).
The local substance application during cannula implantation in this work, that aimed
to mimic the local drug delivery from coated electrodes, served as a proof-of-principle
investigation mimicking the implantation of a device such as an electrode array into the
cortex. The next stage to further consolidate the findings of this work would be coating of
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electrodes with the substances regarded as most efficient, that is memantine, closely
followed in efficiency by minocycline. Coating of electrodes with bioactive molecules in
order to manipulate the biological response is a promising direction in research, since
previous approaches that dealt with different electrode designs, material science strategies
or implantation techniques failed to provide a satisfactory control of the foreign body
response (Polikov et al., 2005). Limiting or eliminating the foreign body response and reliably
enhancing the vicinity of viable neurons to a chronic implant that remain electrically active,
is an obstacle that needs to be overcome to introduce CNS implants into clinical application.
Cortical neuronal ensemble signals, derived from local populations of M1 neurons, might be
used by paralysed patients to reanimate paralysed muscles using functional electrical
stimulation of the neuro-motor system or by people with limb loss to control prosthetic
limbs (Chadwick et al., 2011;Hochberg et al., 2012). The vision of fully-implantable wireless
electrode arrays (Fig. 6.4), deriving signals from thousands of neurons to a BCI via wireless
telemetry, enabling the restoration of limb mobility in paralysed subjects or amputees by
being equipped with touch and position sensors and the functionality of a human limb in
terms of accuracy and power (Lebedev and Nicolelis, 2006), remains an incentive to keep on
improving current electrode designs in terms of biocompatibility.
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